Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AARSD1 MGC2744 ENSG00000266967 "Alanyl-tRNA synthetase domain containing 1" Q9BTE6 17 42950526-42964498 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.2;Spermatocytes: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Supported Approved "Nuclear membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (2.85e-3)" "unprognostic (9.78e-2)" "unprognostic (1.67e-1)" "unprognostic (8.53e-2)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (7.41e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.67e-6)" "unprognostic (2.20e-1)" "unprognostic (2.51e-1)" "unprognostic (3.73e-2)" "unprognostic (4.69e-3)" 18.2 19.6 18.1 13.7 20.2 16.5 20.3 17.9 21.4 19.9 17.2 20.4 12.8 20.7 21.1 18.6 20.3 13.5 34.4 19.5 19.8 20.5 24.4 13.7 17.4 19.3 18.1 26.0 25.5 24.7 20.5 14.6 19.7 18.1 17.4 13.5 20.5 18.4 68.9 15.6 13.7 23.2 17.7 14.2 20.5 72.3 18.8 19.3 21.4 60.5 20.7 19.6 17.6 20.3 38.7 52.4 39.6 39.8 47.0 44.8 30.5 41.2 34.5 46.9 31.1 45.8 32.0 104.3 2.0 43.2 28.7 32.1 55.2 62.2 53.7 35.1 43.7 41.4 57.6 25.3 61.6 81.6 22.2 40.8 33.1 32.6 81.5 32.2 38.3 46.4 76.3 21.3 45.0 22.0 81.8 58.3 27.6 53.5 26.3 53.3 80.8 107.0 46.7 35.8 51.1 32.0 20.0 20.5 54.0 43.0 54.8 68.4 37.3 48.4 43.4 24.9 58.6 33.6 46.3 64.7 31.7 50.1 52.7 4.1 19.0 1.5 20.5 27.3 27.1 27.2 21.4 24.4 29.9 31.2 26.9 26.3 0.6 25.4 24.5 33.3 22.6 17.8 18.1 20.2 17.9 21.4 19.5 19.8 19.3 18.1 19.7 17.7 18.8 20.3 6.3 12.8 8.2 0.0 22.6 8.3 11.7 10.6 26.2 22.1 8.4 8.0 0.7 4.3 13.2 14.7 33.3 8.7 6.9 11.9 3.9 7.2 68.2 7.5 7.0 7.1 12.0 14.7 0.0 6.1 8.7 12.4 12.8 5.3 5.1 11.1 7.5 4.2 5.0 15.2 0.0 6.7 22.4 4.1 6.4 26.9 13.1 6.8 3.6 0.0 6.1 5.5 17.5 0.0 0.0 4.3 4.5 10.9 21.7 9.6 4.5 4.9 9.6 16.2 0.0 7.2 15.0 44.5 21.4 17.4 4.5 2.7 17.7 13.7 10.0 6.7 AC010422.5 ENSG00000269590 "Novel protein" 19 12664828-12669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.2;lymphoid tissue: 1.4;skeletal muscle: 1.3" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 2.5" "Lineage enhanced" "Detected in single" "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "MCF7: 10.8;RT4: 5.5" HPA065685 Uncertain Approved "Nuclear membrane,Endoplasmic reticulum" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Nuclear membrane, Endoplasmic reticulum" "HPA065685: AB_2685531" 0.1 0.8 0.0 0.4 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.4 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.7 1.4 0.1 0.1 0.5 0.0 0.3 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.1 1.3 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 2.4 0.0 0.3 0.7 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.6 0.0 0.3 0.7 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.3 0.9 0.1 0.0 0.0 0.1 0.3 2.7 0.0 10.8 2.8 0.3 0.7 0.0 0.0 1.0 0.0 0.0 0.9 5.5 1.6 1.3 0.0 1.3 0.3 0.0 1.7 0.5 0.0 3.7 0.1 1.4 1.7 1.7 2.5 1.3 3.4 0.6 1.5 0.9 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADPRH ARH1 ENSG00000144843 "ADP-ribosylarginine hydrolase" P54922 3 119579268-119589945 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.9;HEL: 17.1;HMC-1: 18.5;Karpas-707: 25.3;U-266/70: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001701, HPA036961" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 4: Macrophages - Innate immune response" "Nuclear membrane" Nucleoplasm "CAB001701: , HPA036961: AB_2675405" "prognostic favorable (2.42e-4)" "unprognostic (2.29e-1)" "unprognostic (4.77e-1)" "unprognostic (2.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.06e-2)" "unprognostic (2.63e-1)" "unprognostic (4.24e-2)" "unprognostic (3.31e-3)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (6.04e-2)" "unprognostic (2.60e-3)" "unprognostic (8.87e-2)" "unprognostic (2.03e-1)" "unprognostic (4.35e-2)" 10.6 6.2 3.0 7.3 3.3 3.4 7.9 3.3 4.2 6.9 9.2 5.5 2.3 6.0 4.9 4.0 4.2 6.9 8.5 2.9 3.5 4.9 3.1 13.5 11.0 4.6 3.4 1.9 6.7 8.0 2.0 11.3 4.4 6.1 4.1 6.6 5.1 9.3 11.8 2.6 5.4 9.2 4.2 11.9 3.9 2.4 4.6 5.9 5.8 9.9 13.0 6.5 3.4 4.9 2.4 3.0 0.7 0.0 2.4 2.7 0.0 2.1 0.4 1.8 2.3 0.9 2.0 0.6 0.9 3.2 0.1 0.2 2.0 0.0 1.7 23.9 0.2 17.1 0.4 0.0 3.9 0.1 18.5 4.0 0.1 0.9 0.1 0.8 7.3 0.0 1.6 25.3 11.0 0.7 0.0 4.1 6.9 0.2 5.8 0.0 8.2 1.1 1.0 0.9 0.5 0.1 0.0 0.1 6.4 1.0 4.4 10.6 6.0 0.0 1.1 4.6 0.4 24.5 5.8 0.1 3.0 0.0 4.6 13.9 18.7 19.1 0.8 17.2 0.8 11.0 1.9 1.7 11.2 6.8 0.2 0.7 0.6 5.3 13.9 9.8 14.3 7.5 3.0 3.3 3.3 4.2 2.9 3.5 4.6 3.4 4.4 4.2 4.6 4.9 12.6 9.6 8.6 0.3 5.0 0.8 0.7 0.4 0.0 0.5 1.5 1.9 4.7 2.8 2.7 3.7 4.2 5.8 5.0 0.3 1.9 3.6 0.7 0.2 0.9 9.9 0.0 2.7 0.1 3.2 3.8 2.1 2.6 0.5 10.8 2.5 7.1 1.6 9.4 0.0 0.2 0.2 2.0 12.2 11.1 0.5 0.3 14.8 1.8 4.7 10.2 0.8 4.1 0.0 0.6 2.1 0.5 3.0 3.9 0.7 0.0 1.3 2.1 4.3 0.0 3.6 3.9 0.4 0.6 0.1 0.9 11.8 1.2 0.7 0.2 0.2 AK9 "AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954" ENSG00000155085 "Adenylate kinase 9" Q5TCS8 6 109492856-109691217 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.6" "HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear membrane" "HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265" "unprognostic (9.68e-3)" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (2.36e-2)" "unprognostic (3.42e-1)" "unprognostic (7.28e-2)" "unprognostic (1.41e-3)" "unprognostic (6.76e-3)" "unprognostic (1.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-4)" "unprognostic (2.58e-1)" "unprognostic (2.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (8.39e-2)" "unprognostic (5.56e-2)" 3.5 3.1 8.1 3.3 9.9 3.7 4.8 13.5 17.2 3.5 10.9 4.6 3.6 4.3 7.6 4.3 7.9 3.5 4.9 6.4 11.0 5.3 3.1 4.1 4.2 8.8 10.7 3.6 3.4 9.2 7.7 3.1 9.5 3.9 4.5 14.1 5.1 3.9 4.8 3.9 3.6 3.9 10.7 4.0 4.5 16.6 8.7 7.6 6.9 3.5 3.6 3.4 3.2 13.4 2.3 1.6 6.6 11.5 6.1 3.7 4.8 3.5 4.3 3.6 4.9 2.6 4.6 4.9 1.7 3.4 7.9 3.7 1.9 3.9 7.6 10.2 4.0 3.8 3.8 2.6 4.8 4.4 2.3 3.1 7.3 6.6 8.6 8.8 4.2 7.2 3.6 4.0 2.7 4.7 4.1 3.2 1.5 5.1 2.5 5.5 3.7 4.7 5.0 4.3 7.8 6.4 4.2 3.9 5.9 3.7 5.1 5.8 5.2 3.1 2.2 5.1 2.3 2.0 1.8 2.8 6.8 5.9 2.0 17.1 2.8 7.1 5.1 1.5 4.4 13.1 4.9 6.2 2.1 10.8 6.2 5.4 5.6 5.6 4.8 3.1 3.9 1.6 8.1 9.9 13.5 17.2 6.4 11.0 8.8 10.7 9.5 10.7 8.7 13.4 13.3 28.9 17.2 21.2 13.6 2.7 7.7 14.7 3.4 18.3 10.4 6.7 18.9 5.7 19.9 9.2 14.6 3.4 8.6 13.1 0.0 9.1 70.9 76.3 5.4 10.0 19.8 4.2 34.8 4.5 1.5 6.0 12.2 7.3 22.1 10.6 8.9 2.1 3.6 20.2 37.0 15.5 14.2 5.3 3.9 41.7 7.5 5.6 5.4 25.3 5.0 12.6 18.6 22.6 46.9 7.4 8.9 6.4 5.5 5.6 22.9 6.8 152.0 50.7 26.3 9.1 6.9 174.3 34.1 4.0 2.6 5.6 10.3 4.7 11.4 7.9 AKIRIN1 "C1orf108, FLJ12666" ENSG00000174574 "Akirin 1" Q9H9L7 1 38991276-39006059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 1546.1;Late spermatids: 1455.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051871 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear membrane" "HPA051871: AB_2681646" "unprognostic (1.16e-1)" "unprognostic (2.13e-2)" "unprognostic (1.05e-1)" "unprognostic (5.35e-3)" "unprognostic (1.40e-1)" "unprognostic (1.39e-3)" "prognostic unfavorable (5.39e-7)" "unprognostic (3.53e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-2)" "unprognostic (9.49e-3)" "unprognostic (1.47e-2)" "unprognostic (3.89e-2)" "unprognostic (1.22e-1)" "unprognostic (7.13e-2)" "unprognostic (3.77e-3)" "unprognostic (5.17e-2)" 46.0 29.9 37.5 33.5 41.3 77.2 23.1 41.8 43.8 21.9 41.3 35.1 24.2 28.7 42.3 29.2 25.0 41.8 38.5 38.6 47.4 42.9 53.2 30.0 42.3 45.9 45.1 19.6 27.7 43.2 40.0 26.5 47.2 36.3 36.2 37.5 24.4 35.8 30.1 17.3 26.8 41.9 42.4 31.7 33.3 83.2 49.8 41.5 36.1 30.4 42.1 41.2 18.6 48.1 61.4 28.0 117.3 96.9 56.3 66.2 83.8 70.0 73.1 69.2 70.1 73.2 49.5 48.3 63.3 67.1 49.6 41.8 114.7 62.8 110.8 72.2 58.3 142.7 41.6 92.5 74.2 137.5 75.3 68.5 80.5 90.4 73.6 61.6 64.9 61.8 99.0 46.6 87.8 25.2 58.5 60.2 248.2 45.9 47.1 92.4 85.4 48.2 77.7 73.9 81.3 55.2 77.8 41.4 160.1 182.8 37.9 70.6 58.3 42.3 68.4 46.2 72.1 67.1 92.5 102.6 72.7 80.4 73.3 35.7 39.3 83.7 33.4 33.9 50.6 33.7 54.4 51.7 55.4 30.2 63.3 42.0 102.8 72.0 38.8 41.7 54.7 53.1 37.5 41.3 41.8 43.8 38.6 47.4 45.9 45.1 47.2 42.4 49.8 48.1 48.5 64.1 43.9 25.1 83.8 137.9 77.1 34.0 56.9 48.1 69.0 48.6 45.1 31.5 40.1 38.6 47.9 72.9 111.6 48.6 93.9 45.6 1546.1 108.2 56.7 43.5 94.8 57.9 32.9 40.5 76.9 49.9 37.2 93.9 47.6 55.1 35.0 37.3 45.5 55.5 26.6 49.6 36.7 39.9 109.9 1455.5 44.1 65.2 42.7 16.9 85.1 52.1 42.2 23.6 73.2 50.5 37.2 45.5 53.2 67.8 23.9 41.8 38.9 45.0 52.6 61.3 77.5 77.3 103.9 43.4 138.5 167.5 99.9 34.0 41.8 81.4 ANKRD17 "FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16" ENSG00000132466 "Ankyrin repeat domain 17" O75179 4 73073376-73258798 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045024, HPA063731" Approved Supported "Nucleoplasm,Nuclear membrane" No No "Cluster 15: NK-cells - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear membrane" "HPA045024: AB_10964778, HPA063731: AB_2685106" "unprognostic (3.86e-3)" "unprognostic (3.59e-2)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-3)" "unprognostic (3.29e-2)" "unprognostic (3.10e-2)" "unprognostic (1.78e-1)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (3.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.13e-1)" "unprognostic (4.00e-2)" "unprognostic (4.07e-1)" 13.7 13.5 15.6 13.6 16.7 9.2 20.0 23.1 20.4 16.8 16.8 15.8 14.8 14.7 18.5 14.5 18.2 12.4 14.5 16.2 21.1 19.6 20.6 14.2 15.1 15.7 15.9 17.8 18.0 24.5 14.4 19.0 16.0 15.1 19.0 36.0 16.7 13.7 23.2 17.2 15.2 16.4 12.3 15.1 15.7 11.1 18.5 27.2 17.9 26.1 17.7 17.7 12.8 20.1 25.6 27.7 43.1 34.2 47.4 41.5 23.5 36.9 43.1 32.5 31.1 33.9 32.8 69.2 29.9 38.0 17.1 20.9 54.4 32.6 44.6 27.1 23.1 47.1 29.5 49.4 25.4 62.2 27.9 35.2 34.8 46.6 36.9 33.6 43.8 27.9 67.2 24.8 39.4 23.7 51.3 22.1 28.0 33.0 27.6 40.5 47.3 28.8 34.5 38.1 41.6 28.2 35.7 39.7 18.9 33.5 21.3 24.3 53.2 34.0 32.6 30.8 29.3 20.5 11.1 51.5 27.6 26.8 35.6 1.6 1.7 1.8 3.0 1.1 1.5 1.8 1.8 2.0 1.4 2.6 1.7 2.0 1.9 5.6 1.3 4.4 1.2 1.1 15.6 16.7 23.1 20.4 16.2 21.1 15.7 15.9 16.0 12.3 18.5 20.1 42.9 48.1 52.9 194.9 30.9 76.1 36.9 33.9 67.2 57.2 38.6 31.2 82.2 35.8 45.5 40.5 123.0 31.8 40.0 52.8 7.9 30.9 12.7 46.0 57.9 52.2 45.1 36.1 337.8 28.9 24.6 44.8 51.5 60.8 31.6 53.4 43.9 49.7 27.3 69.0 315.8 45.6 26.4 31.2 34.7 5.5 35.1 35.0 28.4 181.8 34.8 30.5 50.4 275.0 296.5 30.2 25.7 37.6 44.2 52.8 39.4 25.4 30.5 84.1 19.7 58.5 48.5 28.1 30.8 64.9 81.3 33.8 32.4 47.6 48.3 48.4 ARL6IP6 MGC33864 ENSG00000177917 "ADP ribosylation factor like GTPase 6 interacting protein 6" Q8N6S5 2 152717893-152762396 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 155.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 214.0;eosinophil: 161.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 214.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014743 Approved Approved "Nuclear membrane,Cytosol" NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear membrane" Cytosol "HPA014743: AB_1845030" "unprognostic (4.41e-1)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "unprognostic (9.86e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (5.43e-2)" "unprognostic (2.07e-2)" "unprognostic (2.00e-3)" "unprognostic (4.95e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.14e-1)" "unprognostic (2.67e-1)" "unprognostic (4.57e-1)" "unprognostic (7.39e-2)" 5.1 3.9 3.0 1.8 4.0 8.3 4.7 3.2 3.0 4.4 2.2 3.7 2.4 4.2 1.2 6.0 3.8 1.2 2.7 2.6 3.1 2.5 1.9 4.0 3.4 3.9 3.3 5.0 2.7 1.1 3.1 4.4 4.3 3.1 1.9 3.2 3.9 1.8 3.5 7.1 3.5 1.6 3.6 4.4 3.1 5.3 3.3 3.9 3.2 2.0 2.4 4.2 5.5 5.3 9.6 6.2 13.7 3.9 4.1 4.6 19.7 11.6 4.9 9.6 12.2 14.2 13.3 17.2 10.6 5.2 4.3 10.7 8.1 5.7 10.4 26.1 15.1 14.2 5.3 13.0 4.5 12.1 12.4 3.3 6.5 10.6 8.9 3.4 7.5 11.9 14.9 10.6 7.8 7.1 12.1 12.6 13.3 3.2 12.7 13.0 13.4 13.9 4.5 7.2 11.6 12.0 10.4 1.1 9.7 4.7 4.7 7.9 10.0 14.4 9.9 10.2 10.3 9.9 10.3 13.1 6.8 10.4 12.3 214.0 9.1 161.8 13.2 10.2 13.2 20.3 13.3 13.5 10.9 18.4 13.6 11.4 24.8 9.7 12.8 24.8 19.7 13.2 3.0 4.0 3.2 3.0 2.6 3.1 3.9 3.3 4.3 3.6 3.3 5.3 34.3 16.0 10.0 30.7 41.9 106.6 48.5 74.0 50.7 6.3 20.3 14.9 4.3 17.2 29.9 11.0 4.2 155.7 42.4 14.1 17.6 24.9 14.1 17.7 20.0 31.3 13.8 81.0 21.0 18.6 136.2 27.9 30.1 25.0 27.3 19.4 28.5 5.9 39.8 8.4 23.8 22.2 38.7 24.2 57.2 24.2 19.6 33.6 46.2 30.9 46.2 19.8 32.0 38.7 56.8 22.5 18.6 17.0 33.8 40.3 16.3 8.8 29.2 15.8 32.9 22.2 24.9 24.4 30.0 43.4 106.6 108.4 45.2 27.9 24.5 51.3 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466186 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 777.4;Distal tubular cells: 1430.2;Exocrine glandular cells: 578.8;Extravillous trophoblasts: 636.3;Hofbauer cells: 787.4;Pancreatic endocrine cells: 589.5;Proximal tubular cells: 1616.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 60000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 328.8 423.5 636.9 268.7 655.2 404.4 310.8 658.3 868.4 247.8 671.0 470.9 442.7 188.3 299.1 526.6 191.7 143.8 1184.8 658.1 663.7 559.3 561.2 241.8 293.1 657.5 648.0 179.1 271.6 509.6 332.1 235.7 647.0 315.5 367.9 320.7 317.8 205.9 1337.1 287.0 384.6 192.0 637.6 281.8 354.7 310.5 652.7 439.3 241.4 1439.0 301.2 303.1 303.5 641.3 1251.5 1130.6 905.3 1400.5 752.1 739.2 561.1 799.3 705.9 947.2 994.6 1226.2 1091.7 1161.7 822.7 548.5 1513.9 735.7 1064.0 981.3 1021.4 831.0 1333.6 800.1 1584.6 1555.4 530.7 1324.4 824.4 835.6 944.9 766.6 858.9 760.5 919.8 1009.4 1681.6 1213.0 1057.4 3128.1 1984.5 2396.1 1228.2 2594.9 1410.9 874.9 741.6 1985.9 1936.7 1376.1 845.3 925.9 1073.7 2519.4 773.1 1365.1 644.9 1687.5 703.0 706.0 1142.1 1197.3 1181.5 685.7 1795.6 2432.4 829.7 1325.8 1131.8 1020.3 904.1 1069.1 440.2 912.7 425.6 597.7 508.3 494.8 1122.9 512.2 445.1 468.3 428.0 555.2 731.2 890.5 754.9 1505.3 636.9 655.2 658.3 868.4 658.1 663.7 657.5 648.0 647.0 637.6 652.7 641.3 147.7 22.4 44.9 0.0 57.9 0.0 0.0 0.0 0.0 0.0 252.4 289.6 0.0 0.0 36.5 386.2 0.0 777.4 125.6 0.0 1430.2 460.9 0.0 302.6 225.3 82.0 0.0 0.0 0.0 578.8 636.3 110.5 0.0 278.3 64.3 188.1 0.0 0.0 787.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.2 0.0 0.0 339.1 0.0 0.0 0.0 0.0 589.5 0.0 0.0 18.6 0.0 0.0 1616.3 51.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 436.3 64.0 206.4 0.0 0.0 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935900-70965431 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 127.4;salivary gland: 139.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 2.2 0.5 0.5 0.2 0.3 0.0 11.8 0.7 0.9 31.1 0.0 0.6 0.5 1.4 1.2 1.6 12.8 0.2 1.1 0.2 0.0 127.4 0.2 1.7 0.5 0.1 0.0 1.2 3.3 0.8 4.2 17.9 0.1 2.0 0.1 3.9 139.8 1.4 0.5 32.5 0.6 0.8 0.0 0.0 0.3 0.3 0.0 0.1 0.3 0.2 0.0 0.6 0.8 0.3 0.4 0.3 0.6 1.3 2.6 3.1 21.6 0.4 0.2 0.0 0.0 0.1 2.0 0.1 0.2 1.2 0.0 20.3 0.7 0.0 0.0 0.5 0.6 0.0 0.3 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.3 3.1 0.0 0.1 0.0 0.0 0.2 1.2 0.1 0.3 0.0 0.0 0.0 0.1 0.8 0.2 0.4 0.2 0.5 1.5 0.7 49.2 0.1 2.7 0.6 0.0 0.4 0.6 0.2 0.9 0.5 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.7 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.7 3.2 0.0 0.3 0.0 0.1 1.3 1.7 0.0 0.9 5.6 3.7 0.4 0.0 13.9 0.0 8.4 197.3 0.1 0.6 49.0 0.1 1.5 0.0 0.1 1.1 0.0 0.0 1.0 0.6 38.3 3.8 0.0 0.1 0.0 0.0 0.0 0.1 11.7 1.7 0.4 0.0 321.4 0.0 0.3 0.1 0.0 0.1 30.2 0.0 0.0 0.5 1.0 1.0 0.1 0.4 0.0 1.2 0.0 0.6 0.3 0.2 2.6 3.8 0.0 1.1 1.0 0.4 1.2 0.0 0.4 64.9 0.1 0.1 0.1 0.6 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2 apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 271.6;Inhibitory neurons: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 18 "B-cells: 5.4;T-cells: 8.5" "Cell line enhanced" "Detected in many" "HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: AB_2682776" "unprognostic (1.11e-3)" "prognostic favorable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favorable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (2.63e-1)" 12.8 1.9 5.5 10.2 7.8 5.0 9.6 4.7 3.4 10.7 0.0 6.2 4.4 11.6 2.9 5.9 11.8 6.5 5.3 2.9 6.6 6.7 2.1 3.7 14.7 11.2 7.9 14.5 3.1 13.0 4.7 4.6 7.5 6.4 5.5 2.1 3.7 7.0 16.5 4.8 8.1 6.6 7.9 17.9 3.8 1.5 8.2 18.3 24.0 8.8 14.6 5.4 7.7 5.7 1.7 0.3 6.8 5.9 6.7 1.3 2.4 1.0 0.7 2.4 2.0 3.5 0.4 0.3 1.1 0.9 4.7 0.4 6.7 0.9 1.5 44.2 1.6 0.5 2.0 0.7 2.0 43.7 5.6 1.7 0.8 3.3 5.8 1.1 0.7 4.3 0.8 72.9 2.2 1.4 9.8 10.7 1.5 0.8 1.3 39.5 1.9 26.5 7.4 8.5 7.2 6.4 0.3 0.3 8.5 1.4 0.3 29.9 0.3 9.9 3.3 0.9 5.1 217.4 40.1 2.9 1.9 24.9 6.0 0.3 0.0 0.0 1.9 0.0 7.6 5.4 6.3 3.4 0.1 3.1 3.3 3.2 0.0 0.2 0.3 0.2 8.5 1.3 5.5 7.8 4.7 3.4 2.9 6.6 11.2 7.9 7.5 7.9 8.2 5.7 7.1 0.0 1.1 271.6 84.9 19.5 33.6 1.6 13.6 1.9 39.7 19.7 17.4 18.6 2.4 7.3 0.0 14.0 39.9 2.7 15.6 3.7 0.4 9.8 9.8 5.9 5.4 3.8 60.7 0.0 0.7 15.8 5.6 24.9 15.8 38.8 3.9 1.2 9.4 0.0 102.3 10.5 24.4 15.0 29.6 1.9 8.7 29.0 46.2 88.1 19.7 18.8 18.6 76.4 56.7 0.2 5.9 13.9 50.1 41.6 0.9 18.0 0.1 0.6 26.3 48.8 19.7 0.3 1.3 6.2 17.6 49.1 76.1 24.1 9.8 76.2 BRAP "BRAP2, IMP, RNF52" ENSG00000089234 "BRCA1 associated protein" Q7Z569 12 111642146-111685956 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.2" "Group enriched" "Detected in all" 7 "Early spermatids: 319.6;Late spermatids: 380.1;Spermatocytes: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040357, HPA058820" Approved Supported "Nuclear membrane,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Nuclear membrane" "HPA040357: AB_10967924, HPA058820: AB_2683827" "unprognostic (7.02e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.65e-6)" "unprognostic (2.14e-1)" "unprognostic (9.24e-3)" "unprognostic (2.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (3.66e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-2)" "unprognostic (8.08e-2)" 9.6 8.8 7.8 7.9 9.2 33.6 9.2 9.8 9.8 8.0 7.3 9.6 9.2 8.8 6.9 9.5 8.5 7.5 9.7 8.1 8.8 8.5 10.0 8.0 10.5 8.8 9.2 9.8 8.2 10.5 6.2 10.6 8.8 8.3 9.2 9.1 8.4 8.3 19.8 12.8 8.8 9.4 8.5 9.0 7.7 67.2 8.4 12.8 9.9 14.0 10.8 9.2 8.1 10.6 14.6 21.1 16.9 19.5 17.7 14.8 28.2 20.0 16.7 22.8 17.5 28.6 10.0 28.0 11.7 19.1 12.9 17.6 23.8 16.4 24.2 18.0 15.4 34.8 12.9 19.4 22.2 30.7 22.5 16.9 22.8 19.7 31.8 19.6 20.0 19.0 36.7 8.9 19.0 18.6 25.7 29.6 22.8 15.4 22.1 23.6 18.4 25.1 15.0 30.3 20.9 15.5 23.5 19.8 19.5 19.3 21.7 19.3 18.8 14.6 13.5 13.3 14.4 22.6 30.9 30.4 13.8 16.8 16.3 22.7 16.8 32.3 17.5 17.5 17.3 16.1 18.5 17.9 15.1 16.5 17.1 17.6 32.7 23.1 14.6 10.9 24.7 16.1 7.8 9.2 9.8 9.8 8.1 8.8 8.8 9.2 8.8 8.5 8.4 10.6 11.6 22.4 11.2 14.7 14.9 11.2 8.9 9.7 12.0 8.9 8.8 7.5 12.7 17.2 10.8 11.0 29.2 13.7 13.7 15.4 5.9 13.5 319.6 11.9 11.6 11.4 9.6 22.9 24.7 7.7 14.9 12.3 15.3 12.4 8.2 13.3 10.4 9.1 10.9 3.3 23.3 12.9 14.2 9.8 11.5 380.1 13.4 11.7 3.6 10.3 19.7 8.6 17.5 13.0 23.3 14.5 12.7 13.5 15.0 13.4 13.5 14.6 13.8 11.8 6.6 11.6 15.1 147.8 38.6 15.4 12.6 22.4 13.5 10.2 11.0 14.5 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61679139-61863528 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0" "Group enriched" "Detected in many" 12 "Early spermatids: 186.2;Late spermatids: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 88.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Cluster 26: Non-specific - Mitochondria" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 0.3 0.3 0.8 1.7 0.6 7.2 0.9 1.3 0.9 0.4 0.0 1.7 2.0 0.8 0.4 1.5 0.3 0.6 0.1 0.5 0.2 0.3 1.6 0.4 2.8 0.3 0.0 1.1 0.3 0.1 0.0 0.8 0.4 0.4 1.9 0.5 0.4 0.2 0.1 2.0 1.9 0.9 0.0 0.7 0.9 7.0 0.2 5.9 0.3 0.1 3.3 0.7 0.6 0.8 26.6 9.4 25.0 14.1 0.9 2.1 5.5 23.6 13.3 24.6 31.8 9.5 8.0 14.9 5.2 4.9 7.7 9.2 12.8 4.5 33.3 3.8 15.8 15.5 14.4 10.5 0.2 20.3 8.8 0.6 0.4 20.2 5.1 3.4 5.0 14.8 11.6 10.5 14.4 88.9 32.5 6.7 5.3 5.9 7.3 19.7 50.1 7.1 3.0 12.8 10.0 24.2 9.4 3.0 3.3 9.1 8.3 7.3 4.5 36.9 26.5 13.5 26.6 6.3 13.3 16.6 7.3 9.3 8.8 1.0 0.1 0.4 0.1 0.0 0.1 0.5 0.3 0.1 0.1 0.6 0.4 0.2 0.3 0.1 0.1 0.1 1.0 0.1 0.8 0.6 1.3 0.9 0.5 0.2 0.3 0.0 0.4 0.0 0.2 0.8 0.2 0.0 0.5 1.0 1.6 2.3 1.3 0.8 0.6 0.3 1.1 1.8 0.6 0.0 4.0 0.0 0.0 2.0 2.0 1.8 0.0 0.3 186.2 0.7 1.7 0.8 0.0 7.4 4.6 0.2 3.0 2.0 2.0 1.6 0.0 15.5 0.4 3.4 1.7 0.0 3.3 1.8 0.0 0.8 1.1 194.1 1.2 1.0 3.6 2.8 0.6 0.2 1.0 1.5 1.0 0.8 0.1 1.2 4.8 0.4 1.4 0.2 0.8 0.2 0.0 2.5 1.8 12.1 6.0 2.9 0.4 0.3 2.3 2.1 4.7 0.7 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 250.8;breast: 200.0" "Cell type enriched" "Detected in many" 6 "Adipocytes: 900.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "OE19: 9.9;U-698: 37.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 250.8 13.3 18.3 3.0 13.1 1.0 200.0 14.9 24.2 12.7 11.2 11.7 1.9 11.0 5.4 5.9 20.0 9.3 104.5 20.6 13.1 22.4 7.9 102.3 7.1 21.9 14.6 5.3 11.9 5.9 4.8 10.5 21.8 8.3 3.6 1.2 6.9 2.6 46.6 11.8 10.8 4.0 12.7 57.3 12.8 4.4 32.2 9.8 29.6 20.7 13.8 10.5 10.4 12.7 0.0 0.2 0.1 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.4 0.1 0.2 1.4 0.0 0.0 0.2 0.7 0.1 0.0 0.2 3.7 1.5 0.4 0.2 0.0 0.7 4.2 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.9 0.3 0.0 0.1 0.1 0.2 0.1 9.9 2.3 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.1 5.5 0.1 0.0 0.3 0.1 37.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 18.3 13.1 14.9 24.2 20.6 13.1 21.9 14.6 21.8 12.7 32.2 12.7 900.4 0.0 3.8 1.3 9.8 2.3 0.6 0.1 0.6 0.6 2.4 3.6 40.6 0.0 0.8 0.0 0.0 0.1 3.9 1.0 3.9 0.0 0.7 1.1 0.5 127.0 4.2 0.4 8.4 0.2 0.1 10.2 0.5 3.4 1.3 7.0 144.9 0.6 0.1 0.0 1.2 3.5 0.0 8.3 1.1 1.4 2.1 1.7 3.6 54.4 0.1 0.3 0.0 1.0 0.6 0.1 1.2 0.4 1.2 0.4 0.0 0.1 2.4 0.3 13.1 8.4 37.5 4.0 9.8 5.5 2.3 0.1 2.2 88.9 1.5 0.5 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986316-105074197 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 462.1" "Lineage enriched" "Detected in all" 13 "dendritic cells: 462.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 11.9 8.5 11.8 10.5 12.0 12.2 10.5 15.8 21.0 12.0 6.9 9.7 10.1 8.3 5.9 10.3 7.4 4.3 9.5 10.8 9.1 9.0 14.6 7.2 11.1 7.0 6.7 8.9 24.7 2.4 7.8 4.4 8.4 9.7 7.5 4.5 14.7 4.2 7.5 10.5 7.8 6.4 4.4 11.4 15.1 6.4 10.9 9.2 11.0 2.1 11.0 9.5 10.3 13.3 23.3 32.4 15.3 39.2 12.7 13.0 70.9 20.6 5.2 12.2 6.8 32.8 11.4 44.2 20.1 9.3 30.5 15.2 12.9 31.1 13.5 12.6 22.9 29.5 14.9 45.4 18.4 44.4 22.1 19.1 12.9 18.5 19.7 20.4 20.0 36.4 24.7 11.1 12.0 38.5 29.2 75.3 29.9 34.6 46.2 39.0 18.6 99.9 16.9 29.9 19.5 14.2 20.0 41.9 32.7 27.8 34.8 17.8 9.9 30.2 20.1 26.3 31.6 23.2 28.5 47.5 14.1 30.7 29.2 8.3 34.0 0.6 13.6 30.7 17.1 34.6 18.1 17.3 106.0 25.4 18.6 17.9 3.3 27.8 17.2 462.1 32.9 21.0 11.8 12.0 15.8 21.0 10.8 9.1 7.0 6.7 8.4 4.4 10.9 13.3 15.7 6.4 33.4 1.3 30.4 39.0 44.2 52.8 23.3 11.5 23.4 31.8 37.9 20.0 39.9 33.1 25.0 34.7 66.9 15.8 27.4 27.2 20.8 33.8 25.0 18.0 12.5 12.4 3.8 55.3 63.7 23.0 15.8 40.7 20.3 17.5 11.0 48.2 37.7 3.3 4.2 20.5 30.5 24.2 69.6 10.6 15.2 37.8 39.2 1.0 42.0 18.9 9.2 2.5 4.0 39.0 14.5 10.1 65.8 39.2 12.8 43.7 25.9 11.9 0.0 22.3 24.9 15.9 31.3 19.2 32.7 22.0 23.4 18.1 28.4 39.3 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 3.0;testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 70.0;Late spermatids: 43.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.1 0.3 1.7 0.0 2.3 0.0 0.3 2.3 2.7 0.3 1.3 0.3 0.2 0.3 0.9 0.3 0.3 0.0 0.1 1.9 1.5 0.4 0.0 0.2 0.0 1.5 1.6 0.6 0.0 3.0 0.4 0.0 1.5 0.2 0.2 0.3 0.4 0.1 0.2 0.4 0.3 0.1 1.2 0.1 0.4 8.7 1.7 1.0 0.2 0.2 0.1 0.3 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.3 2.3 2.7 1.9 1.5 1.5 1.6 1.5 1.2 1.7 1.6 0.0 0.0 0.0 8.5 0.0 0.1 0.2 0.2 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 70.0 0.3 1.6 0.1 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 43.3 0.9 0.0 1.8 1.0 0.0 3.3 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 3.7 0.2 1.0 0.5 0.2 0.9 0.0 0.1 1.0 0.1 0.1 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639850 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 186.0;choroid plexus: 108.6" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 42.3;Oligodendrocytes: 50.8;Proximal tubular cells: 31.2" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 7 "dendritic cells: 1.5" "Cell line enriched" "Detected in many" 5 "WM-115: 557.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 8200000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 17: WM-115 - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.6 23.3 142.5 4.6 165.9 0.6 8.8 166.7 144.2 14.3 108.6 26.5 3.6 14.3 8.7 20.8 5.9 4.8 12.1 133.9 154.4 18.9 6.0 3.8 2.0 158.6 165.0 13.1 15.7 38.1 31.6 0.8 152.7 19.8 3.2 14.5 19.8 14.2 7.6 20.1 7.6 9.1 147.7 2.1 15.1 4.7 163.9 2.9 4.7 2.4 4.5 8.7 14.7 186.0 45.2 12.9 67.3 88.8 0.3 1.4 3.8 2.1 3.6 6.2 9.1 19.4 7.7 0.3 16.2 0.7 3.8 10.5 15.1 9.1 7.5 0.4 11.9 0.4 3.1 28.7 7.9 0.1 6.9 2.7 19.5 32.3 1.2 31.5 4.2 3.9 4.7 0.7 0.7 6.7 6.7 0.9 7.4 9.4 4.4 36.3 0.9 4.3 9.0 9.3 7.8 43.2 4.7 13.7 17.9 10.0 10.1 2.1 1.9 0.9 101.8 0.8 4.4 6.4 4.4 0.3 4.8 0.9 557.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 142.5 165.9 166.7 144.2 133.9 154.4 158.6 165.0 152.7 147.7 163.9 186.0 0.8 0.0 1.7 23.5 1.0 5.0 19.1 7.6 9.1 17.5 8.5 11.8 3.5 4.3 5.4 7.3 2.1 0.2 5.7 0.4 5.9 10.6 21.3 2.5 3.8 2.9 0.0 0.0 11.4 3.2 0.1 1.7 4.1 5.3 0.0 15.5 4.6 3.2 0.4 20.2 22.0 0.4 12.2 0.0 8.2 21.8 0.3 1.1 14.2 3.7 0.1 21.4 0.0 42.3 50.8 3.5 0.0 1.5 2.3 26.3 0.0 31.2 3.3 4.0 0.0 1.9 8.7 0.7 0.7 6.7 8.5 0.0 1.0 1.5 1.2 13.4 CCDC34 "L15, NY-REN-41, RAMA3" ENSG00000109881 "Coiled-coil domain containing 34" Q96HJ3 11 27330827-27363234 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.8" "Cell type enhanced" "Detected in many" "Early spermatids: 383.4;Endometrial ciliated cells: 156.1;Spermatocytes: 336.8;Spermatogonia: 218.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/84: 159.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037574 Uncertain Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear membrane, Nucleoli fibrillar center" "HPA037574: AB_10795136" "unprognostic (8.23e-3)" "unprognostic (1.09e-3)" "unprognostic (7.47e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-2)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.32e-7)" "unprognostic (9.09e-2)" "unprognostic (1.34e-3)" "prognostic favorable (8.52e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (4.97e-2)" "unprognostic (4.14e-2)" "unprognostic (1.64e-2)" "unprognostic (6.11e-2)" 3.8 5.3 16.1 5.6 15.9 13.7 11.2 13.8 32.8 4.4 16.7 8.8 10.7 4.9 11.3 5.5 12.5 3.4 3.4 15.9 15.4 5.0 4.6 2.3 6.5 15.2 14.9 9.7 4.3 8.1 5.5 5.1 15.4 5.4 10.1 6.2 4.1 4.3 3.1 6.5 8.9 3.5 14.3 4.4 9.3 48.8 15.9 15.8 5.6 3.4 8.8 3.3 3.5 14.8 46.1 50.4 41.6 44.7 7.5 17.6 30.8 29.5 11.1 29.8 28.8 28.2 8.3 49.4 20.2 15.8 42.7 40.2 41.9 18.2 54.3 19.5 58.2 39.4 62.6 74.1 3.8 40.6 15.4 5.7 13.4 26.0 12.5 13.2 23.3 70.1 39.0 15.9 32.1 32.6 79.3 63.1 42.9 31.4 44.1 74.8 152.8 7.4 12.8 15.2 32.2 42.2 44.0 19.5 20.8 23.4 52.8 21.4 11.1 47.8 45.2 91.3 69.4 153.2 159.4 34.8 44.5 2.0 42.7 0.0 0.2 0.4 3.1 1.0 3.7 3.4 3.9 4.2 1.0 4.0 4.5 2.8 0.0 3.7 3.8 2.3 6.7 1.1 16.1 15.9 13.8 32.8 15.9 15.4 15.2 14.9 15.4 14.3 15.9 14.8 5.1 0.0 1.7 4.9 10.1 22.8 22.9 33.2 13.1 10.3 71.4 73.3 9.2 27.1 20.6 23.9 12.5 45.5 3.4 41.0 19.6 14.1 383.4 156.1 12.5 11.1 21.6 91.3 11.5 12.3 25.1 17.2 31.1 15.3 7.0 30.9 10.0 16.0 22.0 3.3 7.5 40.5 18.3 8.9 8.4 82.4 21.5 5.7 14.2 0.0 4.7 26.6 7.2 1.0 1.2 5.5 12.1 20.7 13.9 10.3 6.2 17.6 101.5 20.6 6.6 11.6 18.3 336.8 218.8 33.2 20.6 16.1 9.1 10.3 71.2 15.5 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975003 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 732.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027262, HPA078737" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 15: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 2: Hepatocytes - Metabolism" "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717, HPA078737: " "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 95.0 307.2 126.3 53.1 171.3 80.1 100.1 170.2 165.7 96.8 141.7 81.5 94.5 79.9 89.6 46.2 94.1 97.1 71.8 125.5 144.8 261.4 732.2 135.0 56.4 201.5 168.5 104.4 129.3 159.4 84.7 113.8 192.1 83.2 88.6 38.1 61.5 82.7 37.5 46.9 102.8 99.2 158.7 65.1 128.0 49.8 157.2 67.5 161.4 57.3 69.9 91.0 70.7 223.7 154.3 175.8 138.1 277.9 395.1 237.1 100.8 153.1 217.9 278.1 189.1 188.4 248.5 137.7 244.3 242.4 174.6 165.5 195.5 160.7 247.6 194.0 157.7 193.4 107.5 219.3 277.6 216.4 218.5 214.0 197.9 254.3 315.6 341.4 174.3 189.8 210.4 281.0 363.4 255.6 134.2 135.7 200.9 499.4 299.6 160.0 95.4 208.4 311.5 127.2 121.7 185.8 169.6 278.7 183.8 172.1 335.6 296.5 145.4 196.4 93.6 180.1 267.9 189.5 229.0 841.7 222.4 91.0 200.7 212.1 80.2 136.0 76.9 43.7 93.6 34.6 70.3 78.8 69.5 31.9 60.6 60.1 86.5 63.4 32.8 70.1 86.7 88.5 126.3 171.3 170.2 165.7 125.5 144.8 201.5 168.5 192.1 158.7 157.2 223.7 46.3 67.3 67.9 8.8 23.1 24.1 38.2 37.0 18.2 7.5 52.8 27.6 2.8 120.1 23.2 53.3 4.2 77.8 40.2 60.7 13.7 104.6 7.5 24.9 39.9 47.9 24.6 24.8 5.5 92.8 42.4 44.2 16.3 29.7 36.8 33.0 38.9 200.5 55.9 3.3 5.9 29.3 30.5 45.2 35.2 7.9 56.2 54.5 37.4 5.6 39.4 26.5 26.8 7.5 51.3 103.7 32.4 40.3 29.2 52.4 98.8 81.7 21.2 9.9 39.5 37.2 33.8 13.8 6.8 13.9 15.6 54.2 34.3 39.0 29.1 34.2 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129289-50167533 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006780, HPA026589" Approved Approved "Nuclear membrane,Endoplasmic reticulum" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nuclear membrane, Endoplasmic reticulum" "HPA006780: , HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavorable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavorable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favorable (5.76e-5)" "unprognostic (3.26e-1)" 26.2 22.3 27.6 4.8 28.5 5.1 26.6 29.7 48.1 37.2 27.4 24.1 3.0 30.5 12.0 24.0 28.2 6.9 16.2 27.7 29.6 44.1 14.2 22.9 6.1 28.3 28.6 35.1 22.9 9.1 42.3 5.5 28.9 31.2 2.9 5.5 21.5 3.5 5.5 34.1 20.6 4.6 27.5 29.2 21.6 13.8 29.5 7.6 24.8 2.3 3.7 29.5 29.2 29.0 12.1 13.2 17.1 3.5 6.5 3.9 10.6 23.3 6.6 8.0 7.4 36.2 13.9 10.6 20.2 24.4 7.7 7.9 6.1 4.4 6.7 23.4 12.7 6.1 11.2 23.2 16.5 8.0 12.4 19.4 13.9 11.6 6.3 18.7 11.9 10.0 6.1 10.8 8.6 18.7 15.4 45.6 8.2 4.1 7.0 10.7 4.3 12.7 28.7 17.7 5.2 6.9 10.3 9.4 33.6 10.7 13.0 9.9 10.6 17.6 10.2 11.6 8.0 8.1 14.3 11.6 12.8 5.9 8.4 36.3 23.0 42.4 37.0 37.4 28.7 22.0 28.6 28.6 26.8 30.6 20.1 28.9 41.2 39.6 55.1 36.0 37.1 37.1 27.6 28.5 29.7 48.1 27.7 29.6 28.3 28.6 28.9 27.5 29.5 29.0 14.9 19.2 18.4 22.5 17.7 17.3 20.9 29.1 12.0 41.0 11.5 9.8 6.8 14.3 16.5 14.7 20.9 32.9 23.1 8.1 7.9 21.2 0.9 7.7 16.7 17.2 15.6 9.1 47.7 14.0 65.2 21.9 10.7 11.8 15.2 15.0 18.2 4.6 19.0 32.0 56.1 7.9 28.5 17.9 18.3 2.2 16.8 14.3 12.4 20.6 26.6 21.3 24.7 40.2 34.8 19.0 6.8 17.3 12.7 15.5 14.2 7.7 8.6 44.3 32.9 18.2 20.8 7.6 8.1 9.3 14.3 33.7 22.1 15.7 6.7 14.7 CES3 "ES31, FLJ21736" ENSG00000172828 "Carboxylesterase 3" Q6UWW8 16 66961245-66975149 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 38.2;liver: 52.5;skeletal muscle: 24.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 120.1;Granulosa cells: 58.5;Hepatocytes: 53.4;Intestinal goblet cells: 32.0;Paneth cells: 67.0;Proximal enterocytes: 66.0;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 7.4;Daudi: 8.5;JURKAT: 13.5;U-937: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041008, HPA041307" Approved Approved "Nuclear membrane,Endoplasmic reticulum" "Intracellular and membrane" NA NA 1200000 "Cluster 52: Eosinophils - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 32: U-937 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear membrane, Endoplasmic reticulum" "HPA041008: AB_2677247, HPA041307: AB_2677400" "unprognostic (3.91e-3)" "unprognostic (1.22e-1)" "unprognostic (1.94e-2)" "unprognostic (8.99e-3)" "unprognostic (9.32e-2)" "unprognostic (7.84e-4)" "prognostic favorable (7.26e-5)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.43e-2)" "unprognostic (1.84e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-2)" 0.8 0.5 3.1 3.2 2.7 0.9 2.3 2.5 2.9 1.3 1.3 38.2 30.0 0.7 0.2 4.2 2.9 0.9 0.7 3.8 2.0 12.2 52.5 0.7 0.3 3.3 2.7 0.6 4.1 1.0 1.9 0.6 3.5 0.5 31.3 0.6 12.0 0.3 24.7 1.2 23.7 1.2 1.4 0.4 7.7 1.1 2.2 0.2 0.4 1.5 0.2 0.1 0.8 2.2 0.4 3.1 0.3 7.4 0.2 0.2 1.2 0.2 0.2 0.3 0.5 0.5 3.8 8.5 2.4 0.0 0.2 0.6 1.1 0.5 0.1 1.5 5.5 4.3 1.3 2.6 0.0 0.9 0.7 0.3 0.9 0.8 0.1 0.2 0.0 13.5 2.8 1.7 0.3 1.1 1.4 1.4 1.5 2.6 0.4 1.3 0.7 1.3 0.1 0.4 0.4 0.8 0.2 5.8 0.2 0.6 5.0 6.5 0.3 0.4 2.4 0.7 0.2 0.9 3.6 1.3 0.3 7.2 0.2 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 3.1 2.7 2.5 2.9 3.8 2.0 3.3 2.7 3.5 1.4 2.2 2.2 0.1 3.2 6.7 0.7 0.4 0.5 0.0 1.3 1.2 0.2 9.1 5.7 1.4 2.8 0.9 0.0 0.0 0.0 0.0 120.1 0.0 0.2 0.5 3.2 0.3 0.2 19.7 0.0 1.8 0.9 0.0 0.2 11.7 4.4 1.3 58.5 0.4 53.4 0.3 0.0 2.9 32.0 0.0 3.2 0.9 5.4 0.0 0.9 0.0 0.0 0.0 0.4 0.0 1.5 0.1 1.0 67.0 1.2 0.1 0.1 66.0 9.9 4.8 0.2 0.0 0.6 0.2 2.3 2.9 1.1 0.3 0.0 0.4 0.1 44.3 0.2 CLK1 ENSG00000013441 "CDC like kinase 1" P49759 2 200853009-200864744 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033141, HPA062405" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nuclear membrane" "CAB033141: AB_1121713, HPA062405: AB_2684753" "unprognostic (9.79e-2)" "unprognostic (2.05e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (9.19e-2)" "unprognostic (4.50e-3)" "unprognostic (1.52e-1)" "unprognostic (2.77e-3)" "unprognostic (1.78e-2)" "unprognostic (2.09e-2)" "unprognostic (1.09e-2)" "unprognostic (5.63e-3)" "unprognostic (2.03e-3)" "unprognostic (9.66e-2)" "unprognostic (2.30e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.28e-4)" 89.6 82.7 132.9 25.4 137.1 178.0 72.2 140.9 201.6 118.5 136.2 78.3 20.8 65.8 51.1 58.5 85.5 56.5 83.9 133.9 137.7 83.3 84.4 90.3 55.9 138.1 133.4 140.3 63.6 29.0 82.3 64.8 138.6 109.7 24.2 133.8 68.9 49.6 80.4 62.5 51.6 30.9 135.2 113.0 53.2 28.1 134.1 76.0 92.5 71.4 42.0 77.8 112.8 176.0 17.9 13.5 22.6 6.5 24.4 26.1 17.1 19.2 26.8 19.3 25.5 24.6 11.8 5.5 13.1 11.4 11.1 19.7 27.9 8.8 38.2 27.3 24.0 18.1 35.9 30.7 14.7 19.5 31.1 12.3 39.9 23.4 41.8 20.6 11.4 9.5 23.3 77.1 27.0 12.3 23.0 58.4 13.9 11.4 29.8 24.8 25.7 31.8 13.0 11.2 22.0 17.8 16.4 6.1 32.7 12.9 5.3 13.2 19.5 21.4 14.8 21.5 22.0 46.8 20.9 13.7 14.2 15.4 14.9 40.0 7.2 18.6 14.5 5.0 17.3 17.4 15.7 15.8 4.8 11.7 15.6 12.9 16.9 9.5 6.0 11.1 17.2 10.4 132.9 137.1 140.9 201.6 133.9 137.7 138.1 133.4 138.6 135.2 134.1 176.0 122.1 44.8 85.4 112.0 164.2 168.8 263.0 73.6 114.4 59.0 112.9 97.0 96.6 41.5 87.1 27.6 100.1 46.7 213.5 110.9 19.6 31.4 2.3 111.2 108.8 113.6 134.3 87.5 51.7 26.9 56.6 142.5 81.1 173.6 136.9 77.9 82.1 43.3 58.5 52.2 53.6 124.2 50.8 100.5 285.8 9.4 92.9 192.3 154.7 62.8 56.2 54.6 76.2 58.3 169.0 32.0 117.7 75.6 169.0 133.3 88.2 14.9 70.1 99.6 111.7 97.8 128.4 33.1 27.7 117.0 151.7 90.3 261.2 43.0 88.6 184.2 CPNE1 CPN1 ENSG00000214078 "Copine 1" Q99829 20 35626031-35664956 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065876, HPA072634" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA 300000 "Cluster 48: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Nuclear membrane" "HPA065876: , HPA072634: AB_2686541" "unprognostic (5.94e-2)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.74e-10)" "unprognostic (3.10e-1)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" 61.0 47.9 15.5 50.5 15.2 70.9 58.5 14.5 17.5 68.7 17.0 65.4 32.5 74.1 58.5 58.7 62.4 48.3 38.4 15.2 15.8 44.1 38.7 59.6 52.3 16.9 14.6 64.7 48.4 38.6 52.1 69.8 15.4 52.3 47.4 17.7 51.6 41.9 43.7 63.4 62.9 70.3 14.5 78.3 51.0 25.5 14.9 82.8 60.2 33.6 81.8 64.4 59.8 19.6 264.1 202.5 112.0 47.3 14.3 18.6 85.4 123.9 219.8 295.0 192.1 590.5 111.2 181.6 115.8 185.3 251.6 98.1 88.1 233.7 182.8 34.7 65.7 459.1 149.9 440.5 131.9 151.5 61.9 121.6 235.8 118.1 139.0 178.9 188.1 183.9 61.4 90.3 144.0 142.9 226.0 201.9 27.8 264.2 187.6 159.1 334.0 125.4 119.9 183.9 78.9 87.9 277.2 129.6 188.1 31.1 134.3 148.8 123.6 306.6 56.4 101.3 131.6 61.5 66.9 126.9 222.7 81.8 69.6 53.6 102.9 180.5 119.3 100.5 164.8 120.8 115.2 112.5 143.7 113.8 111.3 113.6 140.4 206.7 98.8 78.0 153.7 164.5 15.5 15.2 14.5 17.5 15.2 15.8 16.9 14.6 15.4 14.5 14.9 19.6 47.0 19.2 37.3 33.6 55.2 55.1 71.8 82.3 44.9 34.6 40.2 46.0 15.7 32.9 56.5 25.8 20.9 125.1 73.4 26.8 25.4 72.7 39.6 23.3 44.1 53.2 33.6 42.5 37.2 37.8 76.7 56.2 25.0 28.3 48.2 59.9 34.6 23.3 62.4 21.9 33.7 30.8 81.4 43.0 79.6 9.6 54.7 45.5 48.0 30.0 85.0 24.8 62.8 32.6 39.4 44.2 34.0 61.7 60.2 78.6 38.2 34.8 33.9 18.1 46.0 47.0 55.0 13.1 22.9 41.4 49.0 106.3 77.0 65.9 41.2 71.7 CRAT CAT1 ENSG00000095321 "Carnitine O-acetyltransferase" P43155 9 129094142-129111189 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 227.5;tongue: 201.3" "Cell type enhanced" "Detected in many" "Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019230, HPA020260, HPA022815" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 8100 "Cluster 39: Non-specific - mRNA processing" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427" "unprognostic (5.13e-2)" "unprognostic (9.79e-3)" "unprognostic (1.99e-2)" "prognostic favorable (2.36e-4)" "unprognostic (2.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-2)" "unprognostic (3.13e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.38e-1)" "unprognostic (9.27e-2)" "unprognostic (1.26e-2)" "unprognostic (7.65e-2)" 36.1 51.3 26.4 5.4 26.6 9.0 29.2 27.0 33.8 31.7 27.5 36.1 33.0 24.8 4.0 37.3 23.1 6.6 68.2 25.1 27.8 46.9 151.2 15.2 3.2 28.8 28.2 23.0 107.1 26.3 12.3 6.6 30.6 42.2 4.2 1.7 32.8 8.9 227.5 29.6 37.2 6.8 26.7 15.2 34.0 146.4 30.2 3.1 21.5 201.3 1.6 31.3 27.5 24.4 0.1 39.3 10.7 21.3 13.4 25.9 17.0 15.0 16.6 18.9 12.0 7.8 14.0 1.5 9.2 25.9 23.2 6.7 2.2 4.9 7.2 23.6 0.3 7.3 19.1 30.4 34.1 0.0 26.1 26.3 0.0 15.7 0.9 15.8 26.2 7.2 3.6 5.7 20.0 9.1 0.5 15.9 2.8 32.0 18.0 16.8 21.8 12.2 18.0 0.6 4.2 12.1 0.0 7.1 4.8 3.4 49.7 5.5 22.6 23.0 1.6 32.1 15.4 25.5 22.6 0.1 28.8 4.2 16.8 1.6 8.4 3.5 3.2 5.5 6.7 1.5 4.4 4.3 8.6 1.3 2.6 3.1 1.1 4.4 5.6 3.9 4.5 6.1 26.4 26.6 27.0 33.8 25.1 27.8 28.8 28.2 30.6 26.7 30.2 24.4 10.5 6.4 3.7 5.5 4.9 3.2 4.7 10.8 0.6 1.5 9.7 8.1 57.8 21.5 8.2 3.7 2.1 45.9 6.0 64.5 17.6 22.6 181.2 3.5 15.7 12.9 15.5 17.4 5.3 22.4 55.6 19.3 16.8 9.9 7.0 12.9 14.6 65.7 20.7 1.7 6.1 23.6 14.2 13.9 10.5 521.8 22.1 12.4 5.4 6.5 8.3 15.5 6.2 3.5 4.0 11.6 47.6 24.5 9.6 9.3 136.4 52.0 2.8 1.3 6.6 10.5 15.7 123.5 8.6 57.4 4.5 50.3 7.6 20.1 29.3 13.8 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019458 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 46.0" "Cell type enhanced" "Detected in some" "Adipocytes: 14.1;Endothelial cells: 32.0;Erythroid cells: 86.6;Fibroblasts: 16.8;Hofbauer cells: 15.5;Microglial cells: 23.4" "Group enriched" "Detected in many" 5 "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "NK-cell: 27.0" "Lineage enriched" "Detected in many" 11 "NK-cells: 27.0" "Cell line enhanced" "Detected in some" "HEL: 194.1;HUVEC TERT2: 152.3;NB-4: 382.2;WM-115: 89.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" NA NA 270000 "Cluster 40: NK-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear membrane, Endoplasmic reticulum" "HPA067201: AB_2732760" "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (7.43e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.25e-4)" 5.8 1.9 2.1 1.8 2.5 13.9 6.9 2.8 3.9 12.9 3.1 5.5 0.6 9.5 1.3 4.8 7.9 4.6 1.5 2.6 2.7 1.0 0.3 4.9 4.5 4.2 3.0 1.7 1.2 1.2 1.6 46.0 3.9 10.8 1.4 0.2 4.3 14.4 0.5 3.2 2.4 4.0 3.3 1.2 4.7 0.3 3.4 4.5 5.8 0.2 4.9 12.0 7.3 4.8 0.1 0.0 0.1 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.1 0.1 0.0 0.9 0.0 0.0 5.0 0.0 2.7 0.0 0.0 152.3 0.0 0.0 7.5 0.0 0.0 0.0 382.2 0.7 0.0 0.0 5.7 7.7 0.2 0.0 0.0 0.1 8.8 0.3 0.0 24.5 0.2 0.0 0.0 52.7 0.0 34.6 0.1 0.0 1.0 0.2 0.4 0.0 4.8 89.6 2.5 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.7 0.1 27.0 0.0 0.4 0.0 0.9 2.1 2.5 2.8 3.9 2.6 2.7 4.2 3.0 3.9 3.3 3.4 4.8 14.1 0.0 0.5 0.0 1.2 2.8 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.2 0.4 0.3 0.3 32.0 0.0 86.6 0.0 0.0 0.4 16.8 0.0 0.3 8.9 0.2 0.7 0.0 15.5 0.0 0.0 0.0 0.0 0.8 2.9 0.0 0.0 4.7 8.8 23.4 0.6 0.0 3.1 0.5 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.1 0.0 0.3 1.6 0.5 0.5 8.6 0.0 0.6 DCTN5 "MGC3248, p25" ENSG00000166847 "Dynactin subunit 5" Q9BTE1 16 23641466-23677472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042003, HPA063710" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA042003: AB_10796468, HPA063710: AB_2685101" "unprognostic (5.90e-3)" "unprognostic (3.38e-1)" "unprognostic (1.77e-1)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (6.36e-2)" "unprognostic (6.78e-2)" "unprognostic (9.28e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.59e-2)" "unprognostic (9.55e-2)" 13.9 11.3 14.6 18.1 18.1 41.5 14.2 10.4 18.3 13.6 3.8 19.2 20.8 14.8 12.0 25.2 13.6 14.2 14.7 17.2 13.0 21.0 10.7 14.0 22.1 11.4 13.6 12.0 15.9 19.8 8.5 20.9 11.1 14.1 24.9 21.5 12.8 14.0 13.9 14.1 22.2 21.7 11.4 15.1 16.7 20.6 12.8 20.9 18.8 14.2 32.2 20.6 10.9 12.9 30.0 58.5 56.0 46.9 39.0 28.9 39.2 51.9 32.1 32.9 39.3 66.5 40.3 42.1 41.2 54.8 34.6 30.6 93.4 50.2 40.5 48.1 37.1 51.9 67.2 93.9 26.5 63.7 38.4 24.3 35.3 40.5 42.8 36.5 52.8 52.0 100.7 31.6 53.3 82.4 49.4 18.4 66.3 43.3 25.5 59.8 48.6 45.9 26.2 62.6 46.8 48.5 45.6 36.7 30.5 49.0 51.2 53.2 71.8 44.0 20.0 34.9 36.6 42.6 68.6 66.2 42.0 31.4 48.8 14.3 16.6 20.3 15.5 14.0 17.1 13.9 14.2 17.0 17.5 10.5 12.0 14.3 7.3 22.0 22.0 12.4 19.0 17.2 14.6 18.1 10.4 18.3 17.2 13.0 11.4 13.6 11.1 11.4 12.8 12.9 19.7 16.0 26.2 12.1 19.1 14.7 14.5 12.9 22.8 52.1 15.5 14.5 27.1 15.7 15.6 20.2 91.8 32.9 16.1 36.2 11.7 23.8 23.2 11.9 22.4 22.5 22.1 27.6 13.4 25.2 36.3 16.3 20.9 20.8 27.8 37.3 17.2 14.2 28.4 52.2 13.2 18.9 12.2 19.1 11.4 23.4 13.1 17.1 7.2 6.5 34.4 32.3 30.9 11.1 12.0 45.7 19.4 18.0 17.4 14.4 31.9 23.3 11.2 45.0 13.1 22.4 18.1 70.4 30.6 20.9 14.2 48.2 18.7 17.9 26.2 22.0 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953734-23969279 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favorable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 34.1 45.8 8.6 10.4 9.2 6.9 34.5 8.8 9.7 30.5 10.1 43.5 34.0 27.1 5.2 45.8 23.6 5.9 49.1 8.3 8.6 92.0 109.7 28.0 10.2 9.2 8.6 33.0 40.3 8.8 19.3 5.3 9.2 31.9 13.5 3.9 31.2 8.4 62.2 44.7 38.6 8.3 8.6 32.2 33.7 37.9 9.0 9.6 25.4 14.0 8.5 30.5 33.1 9.5 15.1 29.6 10.4 17.2 16.6 18.5 0.1 27.4 15.3 11.5 9.1 6.5 16.5 13.3 14.3 14.6 7.6 18.1 8.6 12.3 10.1 34.6 16.5 7.8 23.5 36.6 9.5 11.6 45.2 18.0 14.8 9.2 20.8 12.3 14.4 19.6 11.8 30.4 15.8 52.3 21.1 10.7 9.9 18.9 30.3 33.8 18.0 41.4 12.1 17.1 19.9 16.1 27.7 17.6 13.8 6.8 16.0 14.6 25.5 13.3 13.8 13.9 9.0 22.8 22.8 3.5 11.8 12.6 13.6 5.4 54.4 6.0 18.0 45.8 21.4 21.5 20.3 18.2 47.4 18.5 20.1 19.5 2.3 18.1 25.5 39.4 19.4 36.2 8.6 9.2 8.8 9.7 8.3 8.6 9.2 8.6 9.2 8.6 9.0 9.5 16.6 16.0 30.5 6.2 12.5 12.5 10.4 15.7 55.2 5.1 22.2 31.9 35.4 17.2 21.3 14.7 0.0 9.6 17.8 34.2 78.2 6.4 50.4 13.1 11.6 14.6 19.2 20.8 2.6 9.8 6.0 23.7 34.7 7.8 13.9 10.5 20.0 68.1 30.4 6.7 2.1 50.1 8.2 29.2 13.5 66.1 11.1 35.9 5.4 3.7 33.2 18.1 47.4 4.0 5.0 5.3 22.3 17.3 24.6 11.2 51.8 235.4 23.2 1.8 6.6 13.5 18.1 59.4 1.9 61.6 13.4 3.8 18.1 22.9 71.8 9.0 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 136.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" "Secreted - unknown location" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favorable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 27.2 39.5 28.8 14.6 29.6 11.5 30.5 28.3 38.4 26.9 30.8 34.7 34.4 19.7 12.8 38.4 18.6 10.6 45.9 28.5 27.8 122.5 136.2 22.5 14.6 29.3 28.7 25.2 34.0 24.5 16.7 10.0 28.7 32.5 26.6 6.7 24.7 20.7 50.7 37.1 42.0 18.4 28.6 29.3 27.9 41.4 29.4 16.9 21.5 28.5 16.5 26.0 26.1 29.9 18.7 29.0 4.9 24.4 46.2 47.9 0.6 17.3 34.3 24.8 18.4 8.4 22.5 12.6 11.5 35.3 16.0 20.6 22.3 29.1 20.6 43.3 13.3 3.1 24.8 52.4 34.0 15.3 47.9 50.0 36.4 16.3 23.7 17.0 29.5 40.0 10.1 44.9 26.7 61.5 40.4 16.5 9.7 45.9 31.8 64.9 19.9 38.2 35.6 23.7 26.0 15.7 24.5 21.5 15.0 10.3 25.2 24.5 20.8 12.9 13.4 15.4 8.8 25.5 21.1 3.8 11.1 23.7 18.8 4.8 56.3 6.9 19.4 47.2 20.1 21.9 20.9 22.2 45.4 17.4 21.0 19.1 2.6 17.2 29.3 37.4 21.8 33.6 28.8 29.6 28.3 38.4 28.5 27.8 29.3 28.7 28.7 28.6 29.4 29.9 39.3 16.0 29.6 10.4 17.8 27.8 46.1 56.8 27.9 9.9 45.5 54.4 17.2 47.1 34.3 25.8 2.1 21.2 22.9 37.9 127.2 40.0 20.7 20.6 20.1 32.0 37.3 24.2 7.3 55.7 7.3 36.4 13.3 16.5 17.7 31.8 50.0 204.2 146.1 11.8 6.7 61.7 42.7 55.9 42.8 35.4 43.8 41.9 51.6 10.3 65.0 79.5 35.0 10.1 8.5 30.4 54.9 37.2 10.8 32.5 326.4 581.7 28.6 8.3 32.9 24.2 32.7 17.2 1.7 42.1 40.2 13.0 21.3 37.5 78.1 42.4 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045886-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 143.9;ovary: 60.1;pituitary gland: 52.5" "Group enriched" "Detected in many" 5 "Distal tubular cells: 64.6;Theca cells: 206.2" "Group enriched" "Detected in many" 4 "endometrial cancer: 4.3;glioma: 16.3;pancreatic cancer: 5.6;thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 8.2;HSkMC: 17.2;TIME: 11.2;U-251 MG: 9.1;U-87 MG: 16.9" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favorable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.4 20.1 25.3 0.5 18.7 0.1 5.0 2.2 11.5 5.2 3.0 3.3 7.5 2.5 10.6 1.7 3.3 10.2 11.3 7.0 143.9 6.9 9.5 5.1 0.2 39.6 49.2 60.1 20.0 7.5 52.5 0.6 18.5 2.9 0.8 4.0 2.3 2.6 1.1 2.1 1.4 1.2 7.8 2.5 4.2 5.5 104.7 1.6 3.8 1.9 0.3 3.1 6.4 8.0 0.0 1.5 1.6 0.0 5.2 3.9 0.6 4.6 1.6 0.3 1.2 0.0 0.8 0.0 0.2 4.8 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.6 0.0 8.2 0.0 0.0 17.2 0.1 0.7 0.0 0.0 1.0 0.2 0.3 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.1 0.5 0.1 0.0 11.2 0.0 0.5 0.2 9.1 2.7 0.0 0.0 16.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 25.3 18.7 2.2 11.5 7.0 143.9 39.6 49.2 18.5 7.8 104.7 8.0 0.3 0.0 1.8 5.2 0.0 3.2 25.0 0.6 0.6 1.1 5.4 6.5 5.9 7.2 2.5 3.7 10.4 1.1 0.0 0.4 64.6 3.7 0.1 0.7 0.7 1.7 16.2 0.0 2.2 18.7 0.1 10.3 4.1 1.8 0.0 0.8 3.3 3.9 0.1 0.0 8.8 2.3 0.0 0.0 4.8 0.8 6.8 0.3 5.4 0.0 0.0 0.7 1.0 5.0 0.2 2.9 0.1 1.5 0.0 5.3 0.1 11.1 0.9 6.1 0.0 16.9 1.7 0.0 1.4 1.7 2.8 0.4 0.7 206.2 0.7 2.4 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;fallopian tube: 5.1;testis: 4.3" "Cell type enhanced" "Detected in some" "Early spermatids: 42.7;Endometrial ciliated cells: 31.0;Late spermatids: 17.1;Respiratory ciliated cells: 77.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062493 Approved "Nuclear membrane,Intermediate filaments" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.4 0.1 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.4 0.5 0.0 0.0 1.2 0.0 2.2 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 4.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.4 0.5 2.2 2.1 1.4 1.5 0.5 0.5 0.0 0.0 1.1 0.7 0.0 0.3 0.7 2.0 0.0 0.0 0.1 0.1 1.7 0.0 6.3 0.0 0.0 0.3 0.0 2.0 0.0 0.0 42.7 31.0 0.2 0.3 0.0 0.0 2.9 0.0 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 3.6 1.3 0.0 0.0 0.0 17.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 2.5 1.7 0.0 0.8 0.0 0.0 0.5 1.3 0.0 77.8 0.0 0.0 0.2 1.0 0.9 8.8 0.5 0.6 0.0 0.1 0.0 1.9 0.3 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355149 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 235.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 24.1 29.8 18.3 18.1 19.5 27.6 24.5 20.0 20.4 21.6 19.5 23.3 21.4 24.0 23.4 23.2 20.8 17.5 26.8 19.0 18.1 23.9 28.0 21.1 16.4 20.0 18.8 22.6 26.9 32.9 23.7 20.3 19.1 23.4 14.7 16.6 28.4 17.7 37.5 28.5 20.7 19.0 18.4 24.8 23.9 21.4 18.9 17.3 23.5 23.5 16.0 21.6 20.6 20.0 37.4 38.3 23.4 39.3 30.5 31.1 29.6 36.6 63.8 49.5 45.9 44.7 64.3 27.2 28.8 45.1 31.3 61.4 22.2 33.0 26.9 29.9 29.4 14.7 23.0 29.6 68.5 30.1 54.2 39.6 67.6 44.1 55.8 45.0 35.1 25.6 23.2 40.2 43.3 36.7 26.0 26.3 10.8 29.1 11.1 23.4 17.8 18.9 37.7 21.7 16.1 23.0 20.0 74.0 36.8 12.9 28.2 34.2 39.1 24.6 33.4 28.0 46.7 33.8 27.3 16.0 40.6 32.6 17.1 18.7 29.2 18.7 12.8 31.5 11.4 11.5 12.5 9.6 24.6 11.1 10.3 10.2 36.6 13.9 28.9 16.4 13.8 17.5 18.3 19.5 20.0 20.4 19.0 18.1 20.0 18.8 19.1 18.4 18.9 20.0 30.3 28.9 29.3 10.1 30.1 13.4 30.6 38.6 25.6 33.3 36.1 29.6 23.3 50.1 44.3 23.9 22.9 41.1 37.7 38.1 11.7 34.2 122.2 25.1 26.1 25.3 29.4 31.2 12.7 64.3 41.1 28.6 23.4 29.3 40.0 26.4 21.0 29.6 38.1 30.3 13.0 28.8 12.2 36.0 16.0 235.7 36.4 37.6 10.6 7.5 39.6 33.6 35.0 12.1 15.2 34.9 38.1 35.0 34.2 27.4 62.2 34.4 26.8 35.6 52.6 27.4 34.4 32.4 10.9 28.1 15.5 68.0 22.8 37.0 25.9 35.2 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.0" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 67.7;CAPAN-2: 110.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 10.0 5.0 5.6 12.3 6.3 5.1 10.3 3.3 10.1 17.4 13.8 15.8 10.2 9.3 1.1 54.0 10.5 9.3 6.8 4.3 5.9 5.4 8.7 10.3 10.9 11.1 8.1 8.1 10.5 8.4 6.7 5.3 8.1 13.7 8.1 4.4 30.4 3.9 12.5 31.0 13.3 4.3 3.8 13.3 14.2 28.1 13.5 9.0 7.9 2.7 10.1 12.1 27.2 12.8 31.8 67.7 9.9 14.7 5.5 5.4 21.2 6.8 5.7 7.2 9.9 19.1 110.9 9.8 4.7 6.8 38.1 23.2 5.3 32.1 4.5 22.1 11.3 5.6 14.4 16.9 7.4 8.2 13.7 9.6 19.1 18.7 10.0 5.6 5.5 17.2 17.3 14.3 8.8 15.3 12.6 28.6 14.4 23.8 10.2 13.8 9.1 17.7 3.4 24.4 3.9 8.2 10.9 18.4 9.3 8.6 18.5 21.6 5.8 40.5 19.0 13.8 27.1 10.7 13.7 11.2 8.8 8.8 21.3 17.7 11.6 17.2 8.6 13.3 6.2 6.6 7.1 8.5 10.1 7.3 7.1 7.9 22.8 4.2 18.8 17.8 11.0 8.4 5.6 6.3 3.3 10.1 4.3 5.9 11.1 8.1 8.1 3.8 13.5 12.8 7.3 6.4 5.0 5.2 13.1 33.9 19.5 87.2 23.3 2.6 7.1 4.8 2.3 4.3 59.2 7.3 8.4 18.5 12.0 39.1 3.9 19.4 33.0 8.1 3.1 5.9 9.1 3.8 5.7 10.8 13.5 6.5 61.2 10.7 3.8 3.2 7.1 4.3 21.6 3.3 5.2 25.6 22.4 11.0 7.7 10.4 5.6 14.5 7.2 19.7 10.0 5.7 8.2 18.1 10.0 23.1 37.9 4.9 13.9 20.0 21.0 3.2 62.8 9.2 6.6 3.0 7.3 11.0 11.0 27.0 35.4 37.6 9.7 1.9 26.1 62.5 DUSP2 PAC-1 ENSG00000158050 "Dual specificity phosphatase 2" Q05923 2 96143169-96145440 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 129.5" "Cell type enhanced" "Detected in many" "dendritic cells: 919.7;Glandular and luminal cells: 321.1;Langerhans cells: 924.0;Macrophages: 353.9;T-cells: 764.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebral cortex: 55.0" "Immune cell enhanced" "Detected in all" "gdT-cell: 199.3" "Group enriched" "Detected in all" 10 "NK-cells: 148.1;T-cells: 199.3" "Cell line enhanced" "Detected in many" "Daudi: 30.4;HeLa: 29.7;JURKAT: 27.6;Karpas-707: 33.8;NB-4: 29.1;RT4: 34.2;SCLC-21H: 29.6;U-698: 43.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA071920 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear membrane" Nucleoplasm "HPA071920: AB_2686472" "unprognostic (2.69e-3)" "unprognostic (6.70e-3)" "unprognostic (1.15e-1)" "unprognostic (5.46e-3)" "unprognostic (3.32e-2)" "unprognostic (8.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.15e-1)" "unprognostic (2.86e-1)" "unprognostic (3.66e-2)" "unprognostic (3.10e-1)" "unprognostic (6.30e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (1.82e-1)" "unprognostic (2.41e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-3)" 17.0 6.0 7.6 18.6 11.6 129.5 5.5 7.5 55.0 8.1 9.2 4.5 1.6 7.0 7.7 6.8 7.6 12.5 19.5 13.4 6.2 12.7 7.5 18.2 47.1 8.0 6.3 7.8 2.3 1.7 35.1 1.3 6.7 17.6 2.0 0.4 3.9 61.5 2.8 26.0 11.8 3.4 6.7 42.0 7.4 3.6 6.9 47.3 6.7 3.7 24.6 39.5 9.0 9.3 3.2 0.0 0.2 0.2 0.4 0.5 4.4 3.7 0.0 5.3 5.1 8.9 0.6 30.4 10.6 4.1 0.0 2.2 7.5 0.0 1.0 0.5 0.0 0.7 29.7 0.0 1.9 12.8 2.6 0.9 2.0 0.9 0.0 0.1 0.0 27.6 0.0 33.8 0.2 5.2 25.5 29.1 6.5 0.8 10.6 0.0 0.4 24.3 0.2 34.2 29.6 1.5 1.4 0.3 5.6 0.0 2.0 14.4 0.1 0.0 7.9 0.0 1.7 2.3 3.9 43.2 0.0 13.9 0.3 2.3 4.3 1.0 199.3 10.5 95.4 17.5 46.7 176.2 10.7 13.9 32.0 99.3 6.1 148.1 9.1 3.0 16.1 40.5 7.6 11.6 7.5 55.0 13.4 6.2 8.0 6.3 6.7 6.7 6.9 9.3 50.8 0.0 7.7 0.7 303.7 96.7 155.0 31.3 70.6 27.8 65.8 72.0 37.8 2.8 12.0 9.2 22.9 0.9 919.7 20.4 1.9 0.9 0.9 115.6 62.7 28.7 87.8 50.5 5.2 1.4 1.7 22.8 86.6 321.1 104.3 7.4 12.8 3.9 80.2 0.0 1.4 37.5 8.2 40.4 924.0 1.4 1.8 353.9 144.1 1.9 3.4 1.5 90.6 1.0 0.5 1.0 2.5 1.9 268.5 70.4 1.6 1.4 2.7 3.6 0.0 14.7 26.6 0.6 4.8 50.4 109.7 1.6 764.7 3.0 51.6 41.1 EIF2B4 "DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta" ENSG00000115211 "Eukaryotic translation initiation factor 2B subunit delta" Q9UI10 2 27364352-27370457 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 196.4;Late spermatids: 299.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032234, HPA039993, HPA068855" Approved Approved "Nuclear membrane,Actin filaments" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear membrane" "Actin filaments" "CAB032234: AB_668909, HPA039993: AB_2676790, HPA068855: " "unprognostic (2.26e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" "unprognostic (7.55e-2)" "unprognostic (2.37e-1)" "unprognostic (4.63e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (3.64e-2)" "unprognostic (2.18e-1)" "unprognostic (3.56e-3)" "unprognostic (1.11e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (5.46e-8)" "unprognostic (1.79e-1)" "unprognostic (1.70e-1)" "unprognostic (8.76e-2)" "unprognostic (1.67e-2)" 21.4 24.8 23.3 15.2 24.3 10.7 20.7 24.0 23.8 21.3 22.5 31.7 14.6 21.0 16.9 27.8 20.3 13.4 28.0 23.2 23.7 18.2 21.5 18.1 17.2 24.4 24.3 19.8 31.4 20.4 20.3 18.8 24.0 25.4 18.4 19.3 24.6 20.8 51.8 29.3 18.4 22.8 23.2 18.6 24.7 38.1 24.4 18.9 18.1 35.2 22.9 24.1 21.4 24.1 38.7 59.8 44.3 34.6 58.4 42.7 48.4 41.0 43.7 55.7 37.3 89.2 16.9 49.7 38.7 48.7 46.6 27.6 62.5 50.8 36.2 37.4 40.7 61.7 39.3 104.5 51.1 58.2 23.0 41.3 51.1 69.2 51.6 40.4 53.3 37.2 59.5 24.9 53.0 35.2 28.8 61.7 49.1 59.8 38.9 52.9 69.9 43.2 50.0 32.7 34.3 37.4 34.1 53.8 42.6 39.6 31.3 23.4 52.8 40.1 47.0 35.4 49.7 50.9 65.7 74.7 33.9 47.9 38.6 56.6 53.9 38.8 32.1 48.1 44.6 31.1 31.6 32.6 52.5 25.3 30.2 32.9 7.7 30.8 52.2 38.6 43.8 43.2 23.3 24.3 24.0 23.8 23.2 23.7 24.4 24.3 24.0 23.2 24.4 24.1 19.9 12.8 14.8 9.8 17.5 35.9 18.9 32.0 15.4 22.6 28.0 18.7 33.0 14.3 27.0 22.0 66.7 40.9 27.8 23.4 19.6 29.0 196.4 22.3 23.9 19.9 24.0 8.2 6.6 33.4 25.0 24.6 14.8 17.6 31.6 16.9 25.7 34.4 24.3 10.1 6.5 24.8 28.5 20.7 28.0 299.6 23.3 16.5 23.2 2.8 29.5 23.2 16.5 6.0 8.8 26.7 27.1 24.8 28.4 21.2 23.0 27.6 24.9 58.9 19.7 17.0 34.9 71.5 38.9 14.5 34.8 46.1 24.3 23.8 20.5 14.4 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379273-154381523 "Disease related genes, Human disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" NA NA 240000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" "Nuclear membrane" "Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 32.8 32.5 27.4 15.4 27.4 26.5 33.2 27.8 31.8 46.6 26.6 45.7 14.7 58.2 16.0 35.0 56.2 11.2 46.2 26.0 30.1 48.7 30.6 33.3 13.8 28.5 28.6 63.9 50.5 21.3 42.6 15.5 28.2 36.5 11.1 12.9 33.5 21.8 80.3 36.3 27.2 19.9 29.2 26.9 38.5 17.3 29.7 13.0 40.6 29.7 15.4 51.2 36.1 31.4 121.3 42.4 29.0 32.7 26.3 50.6 54.7 58.1 58.2 68.5 72.4 37.9 22.6 99.6 92.2 56.2 143.5 65.5 55.8 67.4 29.5 60.6 116.8 43.7 58.4 22.5 67.9 42.9 46.8 44.1 53.2 60.4 75.0 46.5 48.3 37.5 37.0 39.0 47.9 49.2 74.4 78.1 51.3 66.3 128.9 62.1 45.9 92.4 38.4 21.9 37.9 47.8 29.8 47.6 74.2 27.8 33.6 31.2 43.5 35.7 69.6 80.2 84.2 131.4 100.6 179.3 42.3 70.9 38.1 35.5 29.5 46.4 45.2 37.3 41.8 37.8 43.1 43.6 24.8 37.0 37.7 37.7 31.0 28.7 28.1 54.9 43.3 30.6 27.4 27.4 27.8 31.8 26.0 30.1 28.5 28.6 28.2 29.2 29.7 31.4 30.3 32.1 39.5 8.1 93.1 71.8 74.8 60.9 84.2 35.1 53.4 60.1 22.3 35.8 40.4 27.6 12.5 60.7 87.4 16.6 70.5 43.5 16.3 46.5 51.8 36.2 23.9 46.7 9.6 55.0 66.4 52.9 53.5 64.4 55.1 40.9 27.1 38.8 52.2 30.3 8.8 37.0 28.5 25.2 93.0 15.4 40.7 69.4 67.6 10.3 50.2 46.9 34.0 5.5 10.8 47.7 31.3 44.8 125.8 86.4 30.9 49.5 27.9 32.6 26.3 49.5 60.1 25.4 36.2 99.3 77.0 125.1 92.7 42.3 30.4 68.3 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138497261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.7;retina: 9.1;testis: 3.8" "Cell type enhanced" "Detected in some" "Astrocytes: 64.3;Early spermatids: 157.1;Excitatory neurons: 229.3;Inhibitory neurons: 267.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RH-30: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.1 2.6 4.8 0.1 4.8 0.0 0.0 6.1 10.7 0.0 0.0 0.8 0.3 0.0 0.1 0.0 0.0 0.0 0.1 6.8 1.1 0.3 0.0 0.0 0.0 5.0 3.0 0.0 0.4 0.0 1.3 0.0 5.1 0.2 0.6 9.1 0.0 0.2 0.0 0.0 0.3 0.0 1.8 0.0 0.6 3.8 3.4 0.1 0.0 0.3 0.0 0.4 0.1 5.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.8 6.1 10.7 6.8 1.1 5.0 3.0 5.1 1.8 3.4 5.7 0.0 0.0 0.0 64.3 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 1.4 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.1 1.8 0.0 229.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 267.0 0.0 0.0 0.0 0.4 32.7 1.5 0.1 0.0 8.4 0.0 2.9 0.0 34.2 17.5 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.3 0.1 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM166C "C2orf70, LOC339778" ENSG00000173557 "Family with sequence similarity 166 member C" A6NJV1 2 26562585-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 26.6" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 21: OE19 - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane, Vesicles" "HPA062453: AB_2684769" "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.1 0.1 0.8 0.1 0.7 0.0 0.2 0.5 0.6 0.3 4.1 0.6 0.1 0.2 0.3 0.1 7.6 0.0 0.4 0.8 2.5 1.0 0.0 0.4 0.0 2.0 2.0 0.0 0.7 0.1 0.7 0.0 1.2 0.2 0.4 0.1 1.9 0.2 0.1 0.1 0.1 0.1 1.5 0.0 4.8 26.6 2.9 0.0 1.1 0.0 0.0 0.1 0.0 1.0 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 3.7 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 0.6 0.8 2.5 2.0 2.0 1.2 1.5 2.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;retina: 71.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 138.0;Cone photoreceptor cells: 141.8;Excitatory neurons: 103.4;Horizontal cells: 85.8;Inhibitory neurons: 101.3;Muller glia cells: 191.3;Rod photoreceptor cells: 179.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 31.9;Hep G2: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 28: BEWO - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.1 2.8 13.2 0.7 14.7 1.1 0.5 4.4 12.9 1.0 0.0 1.3 0.3 2.4 18.0 0.3 2.6 2.1 1.3 9.4 27.2 4.7 2.2 0.3 1.5 14.1 10.6 2.1 1.3 5.1 2.1 0.7 9.6 4.5 2.0 71.4 1.4 4.6 0.1 0.2 0.3 0.3 17.0 1.7 1.4 12.4 17.0 5.1 7.1 0.1 1.6 3.1 0.2 17.1 8.0 7.2 4.8 6.7 0.0 0.0 31.9 1.3 2.5 5.1 5.1 3.0 5.2 0.0 3.4 0.1 13.9 5.4 10.2 15.3 5.5 5.7 11.9 2.2 1.3 23.4 0.2 0.0 0.1 0.1 16.2 1.3 7.2 0.8 0.0 7.3 0.0 0.1 3.0 2.2 7.4 0.1 12.8 1.8 4.1 10.9 3.2 0.5 4.8 12.8 2.8 3.8 12.9 5.5 1.0 21.5 5.6 1.4 0.0 0.3 4.8 0.0 5.5 17.7 18.5 0.0 0.6 0.0 0.6 0.0 0.0 0.0 1.0 0.0 1.4 0.2 0.6 0.9 0.0 0.4 1.2 1.3 0.0 0.3 0.0 0.2 0.3 0.6 13.2 14.7 4.4 12.9 9.4 27.2 14.1 10.6 9.6 17.0 17.0 17.1 0.3 0.0 0.0 32.0 5.7 0.3 6.5 2.8 1.2 138.0 1.2 1.5 1.6 1.5 3.5 49.7 141.8 5.4 14.2 1.6 3.9 1.9 15.5 8.5 1.9 2.6 3.5 1.3 103.4 0.0 0.5 1.5 6.6 10.9 1.3 24.7 0.0 4.1 0.5 85.8 101.3 1.3 2.0 1.9 0.0 29.0 5.0 0.7 1.8 14.0 0.9 191.3 11.3 67.3 58.2 2.9 0.5 4.1 4.8 8.1 2.2 2.8 2.8 179.7 0.0 0.3 1.5 25.2 13.4 1.4 0.1 0.3 7.8 5.7 1.4 4.4 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729940-82733864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.9" "Cell type enhanced" "Detected in some" "Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Enhanced Approved "Nuclear membrane,Mitochondria" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 15: RT4 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" Mitochondria "Nuclear membrane" "HPA066861: AB_2685738" "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favorable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 0.5 0.6 18.0 0.2 20.3 0.1 0.4 19.8 14.3 1.3 5.9 1.4 0.2 0.7 0.1 0.3 1.0 0.0 1.7 14.5 14.7 0.7 0.0 0.0 0.0 26.9 20.8 0.8 0.5 0.1 1.2 0.0 16.3 0.6 0.0 0.6 0.8 0.5 0.2 0.3 0.4 0.1 23.9 0.0 0.4 0.2 19.9 0.0 0.8 0.1 0.2 1.1 0.7 23.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.3 1.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 20.3 19.8 14.3 14.5 14.7 26.9 20.8 16.3 23.9 19.9 23.6 0.7 0.0 0.0 56.2 0.0 0.3 0.2 0.1 0.0 0.8 1.0 3.6 2.9 0.0 0.1 5.5 0.0 0.0 0.0 0.0 3.9 0.1 0.0 24.1 1.8 1.3 0.0 0.0 0.4 0.0 0.0 1.2 0.0 2.4 0.0 0.6 0.0 0.0 0.1 0.0 0.6 1.5 0.0 0.0 0.3 0.4 0.6 0.2 1.8 1.9 0.0 18.4 0.0 22.1 19.0 0.0 0.0 0.4 0.0 0.2 0.1 0.4 0.1 1.1 0.0 1.6 7.0 0.1 1.6 0.3 0.0 0.0 0.1 2.2 0.2 0.1 FUT11 MGC33202 ENSG00000196968 "Fucosyltransferase 11" Q495W5 10 73772276-73780251 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.6;Late spermatids: 234.7;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014033 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 1200000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA014033: AB_1849192" "prognostic unfavorable (6.78e-4)" "prognostic unfavorable (2.39e-6)" "unprognostic (1.47e-2)" "unprognostic (2.42e-3)" "unprognostic (3.27e-1)" "unprognostic (7.64e-2)" "unprognostic (2.29e-2)" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (9.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.59e-2)" "unprognostic (1.71e-1)" "unprognostic (3.61e-1)" "unprognostic (2.66e-2)" 9.4 5.1 2.5 6.8 3.2 6.4 5.2 4.4 2.8 8.9 1.8 4.5 3.1 6.0 3.2 7.0 4.7 9.0 9.4 2.1 3.8 4.7 5.1 8.7 6.4 4.9 4.8 6.3 4.1 3.7 3.1 17.4 4.1 4.3 3.8 10.0 4.1 6.4 4.1 4.5 3.7 8.3 4.1 10.2 4.9 10.2 5.0 4.3 7.0 4.8 6.2 7.0 4.8 4.9 26.4 14.2 9.9 20.8 19.2 22.2 2.9 13.1 31.3 16.3 31.7 4.7 13.8 6.1 9.3 21.7 5.5 10.9 5.2 13.3 18.1 14.4 10.9 8.1 11.4 7.6 7.5 11.6 24.5 14.8 3.0 15.5 15.9 50.3 30.1 2.7 8.1 10.5 16.4 3.2 2.0 6.0 4.7 2.5 35.1 2.8 6.1 7.2 5.9 4.7 3.0 9.6 11.5 12.0 7.5 8.4 8.2 5.0 31.3 21.1 9.0 10.6 16.4 13.8 5.1 1.4 29.6 10.2 7.0 5.4 1.4 1.4 20.0 1.6 14.2 2.1 5.9 14.3 1.7 1.8 4.3 8.9 0.3 10.9 1.8 3.5 2.6 6.9 2.5 3.2 4.4 2.8 2.1 3.8 4.9 4.8 4.1 4.1 5.0 4.9 22.4 16.0 13.1 6.2 12.1 13.6 5.6 22.7 5.2 14.6 6.1 6.1 12.2 7.2 9.8 11.0 14.6 10.7 23.1 4.9 0.0 13.3 171.6 6.7 12.0 28.0 4.8 15.8 6.0 6.8 25.2 15.8 2.6 10.5 14.0 7.1 38.2 5.2 12.5 20.2 5.7 4.6 2.0 18.1 16.7 234.7 16.1 11.0 17.8 11.2 11.4 8.3 69.0 5.0 6.5 10.3 5.2 14.7 10.2 8.9 2.6 3.4 9.8 13.0 6.6 14.3 11.7 20.7 19.0 5.5 11.5 9.7 19.9 6.8 3.1 6.4 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 7.5;salivary gland: 4.5" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 97.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MOLT-4: 6.5;RPTEC TERT1: 7.3" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear membrane, Vesicles" "HPA068838: AB_2686047, HPA075209: AB_2732285" 0.3 0.2 0.4 0.0 0.4 0.0 0.2 0.5 0.5 0.4 0.2 0.9 0.1 1.0 0.8 0.1 0.6 0.9 0.6 0.4 0.4 7.5 0.2 0.4 0.0 0.3 0.3 1.3 1.9 0.0 0.3 0.2 0.3 0.3 0.0 0.0 4.5 0.1 0.2 0.1 0.3 0.3 0.3 0.9 0.3 0.3 0.3 0.4 0.3 0.2 0.1 0.4 0.2 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 0.0 0.0 0.2 0.0 7.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.6 0.0 11.0 0.0 0.0 0.0 0.0 97.8 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.3 2.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 15.8 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 FZR1 "CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242" ENSG00000105325 "Fizzy and cell division cycle 20 related 1" Q9UM11 19 3506311-3538334 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 104.2;Late spermatids: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043536 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA043536: AB_10968058" "unprognostic (2.78e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (9.20e-2)" "unprognostic (1.61e-1)" "unprognostic (9.70e-2)" "unprognostic (1.18e-1)" "unprognostic (4.15e-3)" "unprognostic (1.41e-2)" "unprognostic (3.75e-1)" "unprognostic (5.41e-3)" "unprognostic (1.75e-1)" "unprognostic (9.04e-2)" "unprognostic (1.04e-1)" 14.8 25.2 17.0 9.3 14.0 33.5 16.4 19.1 17.2 21.3 5.2 17.2 21.9 19.3 4.0 23.5 18.2 9.4 13.0 16.7 17.1 18.1 23.5 15.6 11.4 19.2 17.3 22.9 17.3 10.9 34.1 8.9 19.3 19.1 3.7 5.6 19.7 10.5 18.5 26.2 18.4 6.3 12.0 18.8 15.6 52.7 15.8 13.9 24.0 7.5 7.0 16.2 20.9 13.5 44.0 25.7 24.3 22.4 7.5 10.4 18.9 26.7 17.8 31.0 24.2 26.2 21.1 24.3 13.5 19.7 15.0 25.2 13.7 23.4 6.2 32.9 23.5 11.6 19.5 26.2 13.4 20.9 23.8 9.8 13.5 18.8 11.2 11.7 18.4 23.0 21.0 41.1 16.1 22.8 37.5 15.2 20.5 13.6 20.1 28.0 20.6 23.6 15.6 21.6 22.3 25.0 24.1 17.5 13.1 5.5 18.2 19.1 24.9 17.6 21.3 42.9 47.4 42.9 10.8 18.5 24.4 41.5 22.3 1.1 0.7 2.0 1.0 0.7 0.6 1.0 1.0 0.7 0.6 0.8 0.6 0.8 1.3 1.2 0.5 0.5 0.9 0.6 17.0 14.0 19.1 17.2 16.7 17.1 19.2 17.3 19.3 12.0 15.8 13.5 8.1 0.0 5.0 6.5 15.4 17.8 35.8 10.6 6.2 20.7 14.5 11.2 3.4 17.2 8.6 12.9 10.4 21.9 11.0 25.8 5.9 16.5 104.2 14.1 8.2 11.0 21.6 26.5 6.3 14.9 14.2 10.1 26.5 14.3 3.8 20.4 10.0 17.9 16.4 30.3 9.1 18.1 18.3 7.9 11.4 208.2 12.8 11.9 12.4 3.7 18.1 8.5 9.2 6.6 10.4 28.1 17.0 9.4 13.7 20.6 17.4 13.5 10.8 15.6 6.6 7.3 12.9 58.4 15.8 11.9 22.6 45.4 11.9 15.6 16.1 28.3 GLE1 "GLE1L, hGLE1, LCCS1" ENSG00000119392 "GLE1 RNA export mediator" Q53GS7 9 128504719-128542288 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041689, HPA043538, HPA061560" Supported Supported "Nuclear membrane,Nucleoli" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear membrane" Nucleoli "HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560" "unprognostic (8.74e-3)" "unprognostic (2.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.49e-4)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (7.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.95e-2)" "unprognostic (4.00e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.62e-1)" "unprognostic (1.99e-3)" "unprognostic (5.64e-2)" 11.6 14.0 9.2 15.7 9.2 15.1 15.7 12.4 11.3 13.0 13.4 17.4 16.2 11.6 10.8 16.4 14.1 7.8 14.9 8.9 8.8 14.1 16.3 12.3 20.4 8.7 9.2 16.2 9.5 17.6 14.1 9.2 8.6 11.8 18.3 16.5 11.1 12.4 22.5 19.1 15.8 12.9 8.4 15.2 12.9 32.0 9.3 25.9 13.3 12.4 22.2 12.8 12.3 8.9 29.6 54.5 26.2 44.9 25.3 25.5 34.6 29.2 24.9 40.2 28.4 36.8 20.1 59.6 23.0 33.0 38.6 101.4 45.9 41.7 34.5 56.9 29.8 30.6 57.8 34.6 28.5 49.9 38.8 18.1 39.7 45.6 48.5 22.3 22.9 54.7 44.7 51.0 46.7 68.6 49.5 35.2 22.2 79.1 46.7 49.8 64.2 79.0 27.3 26.1 30.9 23.1 71.3 42.7 25.9 21.1 78.9 34.9 17.0 42.5 28.1 50.2 41.2 50.9 131.9 45.9 39.9 37.5 46.8 40.0 21.1 24.4 22.1 26.0 18.1 13.4 17.2 20.0 22.1 20.5 15.2 17.7 18.0 27.4 27.5 13.0 22.3 19.8 9.2 9.2 12.4 11.3 8.9 8.8 8.7 9.2 8.6 8.4 9.3 8.9 4.0 9.6 9.0 11.1 11.4 6.5 5.3 10.4 8.6 7.6 8.8 7.6 13.0 5.7 7.2 7.3 8.4 16.1 6.9 13.2 5.9 11.7 77.0 12.2 7.4 3.6 5.4 12.0 14.0 6.2 11.7 7.6 10.2 9.4 9.5 10.9 4.6 14.2 15.7 10.1 15.5 12.7 8.2 15.1 5.7 58.1 10.2 13.5 3.6 10.3 20.0 8.9 15.5 18.1 15.5 8.3 8.0 6.4 13.4 6.1 16.3 13.7 12.6 8.6 13.1 7.7 7.3 51.3 25.5 14.4 6.8 13.3 12.1 7.1 14.1 5.4 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124743885-124765792 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 109.5;retina: 39.0" "Group enriched" "Detected in many" 8 "Muller glia cells: 616.6;Oligodendrocytes: 324.9" "Group enriched" "Detected in many" 4 "glioma: 19.2;liver cancer: 5.7;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" No No 900000 "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "Nuclear membrane, Cytosol" "HPA042903: AB_2678219, HPA068009: AB_2685940" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favorable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 0.5 0.1 28.3 0.1 65.3 0.0 0.5 53.8 43.4 0.3 5.2 0.6 0.0 1.6 0.2 3.7 0.6 0.2 0.1 31.2 40.4 0.3 10.0 0.2 0.1 62.8 56.3 0.0 1.5 0.1 0.2 5.1 62.5 0.5 0.3 39.0 0.9 0.5 0.6 2.3 0.6 1.2 45.2 2.1 1.3 10.6 47.8 0.0 0.0 0.1 0.0 1.4 0.6 109.5 0.1 1.4 7.5 0.0 0.0 0.0 2.1 0.5 1.9 1.9 0.4 0.3 0.7 0.0 0.0 17.7 0.2 0.1 2.2 0.0 0.4 0.3 1.0 0.1 4.4 0.0 2.2 0.0 0.3 0.0 7.7 0.0 0.1 0.0 3.6 0.0 0.0 3.4 0.0 0.4 0.0 0.0 1.1 0.0 3.5 0.0 0.0 0.0 0.0 0.1 1.7 2.7 0.0 6.8 2.6 8.0 1.7 0.0 12.7 1.5 0.6 0.0 0.0 1.1 0.0 0.0 0.7 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 65.3 53.8 43.4 31.2 40.4 62.8 56.3 62.5 45.2 47.8 109.5 0.1 0.0 0.0 5.9 0.0 4.6 0.5 4.4 6.8 55.8 4.6 3.0 0.6 7.2 1.8 1.8 6.2 10.1 0.0 0.1 0.0 5.1 0.4 2.0 0.4 0.7 0.0 0.0 6.0 0.6 19.7 1.9 0.0 3.4 0.0 0.3 0.4 22.4 1.2 18.5 1.1 1.1 2.0 0.3 0.7 1.7 2.8 0.2 3.6 1.0 0.6 616.6 0.0 1.5 324.9 0.4 0.2 0.7 0.0 3.2 0.0 0.0 1.4 22.5 0.0 4.8 0.7 0.6 2.2 4.6 10.2 3.0 0.5 0.1 0.0 0.4 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763035-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "HPA069179: AB_2686099" "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 11.0 10.9 18.1 9.6 20.4 36.8 19.5 25.1 23.1 10.9 23.8 10.8 10.2 12.2 15.1 11.4 11.9 19.6 10.0 19.8 19.9 9.5 12.9 10.5 18.8 21.7 19.0 13.8 13.1 13.6 9.0 12.5 25.9 10.2 13.1 18.6 9.7 10.0 13.6 20.9 10.8 14.3 17.9 13.8 12.1 13.9 19.5 13.4 15.1 7.3 10.9 11.6 9.4 31.8 14.4 19.2 28.4 22.2 13.1 19.4 28.0 26.2 16.3 24.7 25.0 41.4 23.0 29.8 15.9 15.7 24.1 19.2 24.4 23.3 28.7 35.0 26.6 37.2 59.9 38.6 21.8 32.8 28.9 25.8 21.4 17.8 25.0 21.9 22.6 25.7 45.6 54.6 14.9 34.0 28.6 29.2 16.9 16.9 29.3 24.4 20.7 19.8 17.6 43.2 22.6 20.5 16.7 14.6 17.8 35.9 15.4 21.1 15.0 21.2 15.1 16.7 19.3 26.0 34.4 22.2 21.8 24.4 16.9 8.4 4.7 4.4 3.9 3.1 3.5 4.8 3.5 4.0 2.8 6.8 4.2 4.0 4.4 4.8 5.8 4.3 4.8 2.3 18.1 20.4 25.1 23.1 19.8 19.9 21.7 19.0 25.9 17.9 19.5 31.8 17.4 22.4 16.0 19.2 11.6 4.0 12.2 16.6 10.2 18.1 8.8 8.8 35.8 7.2 21.4 14.7 18.8 15.3 18.1 7.7 13.7 12.4 4.4 18.2 17.4 17.0 12.5 19.1 24.7 12.3 12.6 12.9 11.2 13.3 14.0 24.7 12.8 8.2 13.5 0.0 29.8 10.1 16.2 12.7 5.0 4.6 13.4 11.8 7.2 27.2 22.0 12.5 9.2 23.1 38.5 14.7 6.4 10.9 16.3 8.4 12.9 10.9 37.2 15.6 6.6 10.1 13.6 44.7 24.8 11.6 5.5 15.7 12.2 18.2 11.9 9.4 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450169-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.3" "Group enriched" "Detected in many" 10 "Early spermatids: 224.6;Late spermatids: 808.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055969, HPA062366" Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" Cytosol "HPA055969: AB_2682991, HPA062366: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 21.9 12.8 62.7 7.0 70.1 1.8 16.8 55.1 73.3 16.1 40.8 19.2 3.0 13.5 7.0 7.6 13.5 8.8 28.1 62.3 63.9 27.0 7.6 10.8 8.3 66.2 65.4 15.6 6.6 12.9 22.6 3.5 66.1 12.5 4.2 16.0 6.2 11.1 16.8 9.5 10.4 9.7 59.5 7.5 12.5 43.9 61.3 4.6 13.7 13.4 5.3 18.4 13.0 68.9 14.8 16.6 20.6 22.3 44.7 37.9 14.6 19.5 21.8 14.5 15.7 24.9 24.0 7.5 9.4 29.4 45.9 10.6 17.4 3.7 11.6 9.0 10.3 2.9 7.8 42.0 22.7 0.7 3.0 15.5 6.7 16.5 13.0 21.9 10.4 8.4 3.4 21.6 26.4 15.2 0.3 4.6 9.6 20.5 15.8 7.6 17.9 0.3 24.8 6.4 13.0 8.8 10.6 6.2 32.5 15.2 4.5 3.2 17.8 19.8 4.6 36.6 16.8 13.2 14.0 3.3 15.9 5.9 29.8 0.0 0.0 0.0 0.5 0.1 0.5 1.9 1.6 1.3 0.0 1.1 1.1 1.1 0.1 0.4 0.3 0.0 1.3 0.2 62.7 70.1 55.1 73.3 62.3 63.9 66.2 65.4 66.1 59.5 61.3 68.9 22.2 0.0 7.4 27.1 5.9 11.5 10.8 0.9 4.0 22.6 3.8 6.9 11.0 14.3 5.5 18.4 0.0 2.5 5.5 0.9 17.6 4.7 224.6 7.3 9.0 14.6 13.1 0.8 47.4 5.8 7.4 13.3 1.5 8.1 1.3 13.0 15.0 6.3 6.6 23.5 33.2 0.9 4.1 1.3 9.3 808.8 13.7 6.0 17.8 10.3 2.7 22.2 3.1 18.6 37.5 6.3 0.0 23.7 5.1 10.0 1.1 43.7 1.8 15.6 6.6 5.8 26.4 26.8 15.4 0.9 8.0 1.4 13.3 3.0 1.3 6.0 HOXA7 "HOX1, HOX1A" ENSG00000122592 "Homeobox A7" P31268 7 27153716-27157936 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 29.1;Distal tubular cells: 131.0;Early spermatids: 29.4;Proximal tubular cells: 53.4;Spermatocytes: 27.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 29 "medulla oblongata: 4.6;pons: 2.1;spinal cord: 8.2;white matter: 5.1" "Immune cell enriched" "Detected in single" 6 "NK-cell: 4.7" "Lineage enriched" "Detected in single" 6 "NK-cells: 4.7" "Cell line enhanced" "Detected in many" "HAP1: 36.9;RPTEC TERT1: 45.4;SCLC-21H: 36.3" "Region enriched" "Detected in single" 12 "pons and medulla: 1.3" "Region enriched" "Detected in some" 6 "spinal cord: 21.4" HPA074048 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Nuclear membrane" "HPA074048: AB_2686655" "unprognostic (5.40e-2)" "unprognostic (2.34e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (3.30e-1)" "unprognostic (2.53e-1)" "unprognostic (3.02e-1)" "unprognostic (3.24e-2)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.04e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.15e-5)" "unprognostic (9.08e-2)" "unprognostic (8.90e-2)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" 8.2 17.8 0.0 5.9 0.0 0.3 9.4 0.0 0.1 4.2 0.0 13.8 0.2 5.8 17.8 2.8 15.5 0.1 0.0 0.0 0.0 20.1 0.0 2.7 2.1 4.6 0.1 0.8 0.2 0.2 0.0 0.3 2.1 4.9 8.9 0.0 0.0 6.7 16.5 12.0 8.6 3.8 8.2 1.7 3.9 2.4 0.1 2.9 0.5 0.1 0.4 7.3 5.2 5.1 13.6 4.6 0.0 14.1 0.0 0.0 0.8 4.7 8.0 9.6 11.0 7.0 5.1 9.2 12.8 3.7 0.3 9.1 36.9 0.0 5.8 0.0 23.2 0.6 4.8 0.2 0.9 0.8 0.5 7.5 0.4 1.1 12.9 0.0 18.5 15.7 0.0 0.0 3.7 2.4 0.0 2.2 0.5 9.6 1.4 4.8 8.5 0.0 45.4 9.1 36.3 0.1 25.6 0.0 0.1 2.5 0.4 3.7 1.6 0.0 8.6 26.0 4.6 0.0 0.2 0.2 0.0 17.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 4.7 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.1 2.1 8.2 0.1 5.1 11.0 0.0 0.0 0.0 0.6 9.1 7.2 0.1 12.0 0.0 18.7 29.1 0.4 0.0 0.1 12.9 0.0 1.1 1.3 10.3 131.0 0.0 29.4 0.2 2.1 5.9 16.2 5.5 0.0 0.0 3.9 5.8 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 12.5 0.0 0.0 1.9 7.2 0.6 0.6 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.8 0.0 1.7 5.2 2.3 53.4 0.1 0.0 0.0 10.8 16.1 27.4 4.1 8.6 12.4 0.3 1.0 1.2 16.1 5.3 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594392 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 8.7 8.2 15.9 13.2 19.5 12.7 6.1 18.8 22.0 7.0 1.0 11.3 7.3 7.5 5.2 7.7 6.6 9.9 10.5 15.9 9.9 5.2 4.1 9.6 17.2 9.2 3.5 7.0 6.6 8.9 7.7 8.1 9.2 6.0 7.9 10.7 5.6 6.3 8.4 4.1 8.8 9.8 4.7 16.7 7.3 5.9 5.9 20.3 5.9 11.6 12.5 10.8 5.5 10.1 12.7 11.0 18.2 14.8 10.4 11.1 19.2 10.0 9.4 10.9 11.3 14.6 11.5 7.8 13.3 15.4 14.0 12.6 12.6 11.1 8.5 27.7 10.9 9.5 9.7 6.5 8.8 17.3 34.3 9.9 9.9 10.6 9.0 9.5 15.1 44.9 8.5 67.4 8.3 16.2 26.3 16.8 17.6 7.4 11.3 12.0 12.5 51.9 5.6 41.6 12.8 15.7 12.1 10.1 9.5 18.7 4.8 13.8 14.3 12.7 17.9 10.1 7.5 50.2 31.1 5.8 10.5 16.2 11.5 1.1 1.0 2.3 2.8 2.2 3.3 0.4 1.6 1.8 1.1 0.1 2.2 2.5 1.1 3.2 3.4 3.3 0.9 1.0 15.9 19.5 18.8 22.0 15.9 9.9 9.2 3.5 9.2 4.7 5.9 10.1 14.6 6.4 13.1 50.9 11.2 8.0 6.4 2.8 9.1 49.7 5.3 4.2 12.6 2.8 7.8 5.5 8.4 10.2 64.6 4.1 3.9 4.0 13.5 6.2 9.1 14.2 5.4 7.2 150.5 1.5 8.7 9.9 6.6 6.3 0.0 22.4 14.3 3.4 10.5 33.7 124.4 5.6 4.1 36.4 18.4 10.9 9.3 25.3 10.6 73.1 26.8 8.4 71.1 55.8 26.1 3.8 2.5 12.0 48.6 5.9 1.2 3.3 5.1 14.1 6.6 9.9 12.4 8.6 14.0 5.2 6.1 9.4 48.3 9.4 3.6 6.8 KDR "CD309, FLK1, VEGFR, VEGFR2" ENSG00000128052 "Kinase insert domain receptor" P35968 4 55078481-55125595 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6" "Cancer enhanced" "Detected in all" "renal cancer: 27.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 74.8;TIME: 83.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004028, HPA073577" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 11000000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Nuclear membrane" "CAB004028: AB_2212507, HPA073577: " "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (9.65e-2)" "unprognostic (1.97e-1)" "unprognostic (9.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.78e-3)" "unprognostic (2.59e-2)" "unprognostic (1.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.79e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.00e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" "unprognostic (1.86e-1)" 41.6 11.7 2.7 4.3 3.8 0.0 26.1 2.8 4.1 14.8 10.4 6.3 2.2 39.5 2.9 4.0 17.9 5.6 20.6 2.1 2.8 15.7 9.2 23.5 2.8 3.2 3.6 5.2 6.2 8.6 11.0 30.9 3.5 11.7 1.0 16.4 5.3 10.0 6.5 5.9 7.5 7.5 3.3 4.4 8.4 1.8 4.5 1.0 34.4 4.6 1.0 8.6 7.5 3.4 0.0 0.0 4.4 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.5 0.0 0.0 0.9 0.0 0.0 0.4 0.2 74.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.8 2.8 4.1 2.1 2.8 3.2 3.6 3.5 3.3 4.5 3.4 157.8 0.0 4.9 0.0 1.4 2.5 0.5 0.1 1.8 11.7 1.3 2.5 9.4 1.5 18.4 0.0 0.0 0.1 0.8 0.0 0.0 0.5 0.8 0.4 2.6 143.8 0.0 2.7 0.1 0.0 0.1 8.3 0.0 0.8 2.5 0.0 158.1 3.3 0.4 0.0 1.3 0.0 0.0 10.6 2.1 0.9 0.0 1.2 7.2 7.5 0.0 206.6 0.0 0.0 6.1 0.5 0.0 0.4 1.3 0.5 0.0 0.0 3.9 7.9 0.0 0.9 7.5 0.3 0.9 0.8 2.7 0.1 0.6 1.6 0.0 1.4 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981389 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 92.2;Inhibitory neurons: 54.6;Oligodendrocyte precursor cells: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 20.6;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" NA NA 14000 "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favorable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 0.6 1.7 2.7 0.3 3.0 0.3 1.5 0.0 4.4 1.4 0.0 0.8 0.7 1.7 1.8 0.5 2.2 1.0 1.2 4.3 0.8 3.9 0.4 1.8 0.2 1.6 2.5 1.2 6.3 2.4 1.8 1.3 0.0 1.5 0.7 5.7 2.4 5.5 0.5 0.8 0.7 1.3 1.4 0.3 1.3 1.2 2.5 2.4 0.7 0.8 0.2 1.1 0.6 2.4 4.9 9.2 9.1 14.9 0.1 0.0 4.2 5.2 4.6 2.6 3.4 8.4 2.6 0.0 2.9 8.2 8.6 1.0 5.7 1.4 3.6 2.5 3.8 2.6 11.5 2.2 1.3 3.8 3.2 1.2 2.8 0.9 1.4 3.5 4.8 3.4 1.7 0.1 3.6 4.5 2.9 4.7 7.8 4.1 20.6 6.8 4.5 0.0 1.7 3.3 11.8 21.5 2.6 5.2 2.2 5.1 3.7 2.4 3.3 2.9 2.8 0.1 5.1 0.9 0.0 0.1 4.0 1.4 7.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 3.0 0.0 4.4 4.3 0.8 1.6 2.5 0.0 1.4 2.5 2.4 2.0 0.0 2.2 11.8 0.1 0.5 2.1 1.6 0.6 18.5 6.3 4.6 2.5 0.0 2.9 7.3 56.3 2.5 0.2 0.3 0.0 2.3 0.5 8.5 8.1 4.8 10.8 1.3 92.2 3.2 2.2 3.0 3.6 8.0 16.5 13.8 2.2 0.8 0.5 3.3 54.6 2.5 6.1 0.8 1.2 0.2 1.5 0.5 1.8 26.2 0.0 7.2 0.0 69.9 2.2 5.0 1.4 2.6 1.0 3.1 0.5 8.1 12.2 29.2 6.6 2.2 2.9 0.3 7.2 0.1 0.9 1.5 1.1 2.4 2.9 1.6 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 87.0;Erythroid cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 4.1 4.8 2.0 3.6 2.4 8.6 5.4 9.4 3.7 4.6 0.0 2.9 2.1 6.1 3.7 3.3 2.8 4.6 3.5 2.3 3.0 3.6 4.9 2.7 4.6 2.9 2.4 7.6 2.8 5.2 3.7 9.4 2.8 5.2 2.6 4.0 2.7 3.6 1.6 2.5 2.4 4.4 1.4 4.5 2.1 8.0 2.8 5.9 5.7 3.4 3.9 4.8 2.6 2.6 8.6 3.5 21.9 25.1 8.5 13.7 12.0 14.1 11.6 12.0 14.4 5.9 2.7 3.4 11.4 10.4 10.6 4.2 16.7 8.3 16.4 10.7 12.7 35.9 8.0 13.3 11.1 29.0 12.7 10.1 5.9 10.6 11.7 8.5 11.5 9.1 49.9 2.7 14.4 6.8 14.0 17.5 14.2 3.0 5.0 12.8 16.0 8.4 8.0 17.6 18.5 16.8 9.3 3.0 10.6 15.1 7.2 26.0 9.4 18.6 7.7 17.9 10.2 10.9 15.4 16.8 11.5 21.0 7.7 0.2 2.5 2.0 2.3 2.0 2.7 3.7 3.4 3.0 3.9 3.1 4.2 3.6 0.1 5.3 2.0 4.0 4.4 1.9 2.0 2.4 9.4 3.7 2.3 3.0 2.9 2.4 2.8 1.4 2.8 2.6 15.4 9.6 6.3 10.4 8.8 10.5 4.5 13.0 13.1 15.4 7.4 11.7 23.1 1.5 7.8 7.3 2.1 43.3 11.7 1.0 11.7 7.0 87.0 4.6 29.6 12.5 5.4 74.9 32.4 5.4 33.2 21.4 3.1 3.2 13.3 30.5 8.2 4.0 12.5 10.1 32.7 2.4 6.1 6.6 7.1 21.9 12.8 8.9 3.6 12.2 9.7 9.6 15.5 23.6 24.4 2.8 0.9 14.7 13.0 2.3 0.7 14.6 8.4 8.2 19.7 19.5 17.6 23.4 17.9 8.7 4.4 10.7 10.6 29.5 3.2 1.6 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180912897-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 25.3" "Group enriched" "Detected in many" 13 "Bipolar cells: 95.3;Cone photoreceptor cells: 131.3;Rod photoreceptor cells: 176.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SH-SY5Y: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: AB_2684585" "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 5.7 1.2 3.8 1.3 3.9 0.4 4.0 15.4 6.1 7.2 4.3 8.4 2.4 8.1 1.3 3.5 6.1 2.5 7.7 4.9 2.4 6.2 0.5 3.6 1.2 3.6 3.2 5.8 1.7 0.3 1.8 2.8 2.9 4.8 0.6 25.3 3.2 2.1 2.0 2.5 2.9 3.1 2.8 2.5 3.2 1.7 4.0 0.3 6.1 0.4 0.4 7.4 4.2 5.3 1.7 0.8 1.4 3.0 4.3 10.5 4.8 3.3 3.8 1.6 0.9 1.6 1.7 0.7 3.0 4.1 0.8 3.2 0.3 0.1 0.5 0.9 1.3 2.4 0.6 2.2 5.9 1.5 1.7 5.0 0.1 0.2 0.1 2.7 2.2 2.5 2.1 1.1 1.4 1.4 2.1 0.6 3.3 0.5 0.4 1.1 17.8 2.5 2.6 1.6 12.2 44.7 1.0 1.1 7.3 1.4 1.3 2.1 5.2 3.4 2.5 4.0 1.3 2.3 3.2 1.6 0.4 1.2 2.3 1.3 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 3.8 3.9 15.4 6.1 4.9 2.4 3.6 3.2 2.9 2.8 4.0 5.3 1.0 0.0 1.8 9.8 0.5 0.4 0.8 0.8 0.6 95.3 0.5 0.6 3.5 1.5 1.3 1.8 131.3 0.3 0.5 0.0 1.9 0.4 4.6 0.8 3.6 2.1 0.0 0.0 5.0 0.2 0.4 3.3 0.0 2.2 1.3 1.6 1.8 0.1 1.8 3.3 1.5 0.0 0.0 0.3 0.4 1.8 7.8 0.5 3.6 1.0 1.0 10.0 0.0 4.5 1.4 0.7 0.0 5.7 0.1 0.4 0.2 1.8 0.1 176.0 6.6 8.4 2.4 0.6 0.6 0.2 0.3 0.3 0.4 0.6 0.1 0.0 KLHL11 FLJ10572 ENSG00000178502 "Kelch like family member 11" Q9NVR0 17 41848518-41865423 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 108.3;Late spermatids: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023021, HPA052403, HPA054269" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear membrane" "HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432" "unprognostic (9.90e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-1)" "unprognostic (2.07e-1)" "unprognostic (1.84e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-2)" "unprognostic (1.50e-1)" "unprognostic (1.83e-2)" "unprognostic (3.25e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-3)" "unprognostic (4.05e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-2)" "unprognostic (5.07e-2)" 2.0 2.5 7.5 2.0 6.9 9.1 3.6 8.7 8.2 2.2 1.6 2.0 1.7 2.8 4.0 1.8 2.5 1.6 2.0 9.7 7.6 2.6 2.5 2.3 2.8 6.8 6.3 3.9 3.0 4.6 0.8 2.0 7.4 2.9 1.8 7.1 2.2 2.7 4.3 3.2 1.7 1.8 5.1 2.8 2.2 9.7 7.5 2.7 4.5 1.9 2.8 1.6 0.8 7.0 3.3 5.6 3.9 10.3 5.3 2.8 6.8 3.1 2.9 3.3 3.1 5.2 2.5 10.7 3.4 3.8 3.0 9.3 10.1 4.4 6.0 4.1 4.5 3.8 8.2 7.1 4.9 4.7 4.1 3.4 4.0 4.4 8.3 3.4 3.4 5.3 3.4 9.1 4.3 4.2 7.1 4.9 3.4 2.9 1.8 6.1 9.5 7.7 3.7 5.7 9.8 4.8 5.4 24.9 4.2 3.8 10.9 3.8 5.3 5.1 6.9 4.9 6.2 5.6 5.1 7.9 5.4 4.9 4.8 0.2 0.5 0.3 0.5 0.7 0.8 0.6 0.6 0.6 0.5 0.8 0.7 0.6 0.2 0.4 0.4 0.3 0.4 0.4 7.5 6.9 8.7 8.2 9.7 7.6 6.8 6.3 7.4 5.1 7.5 7.0 1.2 0.0 0.5 6.8 4.5 0.5 1.4 0.2 14.8 3.8 0.9 1.8 0.2 0.0 1.5 0.0 4.2 0.4 3.6 0.3 0.0 0.4 108.3 1.6 3.4 1.5 0.0 3.0 16.6 0.2 0.4 3.0 10.7 1.9 0.0 1.1 0.0 0.0 0.3 8.4 18.0 0.7 0.0 0.0 1.0 41.8 0.3 1.5 1.8 4.7 0.9 1.8 1.0 11.1 13.9 0.5 0.1 0.0 5.8 0.9 0.9 0.2 0.0 3.6 6.6 2.2 3.2 5.5 2.1 5.5 0.3 0.4 4.6 0.9 0.6 0.9 KLK7 "PRSS6, SCCE" ENSG00000169035 "Kallikrein related peptidase 7" P49862 19 50976468-50984099 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 94.7;skin 1: 201.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 139.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018994, CAB026342, HPA062126" Enhanced Supported "Nuclear membrane,Plasma membrane" "Secreted in other tissues" NA NA 3700000 "Cluster 11: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane" "Nuclear membrane" "CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691" "unprognostic (1.88e-2)" "unprognostic (6.41e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (8.06e-5)" "unprognostic (4.33e-3)" "unprognostic (2.28e-1)" "unprognostic (4.44e-3)" "unprognostic (2.99e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.10e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-1)" "unprognostic (4.47e-2)" "unprognostic (1.12e-2)" "unprognostic (5.60e-3)" 7.1 0.1 8.4 0.1 9.2 0.3 11.2 0.9 7.4 19.7 1.0 0.1 0.5 0.7 0.2 94.7 16.3 1.3 0.2 6.5 1.4 12.1 0.1 3.1 0.0 4.3 1.4 0.1 0.1 0.3 0.7 0.0 4.9 0.1 0.0 0.1 21.6 0.2 1.0 201.2 0.0 0.2 2.1 0.8 0.3 0.3 7.4 0.9 0.2 0.0 10.9 0.0 30.9 3.0 5.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.8 8.0 0.0 1.1 0.0 0.1 31.7 0.0 1.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 8.4 9.2 0.9 7.4 6.5 1.4 4.3 1.4 4.9 2.1 7.4 3.0 0.0 6.4 1.1 0.0 0.0 5.0 0.1 0.5 4.6 0.0 9.4 10.4 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.6 0.2 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 5.9 10.7 0.0 0.1 0.0 0.1 2.7 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703524 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 273.0" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 20.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "HaCaT: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" NA NA 1200000000 "Cluster 61: Skin - Cornification" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 28: Keratinocytes - Keratinization" "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.6 0.0 0.0 0.0 0.0 0.1 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 273.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.2 0.0 0.0 0.0 0.0 0.0 LCORL "FLJ30696, MLR1" ENSG00000178177 "Ligand dependent nuclear receptor corepressor like" Q8N3X6 4 17841199-18021876 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 133.6;Microglial cells: 135.9;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 164.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028794, HPA028795, HPA060033" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear membrane" "HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192" "unprognostic (1.06e-1)" "unprognostic (4.95e-2)" "prognostic favorable (9.65e-4)" "unprognostic (3.22e-3)" "unprognostic (3.62e-2)" "unprognostic (2.54e-4)" "unprognostic (8.90e-4)" "unprognostic (3.46e-1)" "unprognostic (3.52e-2)" "unprognostic (7.59e-2)" "unprognostic (2.10e-1)" "unprognostic (1.22e-1)" "unprognostic (7.39e-2)" "unprognostic (1.70e-2)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (7.27e-4)" 2.6 3.7 2.8 3.0 3.6 3.7 2.8 6.4 3.4 2.6 2.1 3.2 5.8 3.0 2.8 2.5 2.0 3.4 1.6 2.3 6.9 4.0 3.4 2.8 3.6 3.4 5.0 4.1 3.3 4.6 1.6 3.9 3.6 2.7 3.6 6.5 2.3 2.1 2.8 4.9 7.0 2.7 3.4 3.4 4.5 5.8 6.3 3.9 3.7 2.9 2.7 2.7 1.9 5.5 5.3 3.4 11.5 5.1 7.1 10.5 2.8 5.9 6.3 5.0 6.7 2.1 7.0 11.4 2.7 3.5 8.8 2.2 4.9 2.2 5.4 1.6 3.7 9.7 5.6 2.4 4.6 7.5 6.7 6.0 2.9 3.3 8.1 7.9 7.1 6.9 5.6 12.1 6.3 1.7 7.3 13.0 5.3 4.1 5.3 7.8 9.1 6.1 7.1 3.0 8.7 10.2 4.8 2.7 3.3 5.2 5.0 4.3 5.8 7.9 4.6 6.7 11.5 12.0 6.2 9.6 6.5 7.9 7.1 7.6 3.3 3.3 2.2 3.5 1.7 2.8 1.3 1.3 2.8 3.5 1.5 2.2 2.5 2.3 3.0 2.3 2.2 1.3 2.8 3.6 6.4 3.4 2.3 6.9 3.4 5.0 3.6 3.4 6.3 5.5 16.9 12.8 15.6 65.6 18.2 23.8 4.4 7.9 17.1 18.4 13.0 9.0 9.4 34.3 9.5 7.3 41.7 8.8 20.9 16.1 9.8 12.3 33.2 14.0 13.1 23.4 35.4 10.1 69.2 10.9 9.0 10.2 14.8 11.8 19.6 26.5 12.8 13.6 16.4 20.2 133.6 23.5 8.2 18.9 29.2 20.1 14.6 23.5 3.6 135.9 21.0 10.4 13.4 117.1 164.2 12.4 16.1 7.5 40.7 10.1 34.1 14.6 15.9 22.5 19.7 13.6 12.8 52.2 16.3 13.6 19.0 9.9 11.6 19.8 16.5 6.3 LFNG SCDO3 ENSG00000106003 "LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q8NES3 7 2512529-2529177 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 74.4" "Cell type enhanced" "Detected in many" "dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069130 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 880000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "Nuclear membrane" "HPA069130: AB_2686091" "unprognostic (4.58e-2)" "unprognostic (1.17e-2)" "unprognostic (2.52e-2)" "prognostic favorable (6.36e-4)" "unprognostic (1.85e-2)" "unprognostic (8.34e-2)" "unprognostic (4.15e-1)" "unprognostic (7.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (5.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.09e-1)" "unprognostic (1.97e-2)" "unprognostic (2.28e-2)" 16.7 6.5 23.3 17.3 25.9 9.8 13.7 29.3 22.4 9.9 11.1 23.1 15.5 9.4 2.2 11.4 6.1 11.8 13.1 17.4 30.1 9.0 2.5 14.4 18.6 34.1 35.6 1.8 74.4 3.0 3.7 6.5 24.8 17.1 12.0 3.0 33.4 4.6 4.6 58.2 17.2 5.8 25.0 20.9 37.8 4.2 38.1 5.8 6.7 3.6 10.8 12.2 13.8 23.6 1.5 14.3 18.4 2.5 2.0 1.7 1.2 5.4 2.8 4.7 5.9 6.0 37.7 1.1 16.7 14.8 8.1 27.1 2.9 5.1 2.3 8.6 0.6 4.3 7.7 3.2 0.1 6.2 7.7 3.3 12.6 7.8 0.8 3.2 1.9 0.3 0.7 0.2 3.6 34.5 0.1 8.7 22.4 46.4 10.3 1.8 46.0 2.9 1.8 4.5 16.9 4.2 6.2 1.4 0.3 4.7 10.2 7.3 4.5 10.5 49.7 0.4 15.4 0.2 0.0 1.4 11.8 16.4 2.0 6.3 5.3 12.7 1.8 6.9 2.0 1.1 1.7 0.9 2.3 2.0 1.8 1.8 2.8 1.3 6.6 0.6 4.2 1.7 23.3 25.9 29.3 22.4 17.4 30.1 34.1 35.6 24.8 25.0 38.1 23.6 23.3 6.4 6.0 18.9 15.6 6.8 2.5 10.6 3.4 8.5 5.3 12.4 3.6 5.7 2.8 0.0 0.0 0.1 40.3 23.1 0.0 1.2 0.1 2.4 8.5 16.0 87.4 2.7 0.0 6.4 0.3 5.7 30.5 1.2 17.7 0.1 13.9 0.6 7.0 0.0 0.1 34.5 6.1 30.4 13.8 0.5 1.8 30.6 3.6 11.2 38.2 31.3 19.6 1.5 0.1 21.7 3.1 0.0 12.6 2.2 8.8 0.4 1.2 0.8 0.0 0.6 5.0 0.3 3.1 0.6 4.0 0.0 15.9 0.5 15.3 0.7 MAD1L1 "HsMAD1, MAD1, PIG9, TP53I9, TXBP181" ENSG00000002822 "Mitotic arrest deficient 1 like 1" Q9Y6D9 7 1815793-2233243 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 316.9;Late spermatids: 685.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003635, CAB015338" Supported Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 17: WM-115 - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "CAB015338: AB_627901, HPA003635: AB_1853472" "unprognostic (1.85e-1)" "unprognostic (3.76e-2)" "unprognostic (4.26e-3)" "unprognostic (8.32e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" "unprognostic (2.70e-2)" "unprognostic (1.18e-2)" "unprognostic (4.78e-2)" "unprognostic (5.76e-2)" "unprognostic (1.89e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (5.18e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (4.57e-1)" 9.4 6.0 6.2 11.1 8.3 14.9 9.0 4.6 8.4 11.4 5.1 7.7 6.0 9.3 2.5 9.2 7.4 4.8 8.8 5.6 6.7 6.5 6.4 10.2 17.8 7.8 6.6 7.4 5.6 4.1 7.1 5.0 7.6 8.2 3.4 4.0 7.3 5.6 13.6 14.5 9.7 5.3 5.5 18.2 6.6 10.7 7.0 15.3 8.6 5.0 10.7 8.3 10.1 9.4 37.2 15.5 16.5 30.1 11.1 11.2 26.5 25.6 13.0 26.0 20.7 28.5 21.5 23.4 10.4 14.7 39.9 28.5 12.4 18.3 15.7 11.1 17.8 30.1 19.4 45.0 15.7 21.1 55.1 13.9 13.3 28.8 14.0 6.3 14.9 13.7 30.3 17.4 10.3 45.4 8.7 61.0 30.7 5.8 20.5 38.5 16.7 17.5 12.7 18.7 10.7 33.4 20.0 24.9 65.2 11.2 17.1 48.9 17.6 21.8 60.0 62.3 26.0 30.3 31.4 27.3 18.1 60.6 80.3 60.4 36.2 25.4 71.3 62.4 66.6 54.6 69.2 72.3 63.4 63.0 92.0 66.0 8.6 22.7 60.1 26.0 131.5 53.6 6.2 8.3 4.6 8.4 5.6 6.7 7.8 6.6 7.6 5.5 7.0 9.4 9.3 3.2 10.4 12.1 33.8 17.6 13.9 14.0 15.4 8.3 6.2 6.5 7.4 14.3 11.9 7.3 10.4 16.2 35.7 12.4 15.6 12.3 316.9 5.5 6.7 10.7 32.4 19.1 20.9 11.4 16.3 11.4 11.7 6.9 41.8 15.5 6.4 36.4 39.6 23.5 24.4 9.4 16.2 31.4 84.1 685.9 12.5 28.2 37.4 21.5 25.7 24.3 47.4 16.1 32.4 16.5 7.9 10.5 14.9 9.4 5.4 15.2 6.6 13.9 19.7 11.2 10.2 60.3 33.8 9.3 21.5 24.5 43.1 17.5 8.8 9.7 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934834 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 251.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 275.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear membrane" Nucleoplasm "HPA043209: AB_2678364" "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavorable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 35.2 20.2 15.8 9.9 16.4 66.1 30.5 13.6 24.1 43.1 19.3 30.3 12.3 34.7 3.3 27.6 36.9 12.5 26.5 16.1 14.4 33.6 10.8 36.9 13.2 16.9 14.7 41.6 29.0 3.6 28.7 11.5 14.7 34.3 3.8 1.1 30.4 11.3 14.0 22.0 31.0 7.6 13.2 36.1 31.6 15.6 17.6 6.3 37.6 3.4 6.3 34.6 32.8 14.3 50.4 46.2 13.3 33.7 21.7 15.5 36.0 45.1 21.9 21.5 24.6 24.7 117.3 8.8 23.7 28.4 40.0 45.9 12.1 65.6 5.8 56.9 40.7 19.1 39.2 25.9 36.5 59.9 27.1 23.5 37.5 24.5 15.4 33.4 24.7 20.0 26.4 18.0 16.5 53.8 16.9 275.6 43.0 38.9 54.5 20.7 6.4 41.8 32.9 30.6 34.2 40.7 10.8 31.5 49.1 13.5 82.9 112.9 37.1 17.7 30.4 22.2 36.6 12.2 5.8 13.8 50.0 153.3 27.8 64.7 55.0 117.4 73.0 71.2 62.6 45.1 46.8 82.1 57.4 35.2 23.3 41.1 44.2 45.9 95.8 45.7 34.4 42.6 15.8 16.4 13.6 24.1 16.1 14.4 16.9 14.7 14.7 13.2 17.6 14.3 64.6 38.5 29.1 17.6 41.3 31.4 78.8 251.5 28.5 9.2 56.3 68.1 5.0 28.6 123.2 46.0 8.4 67.4 71.0 37.8 3.9 96.0 11.7 41.5 33.4 41.1 28.2 13.3 21.5 45.9 93.0 42.9 33.6 44.3 32.4 50.7 45.7 3.1 69.6 15.2 14.8 37.2 93.6 49.3 36.7 18.8 36.4 45.6 42.7 9.4 62.1 11.0 64.9 9.5 8.8 86.0 51.5 22.6 28.1 92.1 60.0 17.9 104.9 10.0 92.1 27.0 56.6 15.5 16.1 26.9 26.9 83.7 62.4 44.7 49.4 100.5 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA 23000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 15.0 22.4 12.8 8.6 16.3 19.1 19.2 21.9 19.0 18.6 2.9 15.0 9.3 19.5 20.6 14.1 15.6 14.2 9.9 14.7 10.5 16.8 17.5 12.1 12.4 10.6 11.4 18.5 13.7 20.5 5.3 21.1 10.9 19.3 18.7 20.0 11.5 16.4 4.3 16.4 11.6 16.4 11.3 10.5 15.7 21.3 15.5 7.5 18.3 2.4 11.6 15.3 10.3 17.7 12.4 11.1 21.5 22.9 30.9 28.9 17.9 38.1 19.4 28.4 33.1 9.6 19.0 9.2 7.2 41.8 19.9 11.2 18.5 22.8 25.5 28.2 25.5 30.0 16.0 10.8 39.3 6.2 24.3 22.5 19.6 25.3 18.1 27.4 23.1 21.7 18.6 7.6 28.5 13.4 13.2 7.5 7.8 19.9 21.6 6.5 12.5 6.4 32.1 9.2 17.6 19.2 18.5 17.5 16.1 19.2 20.4 13.4 23.9 18.5 14.4 31.4 11.2 45.6 18.8 15.7 21.2 13.6 15.1 2.6 1.7 1.5 2.2 3.5 1.8 1.3 1.5 2.4 1.9 1.9 1.0 2.0 1.5 1.7 4.0 2.0 3.1 1.5 12.8 16.3 21.9 19.0 14.7 10.5 10.6 11.4 10.9 11.3 15.5 17.7 17.3 22.4 14.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 9.7 7.4 0.0 0.0 3.7 14.7 0.0 18.7 10.7 0.0 19.6 11.6 0.0 8.2 18.1 5.2 0.0 0.0 0.0 8.3 17.0 7.5 0.0 9.7 1.3 11.5 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 9.0 0.0 0.0 4.0 0.0 0.0 17.7 11.7 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 32.7 3.0 13.7 0.0 0.0 MPL "CD110, THPOR, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337818-43354466 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Erythroid cells: 3.0;Excitatory neurons: 2.0;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 57 "HEL: 77.4" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Low region specificity" "Detected in many" HPA007619 Supported "Nuclear membrane,Plasma membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 36: HEL - Hemostasis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 0.6 0.4 0.8 0.2 1.7 1.8 0.4 0.8 1.3 0.3 0.1 0.3 0.3 0.7 1.2 0.5 0.8 0.3 1.0 0.6 1.2 0.4 0.4 0.6 0.2 1.2 1.0 2.9 0.8 0.4 0.0 0.3 1.1 0.9 0.4 1.5 0.4 0.7 0.6 0.5 0.2 0.7 0.7 0.4 0.5 1.2 1.1 0.1 0.9 0.3 0.1 0.2 0.0 2.8 0.4 0.7 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 1.3 0.1 0.3 0.1 0.0 0.6 0.0 0.2 0.0 0.4 0.1 77.4 1.2 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.1 0.1 0.2 0.0 0.2 0.7 0.6 0.4 0.2 0.6 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.2 1.4 0.1 0.1 0.3 0.1 1.8 0.8 1.7 0.8 1.3 0.6 1.2 1.2 1.0 1.1 0.7 1.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013382 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 171.2;intestine: 159.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8" "Region enriched" "Detected in many" 5 "cerebellum: 14.8" "Region enhanced" "Detected in some" "spinal cord: 4.8" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 41.7 3.8 2.6 12.8 2.9 0.0 32.5 12.0 3.9 103.6 5.5 159.2 9.3 171.2 14.2 16.2 98.0 16.7 13.7 2.4 3.1 17.1 7.0 18.7 4.5 4.7 2.8 37.0 3.4 0.5 4.1 11.6 3.3 48.3 8.9 0.2 10.8 45.6 5.1 15.2 38.3 59.3 2.8 13.4 44.1 7.3 2.8 0.7 10.7 3.0 1.3 75.2 65.6 2.5 0.0 0.1 0.1 0.0 67.6 30.0 1.4 39.5 99.1 36.8 24.3 0.0 1.8 0.0 0.8 30.8 0.1 0.1 0.1 0.0 6.8 0.0 0.0 0.0 2.8 0.0 8.5 0.0 0.0 22.1 0.0 23.5 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.9 1.5 0.8 0.1 0.0 3.4 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 2.5 0.0 0.0 0.0 22.4 0.0 46.8 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.9 12.0 3.9 2.4 3.1 4.7 2.8 3.3 2.8 2.8 2.5 3.2 0.0 0.0 0.0 0.6 5.0 0.2 0.0 1.2 0.0 0.3 2.3 0.6 2.8 0.0 11.0 0.0 0.7 0.1 0.0 0.0 0.0 4.9 1.1 20.6 2.3 0.0 0.0 1.1 0.0 0.6 33.3 0.5 0.8 0.0 0.0 3.9 3.8 1.1 0.0 0.2 0.0 0.0 0.0 7.3 7.9 66.2 0.2 7.2 3.7 0.0 3.0 0.0 0.0 0.2 0.1 0.0 100.8 0.1 0.3 0.0 0.9 0.0 0.3 52.6 19.1 63.7 1.3 0.5 0.4 3.8 1.1 0.6 0.6 0.0 0.4 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 10: Non-specific - Unknown function" Mitochondria "Nuclear membrane" "HPA051087: AB_2681339" "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.2 20.3 24.9 11.2 26.8 4.5 20.6 26.5 28.3 16.2 20.0 13.4 12.4 17.4 21.7 9.5 15.4 13.9 15.1 23.4 26.9 20.4 19.2 13.2 15.8 26.7 25.8 18.4 14.8 28.0 12.2 13.9 26.7 20.2 15.7 22.5 17.0 16.9 13.0 11.4 11.9 14.9 26.6 14.3 14.1 11.2 25.0 17.5 23.2 14.2 15.1 12.0 9.3 28.3 16.2 12.8 29.5 10.5 32.6 23.4 9.4 13.8 16.8 23.0 23.7 16.7 13.9 20.4 16.5 18.6 10.1 14.0 18.5 16.1 24.3 22.6 25.4 16.8 25.6 19.2 13.8 18.9 14.5 25.6 19.4 13.6 9.4 20.3 19.4 17.4 20.7 17.6 16.2 8.9 20.8 13.7 16.2 30.1 6.7 17.8 15.6 24.4 15.8 12.8 24.8 17.4 20.0 18.3 13.8 23.1 21.7 19.7 15.9 7.8 8.6 16.4 12.5 19.1 17.5 25.1 11.1 17.5 16.6 9.3 15.2 7.7 14.8 15.1 21.2 17.5 15.5 15.8 16.2 17.3 20.8 17.6 5.2 18.2 12.3 14.0 19.0 14.3 24.9 26.8 26.5 28.3 23.4 26.9 26.7 25.8 26.7 26.6 25.0 28.3 29.8 28.9 24.5 5.5 38.4 22.0 52.6 105.9 22.2 17.5 31.6 33.8 78.1 44.3 64.0 55.2 14.6 95.4 26.7 26.4 137.0 69.8 23.8 26.5 35.8 39.1 31.8 46.3 7.8 44.8 107.0 41.4 20.4 26.6 18.3 34.8 33.9 67.2 80.7 1.7 9.4 35.8 103.7 34.7 23.9 12.9 46.6 25.6 49.8 9.4 73.9 46.1 45.3 6.6 10.4 47.7 45.7 42.9 48.7 50.0 35.3 126.1 50.6 22.6 39.5 25.1 66.4 96.9 39.1 36.7 29.3 56.1 28.8 43.0 48.8 52.6 MRPS23 "CGI-138, HSPC329, MRP-S23" ENSG00000181610 "Mitochondrial ribosomal protein S23" Q9Y3D9 17 57834781-57850056 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 187.7;Proximal tubular cells: 190.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023453 Supported Supported "Nuclear membrane,Mitochondria" No No "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nuclear membrane" "HPA023453: AB_1854125" "unprognostic (3.84e-3)" "unprognostic (3.36e-1)" "unprognostic (1.75e-2)" "unprognostic (2.00e-2)" "unprognostic (7.96e-2)" "unprognostic (3.06e-3)" "prognostic unfavorable (9.52e-4)" "unprognostic (3.71e-1)" "unprognostic (7.92e-2)" "unprognostic (2.63e-3)" "unprognostic (1.39e-2)" "unprognostic (8.74e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (2.83e-1)" 21.7 37.5 22.7 26.4 23.5 24.4 25.4 22.9 29.6 17.8 21.4 22.2 23.8 25.3 29.7 25.1 24.8 16.7 86.3 23.6 23.3 38.5 24.5 21.9 31.1 23.3 23.7 20.2 39.6 47.5 20.3 20.6 24.8 36.2 20.3 31.9 20.9 24.8 61.5 19.8 20.7 21.8 23.5 21.7 39.4 23.4 23.2 30.3 36.7 44.5 26.9 28.2 18.0 25.2 137.6 137.0 71.7 75.7 42.6 49.5 82.5 86.9 64.9 118.4 90.8 102.6 80.1 173.1 251.9 67.0 109.3 66.3 113.8 102.3 98.2 137.7 135.9 125.4 51.3 179.9 80.9 165.7 115.9 45.4 89.9 87.9 90.8 54.0 75.8 90.9 190.5 60.4 94.0 117.8 154.8 96.1 86.8 153.7 142.8 111.1 120.4 144.0 91.7 65.1 95.8 149.2 65.5 54.5 177.6 52.0 169.1 121.8 66.9 100.0 127.5 100.8 186.3 131.6 301.3 197.5 95.1 102.3 93.7 67.7 41.2 66.2 39.2 51.5 41.2 44.3 38.9 39.9 57.8 47.9 41.3 41.5 6.6 47.2 37.8 54.6 41.3 45.8 22.7 23.5 22.9 29.6 23.6 23.3 23.3 23.7 24.8 23.5 23.2 25.2 34.9 48.1 33.6 3.6 30.2 33.4 40.4 109.4 26.7 41.6 30.1 42.4 187.7 27.1 60.5 47.8 12.5 81.6 30.0 18.4 148.7 84.8 5.9 42.5 37.0 40.0 22.1 28.4 6.1 100.0 87.0 37.4 29.6 36.3 23.4 43.9 24.3 39.7 85.5 50.5 6.8 29.2 69.2 35.2 23.5 10.0 32.6 31.5 40.9 4.7 67.1 63.1 48.4 2.5 10.0 87.7 25.5 39.5 29.1 58.9 20.8 190.8 55.6 64.4 26.3 37.5 43.8 38.3 85.9 39.3 32.5 42.5 27.4 65.4 40.9 34.2 MX1 "IFI-78K, lncMX1-215, MxA" ENSG00000157601 "MX dynamin like GTPase 1" P20591 21 41420020-41470071 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 127.0" "Cell type enhanced" "Detected in many" "Adipocytes: 101.8;Extravillous trophoblasts: 77.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 820.2;BJ hTERT+ SV40 Large T+ RasG12V: 734.3;Karpas-707: 160.6;SK-MEL-30: 259.3" "Low region specificity" "Detected in all" "HPA030917, HPA030918, HPA049724" Approved Approved Supported "Nuclear membrane,Cytosol" No NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear membrane, Cytosol" "HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862" "unprognostic (3.62e-1)" "unprognostic (6.84e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (2.27e-1)" "unprognostic (1.35e-3)" "unprognostic (5.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (6.88e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.95e-2)" "unprognostic (8.10e-2)" "unprognostic (3.24e-1)" "unprognostic (1.81e-1)" 25.6 14.9 17.5 29.0 18.9 51.7 23.8 19.4 18.2 37.7 14.4 19.7 30.7 15.9 20.5 42.4 25.2 37.7 22.7 14.3 27.8 27.5 25.3 31.7 38.8 35.9 22.5 27.0 13.1 15.3 30.3 20.7 30.2 15.1 11.6 4.3 127.0 16.4 7.6 11.6 28.8 24.4 62.5 75.3 35.3 8.6 23.2 65.0 26.6 9.7 36.8 29.7 24.4 21.5 16.4 0.5 0.7 1.2 0.6 6.8 0.2 1.0 25.6 820.2 734.3 5.3 33.6 0.2 6.5 2.7 7.8 1.6 0.3 0.8 15.9 4.2 0.2 0.9 2.3 1.9 7.3 0.4 0.4 7.4 2.3 48.8 1.1 0.4 2.8 2.7 0.0 160.6 0.4 1.3 14.5 1.8 2.6 0.5 8.3 12.6 0.1 26.4 3.3 9.9 0.7 0.3 1.1 1.3 259.3 0.1 10.6 6.7 1.7 0.8 0.7 0.1 0.7 35.9 37.6 1.0 0.9 2.2 1.8 31.6 45.0 25.6 17.9 47.6 25.8 38.6 27.3 21.9 31.0 36.7 23.3 16.9 64.7 18.9 44.5 44.7 51.9 35.0 17.5 18.9 19.4 18.2 14.3 27.8 35.9 22.5 30.2 62.5 23.2 21.5 101.8 32.1 25.3 2.6 41.9 6.4 17.6 13.0 15.9 3.7 8.0 8.9 8.8 11.5 22.4 23.9 0.0 3.2 47.2 10.1 19.6 38.6 0.7 16.0 11.1 66.8 0.0 2.1 7.7 56.1 77.3 21.5 34.1 15.9 1.3 38.1 20.3 5.8 53.3 1.7 7.1 16.7 2.0 20.8 16.2 1.2 10.8 50.9 19.6 24.4 32.0 6.8 11.3 2.5 1.2 38.8 4.3 16.6 28.7 9.9 29.2 5.0 32.1 2.4 0.0 7.7 17.8 0.4 4.0 32.6 3.4 4.1 28.3 13.4 7.5 34.2 NAV3 "KIAA0938, POMFIL1" ENSG00000067798 "Neuron navigator 3" Q8IVL0 12 77324641-78213010 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3;ovary: 18.3" "Group enriched" "Detected in many" 6 "Astrocytes: 882.1;Excitatory neurons: 1473.6;Inhibitory neurons: 753.8;Microglial cells: 534.0;Oligodendrocyte precursor cells: 786.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "amygdala: 9.7;basal ganglia: 15.0;cerebral cortex: 17.3;hippocampal formation: 13.6;white matter: 10.3" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 47.0;THP-1: 41.8;U-138 MG: 30.8;WM-115: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032111, HPA061392" Approved Approved "Nuclear membrane,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear membrane" Cytosol "HPA032111: AB_10603881, HPA061392: " "unprognostic (3.51e-1)" "unprognostic (6.72e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (2.14e-1)" "unprognostic (2.78e-1)" "unprognostic (3.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-2)" "unprognostic (2.99e-1)" "unprognostic (1.90e-1)" "unprognostic (5.68e-7)" "unprognostic (6.86e-3)" "unprognostic (1.23e-1)" "unprognostic (1.58e-2)" "unprognostic (2.29e-3)" 3.8 4.8 9.7 1.0 15.0 0.5 4.0 0.9 17.3 1.2 0.0 1.7 0.3 2.0 2.9 1.9 2.2 5.1 1.9 13.6 0.0 0.4 1.0 3.3 0.6 0.7 0.4 18.3 0.5 0.4 3.1 2.2 0.0 2.1 0.8 5.2 0.9 2.5 1.3 2.6 0.6 2.5 1.4 8.0 0.8 2.8 1.6 1.9 1.2 3.4 0.4 3.3 1.7 10.3 3.5 8.7 0.6 0.2 8.5 18.1 0.3 26.5 20.9 10.7 5.3 1.7 0.6 0.2 1.9 22.0 7.2 2.5 7.8 4.0 19.3 0.1 0.2 0.2 3.9 0.2 6.7 0.1 0.2 6.2 0.2 47.0 11.1 9.3 16.4 0.1 0.0 0.1 26.2 0.5 0.2 12.0 2.7 0.3 2.1 1.0 2.1 0.0 1.7 0.1 0.6 0.0 1.6 0.3 3.5 0.8 0.1 41.8 14.1 30.8 8.1 12.0 18.2 1.2 0.0 0.7 8.8 0.5 38.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 9.7 15.0 0.9 17.3 13.6 0.0 0.7 0.4 0.0 1.4 1.6 10.3 11.1 19.2 10.0 882.1 0.0 3.6 8.4 0.2 0.0 5.0 3.8 3.8 3.4 0.0 7.5 0.0 0.0 0.1 0.0 0.2 0.0 4.2 10.4 4.2 8.2 5.6 16.4 0.0 1473.6 1.6 0.1 18.7 0.5 10.3 11.4 0.8 3.9 0.0 7.3 50.5 753.8 0.0 0.0 0.0 3.7 4.7 23.9 1.4 12.4 534.0 0.1 18.3 0.0 786.1 144.1 19.2 0.0 7.5 1.2 18.0 0.0 0.3 8.7 2.0 0.0 28.8 5.3 0.3 0.8 0.2 1.4 0.3 1.3 73.7 0.0 2.9 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.2" "Cell type enriched" "Detected in many" 4 "Astrocytes: 502.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.6;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 46.2;TIME: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 64: Astrocytes - Nervous system maintenance" "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: AB_2673271" "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 4.1 1.2 15.7 2.4 14.1 0.3 2.5 9.7 8.5 2.4 16.6 13.2 15.8 1.2 4.6 10.4 1.0 3.0 15.7 14.6 11.2 5.8 14.8 12.8 1.0 16.2 15.9 0.5 3.3 2.1 1.1 4.3 10.7 0.8 11.4 2.6 3.5 0.5 0.5 11.4 23.2 3.2 9.2 2.6 7.8 0.4 14.4 0.6 1.4 0.8 2.1 2.7 4.5 5.6 5.5 4.7 32.8 13.8 9.4 11.4 12.2 4.8 2.3 1.7 1.6 6.2 3.1 0.0 6.0 4.1 3.1 12.3 20.0 12.5 0.9 0.4 13.4 3.4 2.2 46.2 13.8 12.4 2.3 16.7 7.0 0.9 14.1 1.8 23.3 1.9 0.0 1.8 7.2 10.7 1.3 1.0 13.1 3.1 8.8 14.1 3.4 1.0 11.2 13.7 12.4 0.0 5.1 10.3 33.4 21.5 3.3 3.9 64.3 4.6 4.5 4.6 13.3 1.2 2.7 0.0 0.4 5.0 25.5 0.4 1.2 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.2 15.7 14.1 9.7 8.5 14.6 11.2 16.2 15.9 10.7 9.2 14.4 5.6 6.2 60.9 66.9 502.1 0.5 42.8 3.1 6.6 4.0 0.6 4.1 6.0 22.7 15.7 9.9 29.5 29.2 14.2 0.1 84.1 9.8 3.7 1.1 19.0 1.8 9.3 20.3 2.7 3.3 3.6 3.5 15.6 16.8 16.9 8.8 1.5 26.4 38.1 4.5 37.0 2.9 32.3 6.1 9.4 7.1 0.4 0.6 7.5 21.4 104.0 0.6 15.4 0.0 79.9 2.3 3.9 43.0 0.0 0.1 5.4 87.3 15.8 22.0 1.4 6.6 2.3 4.7 0.0 1.1 7.7 49.2 43.4 1.8 0.8 45.4 10.5 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7957537-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 6.3" "Cell type enriched" "Detected in single" 5 "Microglial cells: 1.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 22.3;BJ: 5.9;HBF TERT88: 7.7;LHCN-M2: 3.7" "Region enhanced" "Detected in some" "olfactory bulb: 2.1" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 61: Skin - Cornification" "Cluster 10: BJ & FHDF - ECM organization" Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.1 0.0 0.3 0.1 5.9 2.8 1.3 2.8 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 1.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 NUP50 NPAP60L ENSG00000093000 "Nucleoporin 50" Q9UKX7 22 45163925-45188017 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047162, HPA048328" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA047162: AB_2679963, HPA048328: AB_2680360" "unprognostic (2.64e-1)" "unprognostic (1.21e-2)" "unprognostic (4.96e-2)" "unprognostic (1.22e-1)" "unprognostic (2.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.46e-3)" "unprognostic (5.83e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "unprognostic (7.22e-2)" "unprognostic (5.31e-2)" "unprognostic (1.97e-2)" "prognostic favorable (4.06e-4)" "unprognostic (1.43e-1)" "unprognostic (3.17e-2)" "unprognostic (3.63e-2)" 14.1 14.8 8.6 23.3 9.9 54.4 13.5 11.9 12.1 14.3 11.2 18.7 16.6 10.1 18.7 20.5 18.1 14.3 7.2 10.7 10.2 13.7 23.5 14.6 33.7 8.1 8.3 13.9 15.9 15.8 6.7 15.5 7.8 12.2 16.7 10.9 11.7 13.4 7.8 19.0 16.3 11.4 8.0 25.5 24.2 29.8 9.2 46.6 15.2 12.7 35.3 19.3 12.3 9.7 75.8 35.5 67.1 43.7 31.0 31.8 70.9 61.9 41.1 46.9 47.1 77.6 32.9 82.7 28.1 41.0 35.1 52.0 83.4 50.5 67.3 44.3 87.4 72.6 54.8 47.7 32.2 193.7 73.7 38.8 34.1 60.1 45.2 22.7 52.4 71.4 76.5 84.3 49.0 50.8 88.2 50.5 50.4 50.0 36.3 91.8 40.7 58.0 37.0 72.5 41.7 40.4 61.5 37.9 74.0 50.9 23.6 50.3 48.3 99.1 88.6 51.6 52.7 58.4 51.3 119.0 37.1 49.2 70.4 55.1 39.1 80.5 20.3 40.2 27.8 19.5 24.5 23.5 25.5 18.1 28.4 19.6 92.7 30.6 24.2 13.9 25.8 34.2 8.6 9.9 11.9 12.1 10.7 10.2 8.1 8.3 7.8 8.0 9.2 9.7 42.7 9.6 27.9 6.2 32.7 85.5 51.9 26.4 48.3 14.6 26.2 16.3 10.8 22.8 29.6 33.1 12.5 22.6 47.5 34.2 13.7 18.9 46.3 56.3 34.7 29.7 17.4 72.4 16.4 20.9 39.8 21.8 59.1 47.3 34.7 23.9 33.2 38.5 28.1 13.5 15.3 24.4 20.3 47.5 32.8 83.3 14.6 33.4 24.9 11.2 56.9 11.1 42.2 11.6 12.5 29.8 33.5 13.9 49.0 60.8 16.9 22.8 50.0 16.3 26.3 15.9 17.1 45.9 44.3 60.6 89.4 56.6 47.1 23.5 26.3 95.3 NUP62 "DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI" ENSG00000213024 "Nucleoporin 62" P37198 19 49906825-49929763 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 119.2;Late spermatids: 315.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005435, CAB020724" Supported Supported "Nucleoplasm,Nuclear membrane" NA Yes 31000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" Nucleoplasm "CAB020724: , HPA005435: AB_1079510" "unprognostic (2.26e-1)" "unprognostic (4.06e-2)" "unprognostic (9.92e-2)" "unprognostic (9.68e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.50e-7)" "unprognostic (2.76e-2)" "unprognostic (3.61e-3)" "unprognostic (3.97e-2)" "unprognostic (4.06e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (5.71e-12)" "unprognostic (3.89e-3)" "unprognostic (3.62e-1)" "unprognostic (3.96e-1)" "unprognostic (3.27e-3)" 19.9 29.4 14.2 37.3 13.2 27.1 18.9 18.4 15.9 22.5 14.0 22.5 23.7 27.6 11.0 25.0 24.8 18.4 20.4 13.9 15.7 18.5 31.7 19.4 38.3 15.5 14.2 29.8 21.0 18.0 22.8 22.4 15.8 19.9 21.1 11.1 21.8 17.5 33.7 23.4 24.3 27.7 13.6 29.8 19.4 50.4 14.7 41.9 16.3 24.5 37.7 24.6 20.1 16.9 126.7 115.5 88.8 74.0 26.0 30.0 79.7 92.8 65.8 99.3 98.8 79.8 71.9 141.2 51.7 60.8 65.9 73.6 108.3 62.1 96.1 211.6 112.0 109.8 59.4 72.6 30.9 108.8 106.8 28.6 44.8 62.0 54.8 44.1 71.5 82.7 138.6 135.5 69.2 59.7 196.7 83.6 82.0 117.4 102.8 170.3 99.9 120.3 46.9 93.7 96.2 68.8 88.2 103.8 46.3 63.8 78.8 51.5 53.0 150.2 85.3 49.1 155.4 96.3 295.9 132.5 62.2 90.1 113.9 12.3 33.4 6.7 17.7 34.7 24.1 15.1 17.6 19.6 33.1 14.9 11.9 15.4 5.2 22.0 20.1 29.0 17.2 22.1 14.2 13.2 18.4 15.9 13.9 15.7 15.5 14.2 15.8 13.6 14.7 16.9 16.8 25.6 22.4 0.0 28.4 34.2 16.5 16.0 21.1 11.4 23.7 26.0 15.4 21.5 18.3 9.2 6.2 37.0 24.4 24.9 9.8 23.7 113.5 19.2 23.9 27.7 21.6 39.1 0.0 16.3 48.4 19.5 20.4 25.6 23.4 30.4 30.4 13.3 49.5 63.9 0.0 27.0 16.2 36.1 119.2 315.1 24.8 41.5 21.4 0.0 77.1 19.1 22.6 0.0 0.0 22.9 22.8 23.0 23.3 24.1 20.6 16.1 19.2 16.3 19.7 18.0 16.0 71.0 39.3 20.0 32.0 21.8 24.4 17.2 33.4 16.6 PHF11 "BCAP, IGER, NY-REN-34" ENSG00000136147 "PHD finger protein 11" Q9UIL8 13 49495610-49528981 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA016566 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nuclear membrane" "HPA016566: AB_2669387" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.98e-6)" "unprognostic (3.49e-3)" "unprognostic (6.29e-2)" "unprognostic (5.50e-2)" "unprognostic (6.91e-2)" "unprognostic (3.05e-2)" "unprognostic (1.64e-1)" "unprognostic (2.37e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (4.46e-7)" "unprognostic (9.81e-2)" "unprognostic (5.36e-3)" "unprognostic (1.05e-1)" "prognostic favorable (3.46e-4)" 28.3 39.5 17.2 33.4 18.8 37.0 32.3 17.6 23.6 29.1 18.2 28.9 25.3 24.0 28.5 23.2 23.0 26.4 21.3 16.4 19.6 33.1 22.4 28.9 43.4 21.2 19.9 22.6 25.1 16.5 16.1 23.9 20.3 26.3 22.0 9.1 39.7 24.6 13.4 27.2 27.6 27.3 20.5 39.3 28.9 13.4 19.4 31.6 34.3 11.3 39.4 28.4 27.4 20.5 12.0 4.9 1.7 0.0 23.5 44.4 14.7 28.5 32.5 40.0 42.1 0.0 28.3 29.2 7.7 32.1 26.5 8.2 10.4 9.8 23.6 59.2 8.8 14.5 9.5 12.8 29.1 10.5 21.5 27.0 15.4 16.2 9.0 16.4 26.0 23.6 3.1 12.4 30.3 9.8 33.7 24.8 5.6 7.8 3.3 32.2 0.0 8.9 36.5 21.8 1.0 0.2 7.6 15.9 0.4 2.1 9.3 23.6 23.2 9.7 3.8 14.0 8.2 8.9 4.9 18.1 20.0 14.9 14.9 26.3 42.4 31.0 42.3 54.1 49.1 40.7 53.6 50.6 39.9 35.0 43.1 48.5 51.3 30.0 51.4 34.8 78.0 42.6 17.2 18.8 17.6 23.6 16.4 19.6 21.2 19.9 20.3 20.5 19.4 20.5 48.0 16.0 28.7 15.7 48.2 22.6 35.1 41.0 29.0 4.4 26.8 25.4 19.5 27.1 40.3 36.8 0.0 26.1 54.6 15.2 35.2 41.1 35.9 38.3 48.9 35.0 4.2 18.5 11.1 42.3 46.4 32.6 23.0 34.9 24.0 30.3 31.1 22.3 41.9 11.8 11.7 15.6 26.4 40.9 31.5 56.3 32.0 46.6 12.4 27.2 66.8 17.0 58.7 16.1 23.9 38.5 8.5 31.6 35.7 35.4 21.4 29.2 63.4 5.0 46.0 26.5 28.7 24.2 6.0 27.1 20.2 21.1 60.4 23.1 15.8 35.8 PLRG1 "Cwc1, PRL1, Prp46, PRPF46, TANGO4" ENSG00000171566 "Pleiotropic regulator 1" O43660 4 154535005-154550400 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035931, HPA035932, HPA061486" Supported Enhanced "Nuclear membrane,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear speckles" "Nuclear membrane" "HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536" "unprognostic (6.51e-2)" "unprognostic (5.66e-3)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.20e-5)" "unprognostic (2.92e-1)" "unprognostic (9.84e-3)" "unprognostic (1.64e-2)" "unprognostic (1.97e-1)" 29.4 21.9 22.8 24.9 26.3 31.1 38.7 26.0 24.3 32.8 20.8 30.9 24.8 34.0 28.6 33.9 34.2 24.8 25.9 22.6 32.6 38.1 43.8 27.3 35.2 30.5 26.8 34.0 19.6 41.1 16.0 28.3 30.7 27.4 34.2 26.4 25.8 33.7 31.7 26.4 25.8 44.6 33.5 27.7 26.4 21.4 25.3 40.4 38.0 39.5 51.2 34.8 22.7 39.2 73.2 58.6 73.7 79.4 85.1 73.5 62.3 91.6 111.2 121.9 98.9 69.3 62.7 79.1 45.7 109.1 80.3 52.4 97.2 122.1 134.5 80.2 48.7 95.1 45.1 67.8 87.0 96.0 76.4 79.7 110.8 144.6 112.6 73.0 106.1 85.3 98.9 98.2 107.2 52.3 73.9 45.7 56.1 57.5 62.7 72.2 38.5 48.2 84.8 46.1 43.0 48.6 55.9 59.3 91.7 69.4 57.1 66.4 69.3 72.4 81.9 64.6 82.9 50.9 72.0 100.6 68.1 45.6 98.8 53.0 37.0 29.7 41.6 43.3 49.9 47.0 43.5 45.7 47.6 36.2 45.9 43.2 9.4 67.6 63.9 46.4 55.7 49.4 22.8 26.3 26.0 24.3 22.6 32.6 30.5 26.8 30.7 33.5 25.3 39.2 26.9 25.6 18.1 29.0 26.9 16.3 31.2 98.7 18.2 26.2 19.6 22.9 24.7 20.0 50.7 22.0 12.5 49.1 23.6 18.0 15.6 48.0 31.7 22.7 33.0 27.5 27.1 30.5 23.6 34.7 37.9 30.9 17.9 20.3 45.7 27.0 16.1 26.8 34.2 62.2 21.7 15.9 73.2 19.3 12.0 5.8 28.0 17.2 14.2 17.8 36.8 31.2 28.8 14.1 25.0 32.6 20.9 35.0 21.8 14.9 33.7 35.0 45.2 21.4 19.7 31.2 40.8 36.4 30.2 25.0 17.3 44.3 26.9 36.8 22.3 20.6 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 25.4 20.4 10.3 18.8 10.1 44.7 21.0 7.2 14.3 18.3 3.4 19.5 21.6 19.6 9.4 20.1 18.7 13.6 16.0 11.9 9.7 16.6 23.5 17.4 21.3 6.8 8.5 23.8 25.5 16.1 21.4 17.0 6.4 19.2 12.1 17.5 19.3 11.2 25.7 21.6 22.8 13.0 2.3 22.9 21.8 18.7 8.8 17.8 20.0 16.0 17.1 18.8 18.1 9.1 49.6 35.4 43.5 98.0 23.0 18.8 36.0 34.6 29.2 33.8 29.3 63.0 30.6 67.7 11.0 30.1 37.5 37.0 43.5 33.6 37.6 59.2 86.5 50.6 36.6 42.4 23.5 106.1 61.8 24.8 23.3 44.9 41.0 21.9 25.5 38.5 141.2 49.3 33.7 37.8 63.7 67.0 45.5 27.4 42.3 57.4 33.8 57.1 17.2 42.8 61.7 54.3 30.3 57.3 31.1 28.8 48.1 55.0 36.2 60.2 36.8 48.0 70.5 58.8 58.8 96.0 35.2 66.6 61.0 0.0 0.8 1.4 1.7 0.5 1.0 1.0 1.1 1.3 0.9 1.1 0.9 1.4 0.9 1.6 1.4 1.5 0.6 1.1 10.3 10.1 7.2 14.3 11.9 9.7 6.8 8.5 6.4 2.3 8.8 9.1 31.8 38.5 28.9 33.0 28.6 25.2 10.1 17.5 29.0 34.6 19.5 19.7 4.4 20.0 19.9 18.4 98.0 17.1 30.6 19.7 5.9 12.3 13.2 14.6 24.7 18.3 18.0 30.7 55.6 17.1 13.2 19.2 32.1 21.3 16.5 31.1 17.2 24.9 16.2 40.4 58.9 21.7 16.2 18.9 21.7 6.3 14.9 23.3 19.6 23.4 13.8 18.2 32.0 30.2 38.6 21.8 14.1 17.7 37.6 22.2 19.1 8.4 17.6 26.6 13.1 27.0 17.6 19.2 13.1 29.6 31.0 19.4 27.9 24.7 23.2 21.9 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" A8CG34 7 75416786-75486299 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 14.9 14.0 3.5 15.5 3.8 28.9 14.2 8.0 9.3 13.8 2.4 14.2 12.0 16.6 9.0 15.9 14.1 12.0 13.9 7.0 4.9 13.1 13.2 12.9 18.2 2.2 3.1 18.7 18.1 16.8 13.4 16.4 2.0 13.0 12.9 26.3 14.3 11.5 19.6 17.7 14.0 15.1 0.3 15.5 14.0 12.5 5.2 17.6 16.7 10.7 19.9 14.3 14.3 5.5 41.8 34.1 46.3 89.0 17.1 19.0 30.4 29.7 27.3 23.7 22.8 41.2 26.5 73.4 12.0 32.6 37.2 36.7 39.6 36.7 38.9 49.9 55.1 36.4 39.6 27.8 22.5 97.0 49.5 16.2 22.8 36.3 26.8 34.5 24.6 29.9 103.8 39.8 38.9 41.8 59.5 49.3 36.9 32.0 38.4 53.0 30.7 37.6 13.1 56.0 51.4 67.4 34.3 54.0 23.8 41.5 47.1 34.2 27.4 57.4 30.6 42.2 62.3 42.4 54.4 88.2 37.3 49.1 53.9 0.2 0.4 0.5 1.1 0.5 1.0 0.8 0.9 0.3 0.3 1.0 0.5 0.6 1.2 0.9 0.3 1.1 0.2 0.6 3.5 3.8 8.0 9.3 7.0 4.9 2.2 3.1 2.0 0.3 5.2 5.5 23.1 35.3 26.2 29.4 27.8 18.0 11.8 13.4 33.6 30.7 21.3 23.4 12.6 21.5 21.4 12.9 68.8 13.4 27.2 12.3 5.9 11.8 2.1 14.2 21.3 20.7 28.7 33.9 59.2 17.1 10.2 21.0 31.6 18.3 7.6 28.6 16.8 15.1 12.0 25.2 60.2 17.4 14.2 16.4 15.8 3.8 18.0 21.7 7.2 35.6 17.1 21.3 37.0 28.1 45.6 18.8 8.0 15.4 37.8 24.6 10.0 9.6 18.7 29.4 13.1 26.1 17.4 19.2 12.4 32.9 18.5 17.0 34.0 22.0 17.0 19.7 POMZP3 "POM-ZP3, POM121" ENSG00000146707 "POM121 and ZP3 fusion" Q6PJE2 7 76609986-76627261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 45.3;Late spermatids: 60.8;Spermatocytes: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA049817, HPA071198" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 71: Testis - DNA repair" "Cluster 12: NES - Nervous system development" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "HPA049817: AB_2680896, HPA071198: " "unprognostic (2.23e-1)" "prognostic favorable (4.34e-4)" "unprognostic (1.06e-1)" "unprognostic (2.17e-1)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (4.31e-1)" "unprognostic (7.49e-2)" "prognostic favorable (9.31e-4)" "unprognostic (4.94e-1)" "unprognostic (3.40e-1)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.99e-2)" 13.7 10.6 5.8 3.6 5.6 6.8 13.2 8.2 9.7 15.3 4.7 15.9 2.4 16.2 4.6 10.7 12.3 2.2 14.7 5.8 6.1 11.3 5.5 10.4 3.3 6.1 5.6 16.6 12.9 2.5 10.1 1.8 5.8 14.4 3.5 6.2 9.4 4.4 19.8 12.2 9.4 6.2 3.9 9.0 12.6 29.5 5.7 4.7 11.3 0.9 3.6 13.9 12.3 6.4 2.8 11.1 17.7 22.7 11.4 4.4 2.6 3.9 6.2 2.7 3.7 6.5 5.0 1.7 1.0 3.6 6.2 1.5 4.1 1.9 2.7 7.0 6.4 7.6 6.2 4.0 2.6 3.4 4.8 3.8 7.3 9.8 3.2 1.4 1.7 2.8 4.2 12.8 12.8 3.5 6.2 14.2 7.9 4.1 5.6 2.4 12.9 2.9 2.1 4.2 9.1 16.7 3.6 16.2 6.1 18.6 6.1 4.5 7.0 8.9 1.2 22.2 9.5 3.2 3.0 12.3 1.7 13.7 12.7 0.6 1.2 2.3 0.8 0.5 1.2 0.8 1.4 1.4 1.2 1.6 1.7 0.9 1.3 1.0 0.6 1.2 1.4 0.4 5.8 5.6 8.2 9.7 5.8 6.1 6.1 5.6 5.8 3.9 5.7 6.4 5.5 3.2 4.1 4.2 8.1 7.0 7.3 11.5 21.1 5.0 8.0 8.4 6.7 2.8 3.5 5.5 12.5 6.9 7.7 8.1 0.0 1.4 45.3 5.8 5.7 4.3 13.1 9.4 8.2 2.2 3.2 8.1 25.5 7.0 5.7 4.7 2.5 1.7 3.2 3.3 8.6 4.8 2.0 4.9 3.3 60.8 6.2 6.5 10.6 2.8 0.8 5.0 2.1 6.6 8.1 1.8 9.3 7.9 15.2 4.7 4.3 5.9 4.1 5.3 13.1 2.9 5.6 33.0 8.0 18.3 7.0 10.4 9.1 2.0 6.3 11.1 PROCA1 MGC39650 ENSG00000167525 "Protein interacting with cyclin A1" Q8NCQ7 17 28703197-28711854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "testis: 177.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 6882.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 5.6;NB-4: 6.0;REH: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023648, HPA030218" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" "Golgi apparatus" "HPA023648: AB_1855726, HPA030218: AB_10601152" "unprognostic (5.78e-2)" "unprognostic (1.17e-2)" "unprognostic (3.11e-3)" "unprognostic (3.07e-2)" "unprognostic (2.97e-2)" "unprognostic (7.26e-3)" "unprognostic (6.90e-2)" "unprognostic (7.11e-3)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "unprognostic (3.01e-3)" "unprognostic (6.88e-2)" "unprognostic (1.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-1)" "unprognostic (1.88e-1)" "unprognostic (5.00e-2)" 2.4 1.7 3.3 1.4 3.2 1.5 1.9 3.8 4.9 3.9 2.9 2.0 1.1 2.9 0.4 1.5 4.3 0.7 2.3 3.1 3.4 8.2 1.2 2.6 2.2 3.7 3.5 6.1 0.9 0.3 2.9 0.6 3.4 3.5 0.4 1.2 1.7 0.5 0.9 1.5 4.0 0.7 3.3 9.8 2.0 177.5 3.2 1.4 1.8 0.5 0.8 2.2 2.7 3.4 0.6 0.9 1.6 5.6 1.0 1.6 1.6 0.9 0.6 0.7 0.6 0.9 2.0 0.0 0.3 0.8 0.1 0.8 1.7 0.2 0.3 1.1 0.4 2.7 1.7 0.4 0.4 4.5 0.1 0.7 0.3 1.2 0.0 0.7 0.1 0.7 2.6 1.6 0.6 0.2 3.3 6.0 4.4 0.3 0.5 7.1 2.4 0.1 0.6 0.2 0.4 0.7 0.4 0.1 0.5 1.0 2.5 3.9 0.5 0.2 1.0 0.6 0.3 0.7 1.0 1.2 0.4 4.1 0.8 4.9 1.1 3.5 0.5 1.6 0.2 1.9 1.1 0.3 0.6 0.5 0.4 0.8 0.7 0.6 1.2 2.5 0.6 0.5 3.3 3.2 3.8 4.9 3.1 3.4 3.7 3.5 3.4 3.3 3.2 3.4 2.3 0.0 1.1 4.6 2.8 1.0 1.2 1.0 0.6 3.7 1.5 1.9 6.6 1.5 1.9 0.0 4.2 0.8 3.9 0.8 0.0 0.6 1682.9 5.3 2.4 2.7 2.4 3.0 0.8 0.2 1.9 2.7 1.1 2.4 15.2 4.2 4.2 0.2 2.8 3.3 1.1 1.5 2.0 5.3 2.9 6882.6 25.4 6.8 0.0 3.7 2.5 7.9 1.0 2.0 0.9 0.6 0.3 19.5 1.2 0.8 2.0 1.2 3.9 4.4 19.7 1.5 2.4 79.2 21.7 1.1 0.3 0.7 2.6 7.5 1.7 0.7 PTGES3L-AARSD1 ENSG00000108825 "PTGES3L-AARSD1 readthrough" Q9BTE6 17 42950526-42980528 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 17.3;tongue: 10.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.5;granulocytes: 3.8;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enhanced" "Detected in many" "RH-30: 4.9;THP-1: 10.8" "HPA021408, HPA022869, HPA023714" Approved Approved "Nuclear membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 43: THP-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (6.47e-2)" "unprognostic (1.25e-1)" "unprognostic (2.87e-1)" "unprognostic (5.44e-2)" "unprognostic (9.34e-4)" "unprognostic (1.56e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-2)" "unprognostic (1.82e-1)" "unprognostic (5.13e-1)" "unprognostic (3.27e-2)" "unprognostic (1.91e-4)" "unprognostic (1.83e-1)" 0.4 0.2 0.1 0.8 1.0 0.7 0.4 0.0 0.8 0.7 0.2 4.3 0.8 3.2 0.4 1.1 1.0 0.8 3.0 0.3 0.3 0.3 0.2 0.4 0.2 0.1 0.1 0.3 0.3 0.3 1.2 0.2 0.0 1.3 1.8 0.6 0.6 1.7 17.3 0.3 1.2 5.6 0.0 0.2 1.5 3.3 0.0 0.2 0.3 10.6 0.2 1.9 0.6 0.3 0.6 0.0 1.7 1.8 0.1 0.0 0.4 1.2 1.5 0.8 0.7 1.2 0.1 0.1 1.2 0.2 0.5 0.0 0.3 0.8 1.2 0.7 0.2 4.1 1.7 2.5 0.0 0.5 2.7 0.0 0.5 1.3 0.0 0.5 0.3 1.1 1.3 0.3 1.6 0.0 1.4 0.4 0.4 2.5 0.4 0.7 4.9 0.5 0.2 0.3 0.8 2.4 1.0 0.3 1.1 2.3 0.5 10.8 0.0 0.5 0.9 0.0 0.4 2.9 0.8 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 1.0 0.0 0.8 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883716 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.0" "Cell type enhanced" "Detected in many" "Astrocytes: 10.1;Early spermatids: 9.2;Horizontal cells: 13.5;Microglial cells: 14.0;Spermatocytes: 17.0;Spermatogonia: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;HEK 293: 6.5;NTERA-2: 7.3;SCLC-21H: 8.9;SH-SY5Y: 19.0;U-2197: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear membrane" "HPA051776: AB_2681605" "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 3.4 0.5 2.2 0.2 1.9 0.0 3.3 11.0 3.6 4.1 0.4 3.4 0.2 3.2 0.2 0.8 3.7 0.7 4.8 1.8 4.0 0.4 0.1 4.5 0.1 3.3 3.7 1.5 3.3 0.3 2.9 2.6 3.4 2.0 0.2 0.3 1.1 1.2 2.8 1.2 1.3 1.0 2.8 0.5 1.3 8.2 2.7 0.2 2.5 2.0 0.1 2.3 2.9 1.7 0.0 2.1 4.4 7.8 0.2 1.9 0.0 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.8 1.5 0.0 3.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.7 4.2 0.0 0.4 1.9 0.0 0.0 7.3 0.1 1.6 5.0 0.5 0.0 0.0 0.0 8.9 19.0 0.0 0.0 0.0 1.8 3.2 0.6 0.0 0.0 0.0 6.1 1.9 0.2 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 11.0 3.6 1.8 4.0 3.3 3.7 3.4 2.8 2.7 1.7 1.8 3.2 1.5 10.1 0.0 0.8 0.0 0.0 0.6 2.1 3.4 1.8 2.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.2 1.1 2.6 2.2 0.0 0.0 2.6 1.7 0.0 3.9 0.0 0.1 0.0 0.2 0.4 0.0 0.1 13.5 3.6 0.3 0.0 0.6 1.2 5.1 3.4 1.0 7.2 14.0 0.0 4.7 0.0 7.1 3.5 0.3 0.1 3.8 0.0 0.4 0.0 0.0 1.5 0.9 6.6 4.7 4.1 17.0 11.7 0.0 0.6 0.1 2.1 0.3 0.0 0.0 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912106 "FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 706.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5" "Cancer enhanced" "Detected in all" "prostate cancer: 152.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 18 "NK-cell: 70.1" "Lineage enriched" "Detected in many" 18 "NK-cells: 70.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Nuclear membrane" "HPA057814: AB_2683536" "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 18.7 29.2 170.9 21.0 171.2 0.9 7.4 168.7 253.4 362.4 153.7 349.6 57.5 706.0 25.0 9.4 256.6 28.5 287.6 176.0 181.8 26.0 82.7 32.5 6.6 198.8 164.5 45.2 225.0 1.4 15.2 8.6 163.0 142.2 6.4 0.8 10.0 54.6 212.3 11.6 73.5 125.4 171.7 12.3 103.4 5.1 183.5 2.9 6.8 68.8 2.9 171.4 75.1 173.2 29.8 0.0 0.5 0.0 12.4 17.9 1.1 2.1 3.6 1.7 1.5 0.0 47.4 0.3 0.4 0.9 0.1 0.2 7.6 0.1 0.2 146.0 4.0 0.1 0.0 1.2 40.6 0.0 0.2 15.6 22.3 0.1 0.3 0.2 0.0 0.0 0.0 0.3 3.7 2.7 0.1 1.3 0.4 0.1 173.8 0.0 1.5 0.8 0.0 0.0 1.5 201.7 3.5 0.0 0.1 1.8 1.3 0.1 0.0 0.8 0.6 0.4 0.5 0.3 0.3 0.0 0.6 0.1 2.7 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.6 0.1 1.0 0.0 0.5 0.2 0.4 70.1 0.0 0.2 0.0 3.4 170.9 171.2 168.7 253.4 176.0 181.8 198.8 164.5 163.0 171.7 183.5 173.2 1.0 0.0 1.5 64.9 3.1 11.6 13.2 26.9 10.2 2.0 4.4 4.4 190.0 78.6 43.8 11.0 0.0 3.0 44.0 2.1 0.0 62.7 0.2 26.5 546.4 6.2 115.4 4.4 14.2 278.2 5.5 41.7 31.1 11.3 1.3 0.6 30.7 104.0 22.7 1.7 19.2 73.7 10.2 3.1 50.3 0.6 8.4 20.3 64.0 13.1 433.5 6.9 61.8 71.9 11.5 63.5 87.7 11.3 1.9 66.1 96.8 0.2 97.0 2.7 6.6 16.6 78.6 0.3 5.8 2.6 5.8 2.3 7.3 0.5 105.8 28.5 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037741 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.7;pancreas: 37.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 132.8;Inhibitory neurons: 67.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 12 "amygdala: 10.6;basal ganglia: 13.6;cerebral cortex: 11.0;hippocampal formation: 17.9;white matter: 11.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" NA NA 21000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.8 6.4 10.6 4.1 13.6 27.7 4.4 0.9 11.0 3.9 0.0 7.9 8.7 4.1 1.1 3.1 8.1 4.0 14.5 17.9 1.1 5.2 0.6 3.5 2.9 0.0 0.0 4.6 37.3 4.2 5.1 4.9 0.0 3.8 8.1 7.2 10.9 4.7 0.8 3.3 8.2 3.3 0.0 3.9 22.4 3.2 0.0 2.8 2.5 2.0 2.5 2.0 2.5 11.9 8.1 9.9 1.9 8.1 0.0 0.0 15.9 10.7 5.0 1.3 1.2 21.9 3.5 3.0 2.9 1.4 13.5 11.0 6.4 20.0 0.4 0.0 6.9 3.7 14.1 9.9 1.9 0.8 3.9 0.5 17.0 5.5 13.9 7.2 0.2 3.7 21.4 1.4 0.0 9.1 3.1 2.0 11.7 3.9 9.5 13.4 6.9 7.8 5.9 4.1 21.6 52.3 15.5 15.8 6.9 7.4 7.8 2.3 2.4 9.1 14.3 1.6 9.1 0.0 0.0 1.2 0.5 6.9 15.1 0.9 1.4 2.1 2.8 2.7 1.1 0.2 0.9 2.1 1.0 0.2 0.1 1.0 4.2 1.9 3.9 1.7 1.0 1.4 10.6 13.6 0.9 11.0 17.9 1.1 0.0 0.0 0.0 0.0 0.0 11.9 1.5 6.4 2.5 13.7 5.6 2.0 6.6 1.8 1.2 23.6 9.9 7.6 20.2 11.5 2.8 12.9 33.3 7.5 27.2 15.2 9.8 6.0 6.1 9.2 6.8 1.6 48.1 0.8 132.8 12.0 6.0 2.2 18.8 9.2 6.3 3.0 3.6 0.8 3.4 37.0 67.9 21.7 8.2 11.1 4.3 8.3 1.8 11.0 3.6 47.8 12.0 2.1 35.0 8.0 4.2 12.4 24.1 1.5 6.4 16.5 5.7 0.8 4.2 4.6 0.0 7.9 2.5 0.4 3.4 2.8 0.4 3.4 8.2 1.5 14.0 11.3 RB1CC1 "ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131" ENSG00000023287 "RB1 inducible coiled-coil 1" Q8TDY2 8 52622458-52745843 "Predicted intracellular proteins" "Autophagy, Cell cycle, Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024391, HPA053049" Approved Supported "Nuclear membrane,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Cytosol "Nuclear membrane" "HPA024391: AB_2671554, HPA053049: AB_2682025" "unprognostic (1.58e-2)" "unprognostic (7.51e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.22e-1)" "unprognostic (4.21e-2)" "unprognostic (7.39e-2)" "unprognostic (1.38e-2)" "unprognostic (9.34e-2)" "unprognostic (1.21e-1)" "unprognostic (8.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.56e-3)" "unprognostic (7.67e-2)" "unprognostic (4.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.42e-1)" 17.6 15.0 37.2 11.8 30.4 52.3 17.0 26.5 40.2 15.2 16.4 13.7 12.9 17.4 13.0 16.9 12.1 13.8 24.1 27.2 23.9 17.1 21.5 14.9 13.3 29.9 25.6 20.1 16.8 22.2 8.0 15.5 24.1 15.5 11.3 20.3 16.2 12.2 38.9 15.0 14.2 15.0 23.0 14.3 14.5 34.7 33.1 22.2 17.7 32.1 12.9 14.3 11.1 43.5 23.8 20.8 25.2 22.1 27.4 31.0 14.4 17.7 36.1 18.4 22.8 14.6 26.3 17.4 29.0 26.2 46.4 31.0 31.4 16.5 34.5 13.1 27.4 29.7 20.8 20.2 33.7 10.7 16.0 29.1 33.4 18.3 49.6 38.2 25.2 26.8 35.8 27.4 22.6 15.6 27.2 15.7 24.9 22.4 10.3 13.7 12.1 17.7 16.9 18.5 24.0 25.0 18.4 20.9 39.8 29.3 23.8 19.3 29.9 17.5 24.2 27.8 15.7 26.8 24.8 17.0 27.6 18.2 20.0 47.9 12.9 24.6 11.6 12.2 11.8 12.3 9.7 11.9 12.6 9.5 11.9 11.0 40.3 14.2 17.1 6.3 14.1 11.9 37.2 30.4 26.5 40.2 27.2 23.9 29.9 25.6 24.1 23.0 33.1 43.5 83.8 195.5 121.7 73.8 66.3 88.3 60.2 32.0 51.2 82.0 45.5 39.5 163.8 20.0 57.4 18.4 68.8 27.0 74.2 45.4 9.8 52.4 61.9 103.6 112.7 66.0 44.2 117.7 104.0 49.3 26.3 78.2 36.2 143.5 25.9 78.1 36.8 44.5 23.6 87.5 123.2 31.9 30.5 44.5 41.4 49.8 77.3 60.5 42.7 76.8 67.6 33.0 64.9 106.1 104.2 63.5 43.3 73.4 86.1 99.0 47.2 27.0 115.3 57.3 46.0 132.2 76.9 238.8 132.7 59.4 91.9 60.5 66.2 68.6 27.7 88.2 RBMX2 "CGI-79, Snu17" ENSG00000134597 "RNA binding motif protein X-linked 2" Q9Y388 X 130401987-130413656 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026609 Approved Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 37: B-cells - Transcription" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nuclear membrane" Nucleoli "HPA026609: AB_1846601" "unprognostic (2.54e-1)" "unprognostic (1.17e-2)" "unprognostic (1.80e-3)" "unprognostic (3.32e-2)" "unprognostic (1.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (7.04e-4)" "prognostic favorable (9.15e-4)" "unprognostic (1.34e-3)" "unprognostic (1.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.44e-9)" "unprognostic (1.06e-1)" "unprognostic (4.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.63e-3)" 15.6 12.2 26.3 10.1 26.1 11.8 14.6 26.1 48.8 21.7 23.6 17.3 10.4 16.8 16.4 13.8 16.3 9.9 13.9 26.3 27.4 14.4 13.0 11.6 14.1 25.8 26.3 18.0 16.5 10.5 11.9 10.5 26.1 15.0 11.6 11.2 11.9 12.3 12.4 17.4 12.8 13.2 25.3 15.1 14.5 7.0 26.2 17.2 12.6 10.0 16.6 16.6 15.6 27.9 22.7 23.3 23.4 24.3 23.1 41.3 23.2 21.0 21.1 23.2 25.4 17.5 27.6 21.8 48.9 16.1 31.1 24.4 37.2 19.2 33.4 20.2 32.5 19.8 22.6 18.6 20.2 30.6 22.8 30.2 27.1 25.9 36.1 33.8 26.1 27.2 17.2 18.8 26.4 39.2 36.4 37.9 17.4 40.0 37.2 27.4 22.7 29.5 23.7 18.0 26.8 32.0 13.2 28.0 39.1 18.8 18.2 22.2 17.5 19.0 15.5 44.8 43.6 24.6 27.9 30.5 22.9 49.5 23.9 9.3 6.8 8.6 7.7 7.7 8.2 10.9 10.0 10.7 5.9 9.0 10.6 9.7 6.0 7.3 7.2 7.7 16.5 4.1 26.3 26.1 26.1 48.8 26.3 27.4 25.8 26.3 26.1 25.3 26.2 27.9 30.5 19.2 19.0 5.5 32.9 32.1 29.0 42.8 22.8 22.0 27.5 33.0 22.6 22.8 40.1 11.0 10.4 33.1 28.4 14.1 15.6 34.2 3.8 21.0 43.5 31.9 40.7 19.4 7.4 35.6 40.8 27.3 13.7 18.3 35.5 27.8 45.0 24.5 34.5 16.8 8.2 23.6 36.7 47.6 24.4 5.8 32.3 27.6 28.4 2.8 41.5 23.3 41.2 7.1 9.4 29.8 18.1 44.0 17.9 26.4 17.9 39.5 27.9 12.5 32.9 30.8 29.8 30.2 53.3 22.4 29.7 25.9 32.0 31.9 29.2 22.9 RCC1 CHC1 ENSG00000180198 "Regulator of chromosome condensation 1" P18754 1 28505943-28539300 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 789.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015413, HPA027573, HPA027574" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA 47000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear membrane" "CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236" "unprognostic (6.23e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.91e-5)" "unprognostic (3.93e-2)" "unprognostic (2.03e-3)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.43e-11)" "unprognostic (1.04e-2)" "unprognostic (2.78e-1)" "unprognostic (3.02e-1)" "unprognostic (6.23e-2)" 14.2 12.1 5.5 31.0 6.1 58.5 17.2 7.3 7.6 14.7 6.5 24.4 27.2 14.2 10.3 32.2 18.9 12.9 6.6 5.8 6.1 9.0 23.9 12.3 37.4 6.8 6.2 16.1 16.1 5.8 3.8 17.7 6.8 10.9 28.1 6.1 20.6 9.2 13.3 14.6 23.4 19.3 6.1 16.1 18.6 57.9 7.6 44.3 11.7 8.0 38.0 23.6 15.8 6.9 263.2 109.7 94.8 112.9 68.4 86.5 106.2 100.2 60.2 158.5 122.9 111.9 206.2 331.0 60.0 99.2 65.3 155.0 306.6 158.1 125.1 133.7 185.0 295.0 140.0 147.2 51.6 329.0 171.5 111.6 106.0 150.0 125.6 100.7 110.6 194.5 222.8 101.1 66.0 140.8 260.5 118.0 205.3 117.8 106.4 252.9 163.3 164.0 60.5 119.9 150.6 76.7 105.3 171.5 87.6 52.7 72.6 99.8 84.5 81.6 162.5 102.0 198.2 60.9 91.2 248.8 80.5 469.7 89.5 5.1 7.7 3.3 5.0 7.9 9.4 7.1 7.8 8.2 14.0 7.2 6.8 7.6 1.8 5.9 5.7 7.7 7.6 6.3 5.5 6.1 7.3 7.6 5.8 6.1 6.8 6.2 6.8 6.1 7.6 6.9 8.9 0.0 10.3 2.0 57.4 36.7 12.4 13.6 92.2 0.8 18.9 15.4 4.6 5.7 16.2 7.3 2.1 25.6 10.7 10.7 3.9 34.0 176.5 12.7 21.1 16.6 5.4 118.1 4.5 23.7 43.5 17.4 68.8 17.4 1.3 14.8 2.9 6.6 20.8 13.5 5.0 16.0 12.2 11.3 20.0 789.4 17.1 21.3 14.2 1.9 16.6 0.5 15.5 2.0 2.9 39.5 7.0 10.5 75.5 21.6 9.6 5.7 14.1 0.3 6.6 15.0 16.6 19.2 18.4 185.3 33.8 24.5 31.7 12.5 25.0 18.4 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56245082 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 108.4;Excitatory neurons: 149.4;Inhibitory neurons: 164.0;Microglial cells: 91.8;Oligodendrocyte precursor cells: 187.0;Oligodendrocytes: 169.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035462, HPA057957" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152, HPA057957: " "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 3.4 5.9 3.9 5.6 3.5 8.5 5.2 11.6 4.0 5.2 1.3 4.0 5.3 5.6 5.3 4.7 5.7 4.0 3.2 3.0 4.4 3.5 4.0 4.8 8.9 3.5 3.3 6.3 3.2 5.7 2.7 5.4 3.7 4.6 5.0 11.0 3.8 5.3 8.8 9.9 4.5 5.7 3.0 7.4 4.8 8.7 3.5 15.2 5.1 9.8 9.3 5.7 2.9 4.2 7.7 15.6 31.3 22.0 11.0 13.9 7.6 6.6 9.1 8.3 13.1 8.4 6.3 24.0 9.7 9.9 7.7 20.9 18.7 14.7 11.1 13.3 6.6 31.5 19.0 17.6 11.6 24.1 4.6 12.0 21.7 9.0 19.5 12.2 14.7 24.1 14.2 12.7 11.9 9.8 21.3 6.9 13.4 5.9 4.5 23.1 20.0 19.8 9.2 24.0 16.4 18.8 8.2 8.3 9.4 21.5 7.1 15.3 11.9 21.8 11.3 5.1 13.2 10.2 11.4 27.6 7.8 22.2 9.7 2.0 0.2 0.5 0.5 0.3 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.6 0.0 0.5 0.2 0.5 1.1 0.3 3.9 3.5 11.6 4.0 3.0 4.4 3.5 3.3 3.7 3.0 3.5 4.2 8.6 6.4 13.4 108.4 9.7 13.4 4.4 9.5 20.5 16.2 9.9 7.5 6.5 2.8 6.2 7.3 10.4 4.2 7.3 5.3 3.9 3.4 19.9 7.2 10.3 9.4 4.8 17.1 149.4 4.7 1.4 6.8 4.6 6.4 12.6 14.2 7.9 8.9 5.6 16.8 164.0 5.7 10.2 9.5 8.8 15.9 6.5 8.8 5.4 91.8 8.4 5.1 2.1 187.0 169.7 3.7 6.0 10.5 7.9 6.6 4.3 4.2 8.5 9.1 0.0 13.2 7.0 6.6 6.8 16.8 17.6 1.6 9.0 10.6 6.8 5.6 RGPD1 RGP1 ENSG00000187627 "RANBP2 like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 8.6;placenta: 6.8;testis: 15.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Early spermatids: 2.5;Excitatory neurons: 4.3;granulocytes: 3.8;Inhibitory neurons: 4.0;Microglial cells: 2.8;Oligodendrocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.6;MOLT-4: 10.7;NTERA-2: 3.1;RPMI-8226: 2.4;SuSa: 5.3" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.1 0.1 0.2 0.1 0.2 0.0 0.1 2.0 0.4 8.6 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.2 1.5 0.3 0.1 1.6 0.3 1.5 6.8 1.2 0.1 0.0 2.1 0.2 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.3 15.4 0.6 0.9 0.2 0.0 0.5 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 10.7 0.2 3.1 0.1 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.7 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.0 0.4 0.1 0.6 1.5 0.3 1.2 0.1 0.6 0.3 0.1 0.0 0.5 1.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.0 0.4 4.3 0.0 0.0 0.8 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 2.8 0.0 0.2 0.0 1.5 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.2 0.8 0.0 0.0 0.3 1.0 0.0 0.0 0.0 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2 like and GRIP domain containing 2" P0DJD1 2 87755960-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.0;dendritic cells: 5.1;Early spermatids: 5.5;Excitatory neurons: 4.3;Late spermatids: 6.7;Plasma cells: 7.5;T-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "T-reg: 9.6" "Lineage enriched" "Detected in single" 11 "T-cells: 9.6" "Cell line enhanced" "Detected in some" "BEWO: 11.0;JURKAT: 5.4;MOLT-4: 13.3;NTERA-2: 5.4;SuSa: 15.2;THP-1: 5.2" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 1.8 2.8 0.8 1.3 0.7 8.9 1.4 2.6 1.4 10.5 1.6 1.7 2.0 1.4 0.4 0.9 3.2 0.4 1.2 0.6 0.6 1.2 9.6 2.6 2.2 1.7 0.8 2.6 7.9 0.3 5.8 9.5 2.0 1.7 0.7 3.4 1.3 0.7 1.0 1.2 3.7 0.5 0.4 3.2 2.7 16.6 1.0 5.6 1.8 0.3 2.5 0.8 1.6 0.7 0.0 0.0 0.6 0.0 0.0 0.0 11.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 2.6 0.2 0.0 0.1 0.0 5.4 4.0 0.3 0.0 0.4 13.3 0.0 5.4 2.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 2.7 4.5 0.1 0.0 15.2 0.0 5.2 0.1 0.8 0.1 0.0 0.0 2.5 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.6 2.1 0.4 0.0 0.8 1.0 0.2 0.3 0.1 0.0 0.0 9.6 0.3 0.8 0.7 2.6 1.4 0.6 0.6 1.7 0.8 2.0 0.4 1.0 0.7 0.9 0.0 1.1 1.0 4.0 0.1 0.0 0.0 0.0 0.5 0.1 0.3 7.0 0.0 0.0 0.0 0.0 0.4 5.1 0.2 0.0 0.1 5.5 1.7 2.3 0.7 0.0 0.0 4.3 0.2 0.6 0.9 0.5 0.7 0.0 0.2 0.4 0.3 0.1 0.0 3.4 0.0 0.0 0.0 0.4 6.7 0.0 1.7 0.0 1.9 0.0 0.0 0.0 1.5 2.2 0.1 0.0 0.0 7.5 0.1 0.0 0.1 0.8 1.7 0.0 1.0 0.8 2.5 0.6 0.0 0.0 1.0 4.5 0.1 0.0 0.0 RGPD3 RGP3 ENSG00000153165 "RANBP2 like and GRIP domain containing 3" A6NKT7 2 106391290-106468413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 6.9" "Cell type enriched" "Detected in some" 4 "Early spermatids: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 1.5;MOLT-4: 4.6;RPMI-8226: 1.4" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.4 0.1 0.4 0.4 0.2 0.4 0.5 0.1 0.9 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 0.4 0.7 0.7 0.2 0.1 1.0 0.6 0.2 0.2 0.2 0.5 0.2 1.1 0.2 0.1 0.9 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.6 0.1 6.9 0.7 1.9 0.1 0.1 0.2 0.3 0.1 0.5 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.1 0.6 0.1 0.2 0.1 0.0 1.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.4 0.3 0.0 0.2 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.5 0.4 0.4 1.0 0.6 1.1 0.4 0.7 0.5 0.0 0.0 1.1 1.6 0.1 0.1 0.1 0.0 0.0 1.6 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.1 0.5 0.0 0.0 2.4 0.2 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.3 4.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.4 3.2 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2 like and GRIP domain containing 4" Q7Z3J3 2 107826892-107892544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 5.8;Early spermatids: 10.4;Late spermatids: 3.1;Spermatocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 77: Retina - Visual perception" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.8 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 1.0 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.3 3.7 0.5 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.2 0.2 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.0 0.3 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.3 0.2 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2 like and GRIP domain containing 5" Q99666 2 109792758-109857705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 10.2 8.3 12.0 5.8 16.4 13.8 10.3 5.9 21.9 8.1 8.1 8.2 7.4 10.4 17.5 5.4 7.6 7.2 8.9 16.5 14.7 7.3 6.8 10.3 6.0 3.5 3.4 13.0 13.5 14.7 8.2 11.1 4.3 12.3 7.2 22.3 7.0 9.6 6.5 11.6 7.4 7.4 2.7 6.4 7.0 41.2 12.6 3.8 14.4 9.7 5.3 7.5 3.9 14.0 24.3 7.8 26.0 19.5 7.7 8.0 1.2 19.3 16.1 13.8 11.2 20.9 7.8 0.6 12.4 11.7 14.6 8.0 14.3 7.0 17.3 3.7 6.4 18.5 4.1 10.2 8.8 1.5 3.1 8.5 9.5 13.3 14.2 14.5 9.4 7.6 8.8 5.4 10.7 4.5 4.0 0.6 12.7 3.0 9.9 4.3 14.4 0.1 10.4 13.7 31.9 4.5 10.0 1.5 14.0 16.5 0.5 5.4 15.6 14.3 21.1 1.0 14.1 12.2 0.5 0.6 11.7 0.2 4.6 5.4 2.0 2.5 1.9 1.0 3.6 1.7 1.5 2.1 1.4 4.2 2.0 2.1 5.5 2.0 1.2 2.5 1.9 0.6 12.0 16.4 5.9 21.9 16.5 14.7 3.5 3.4 4.3 2.7 12.6 14.0 12.9 3.2 11.8 0.0 9.0 3.4 5.0 0.8 2.8 17.7 2.5 1.4 13.8 0.0 3.7 12.9 16.7 2.4 15.9 1.7 0.0 1.7 4.1 12.3 12.0 7.4 5.3 0.0 7.3 1.0 1.8 7.4 5.1 18.6 0.0 9.4 4.2 0.9 1.8 3.3 4.5 1.4 0.0 2.9 6.5 1.7 2.5 6.6 1.8 1.0 0.9 3.8 0.0 0.0 0.2 1.5 1.7 1.2 10.7 5.5 1.7 0.4 2.6 20.3 0.0 9.7 7.8 4.1 2.9 1.2 3.3 4.4 12.4 1.6 1.0 7.3 RGPD6 RGP6 ENSG00000183054 "RANBP2 like and GRIP domain containing 6" Q99666 2 110513802-110577222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 9.6;Alveolar cells type 2: 17.1;Club cells: 8.1;Excitatory neurons: 10.7;Inhibitory neurons: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.5;SCLC-21H: 10.5" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.11e-2)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" "unprognostic (4.14e-4)" "unprognostic (2.04e-1)" 12.9 8.4 5.0 0.7 2.3 6.3 13.3 6.3 6.4 13.3 6.4 11.5 1.5 9.7 0.9 7.4 12.2 0.0 12.9 2.3 4.9 9.5 14.0 14.4 2.3 4.5 1.5 15.2 18.1 2.0 22.9 1.8 2.8 14.8 0.6 1.9 9.7 0.1 14.7 17.2 12.0 1.0 3.9 9.6 11.8 31.9 2.5 0.7 14.2 2.1 0.7 10.8 10.7 7.6 7.0 2.6 1.2 2.0 0.0 0.5 2.9 1.3 0.0 0.8 0.1 5.7 1.5 0.4 4.2 2.5 3.4 5.2 0.2 2.4 0.0 1.6 11.5 6.8 0.9 1.0 0.1 2.2 0.3 0.4 1.5 1.3 3.1 1.0 0.0 2.1 2.7 2.0 0.0 3.7 1.8 0.0 7.6 1.4 6.7 2.6 4.1 0.0 2.6 0.7 10.5 4.8 1.1 0.2 3.1 4.1 0.1 0.4 1.5 1.4 4.0 0.4 6.0 3.8 0.4 0.5 2.6 0.0 2.5 4.7 1.5 2.0 1.6 0.8 2.4 2.0 2.3 1.7 1.0 3.1 2.3 1.4 4.7 1.5 1.8 2.2 0.5 0.3 5.0 2.3 6.3 6.4 2.3 4.9 4.5 1.5 2.8 3.9 2.5 7.6 0.1 9.6 17.1 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.1 0.1 1.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.3 0.3 0.0 0.5 1.8 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.3 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2 like and GRIP domain containing 8" O14715 2 112368369-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 15.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 16.2;hTEC/SVTERT24-B: 13.4" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 36: HEL - Hemostasis" "Cluster 59: Non-specific - Transcription" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 4.3 1.8 2.7 2.8 3.6 10.6 4.5 8.6 7.6 2.8 4.5 2.1 1.6 3.1 5.4 1.4 2.2 2.9 1.8 3.7 3.5 2.4 5.1 3.3 2.4 2.2 2.4 3.2 3.0 2.2 2.6 3.3 1.9 2.6 2.3 7.9 2.5 2.9 1.7 3.8 2.1 2.6 1.1 3.0 1.7 15.6 2.6 3.2 2.4 2.2 3.0 2.6 1.6 5.5 6.1 2.6 4.3 2.6 1.6 3.6 0.1 2.4 1.9 2.3 1.5 5.3 0.4 0.0 1.7 4.0 2.0 2.9 12.3 1.7 2.4 8.7 4.0 16.2 4.5 4.1 2.2 0.1 0.2 0.6 2.2 13.4 3.4 5.7 1.9 2.8 8.4 0.4 3.6 2.5 8.7 2.1 3.0 0.9 3.7 0.0 0.5 0.1 1.3 2.5 2.7 0.5 8.1 0.1 1.7 3.0 1.2 6.8 8.9 1.3 1.8 6.9 4.4 0.0 0.0 0.0 0.5 2.9 0.3 1.3 0.4 0.4 1.0 0.3 1.4 0.5 0.7 0.9 0.4 0.6 1.0 0.6 0.3 0.5 0.8 0.7 0.4 0.3 2.7 3.6 8.6 7.6 3.7 3.5 2.2 2.4 1.9 1.1 2.6 5.5 1.0 9.6 3.6 1.6 2.8 0.4 0.4 0.2 5.2 0.8 0.3 0.3 8.0 1.5 1.9 0.0 2.1 0.2 0.7 0.1 0.0 0.5 24.3 0.6 0.5 1.5 0.0 2.5 9.8 1.1 0.1 2.2 2.6 0.6 5.1 0.6 0.7 0.2 0.4 0.0 7.0 0.4 0.0 0.6 0.8 10.1 0.3 2.0 0.0 9.4 2.3 0.4 0.0 7.5 5.2 0.9 0.0 0.0 2.4 0.0 0.0 0.1 6.7 0.7 0.0 0.9 0.9 6.8 2.7 2.7 0.0 0.4 3.1 0.0 0.0 0.3 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330241-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 26.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 25.7;Basal squamous epithelial cells: 23.3;Squamous epithelial cells: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 9.7" "Lineage enriched" "Detected in many" 6 "monocytes: 9.7" "Cell line enhanced" "Detected in many" "hTCEpi: 44.3;U-2197: 40.7" "Low region specificity" "Detected in many" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favorable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.8 4.3 3.7 2.3 4.9 1.1 4.4 3.3 5.7 8.3 1.5 5.2 2.7 4.4 0.2 20.4 5.6 1.4 3.4 6.3 1.6 4.3 1.3 4.9 0.5 1.0 1.2 3.7 5.2 0.4 7.2 1.4 1.1 7.1 1.0 0.2 5.1 0.8 7.5 26.6 4.3 0.6 0.8 6.1 6.8 3.7 2.0 0.5 2.4 0.5 0.4 5.4 11.3 2.6 2.3 5.7 2.3 5.3 2.8 14.5 1.2 13.7 18.0 14.4 6.8 3.3 9.3 0.5 5.0 13.6 5.2 12.9 0.0 24.3 1.8 1.1 0.0 0.8 4.4 4.1 5.5 0.1 4.2 15.9 44.3 12.4 8.0 17.1 2.8 0.6 0.3 0.1 6.1 0.5 0.3 11.0 0.6 3.9 12.6 0.1 5.4 0.1 3.9 3.0 10.9 2.3 3.2 2.5 20.5 0.6 1.8 1.3 6.5 18.7 7.9 40.7 3.3 0.3 0.9 0.0 26.9 3.5 6.3 0.1 2.7 0.0 0.2 4.7 0.6 0.1 0.4 0.2 1.7 0.0 0.5 0.2 0.0 0.1 9.7 0.0 0.1 1.8 3.7 4.9 3.3 5.7 6.3 1.6 1.0 1.2 1.1 0.8 2.0 2.6 3.9 0.0 0.5 1.3 0.8 13.4 9.3 25.7 23.3 3.8 3.5 4.3 0.8 4.3 4.8 0.0 0.0 0.8 0.5 9.6 0.0 4.1 0.5 2.4 5.1 5.3 3.0 0.0 6.0 6.9 4.8 5.6 5.6 1.8 4.5 0.1 7.9 0.2 4.7 0.0 2.3 4.5 2.0 8.7 6.5 2.0 4.4 6.4 1.8 1.0 8.1 0.7 1.0 0.5 0.5 8.9 7.8 1.9 1.4 4.0 9.1 0.1 3.4 1.2 0.0 4.2 3.4 1.2 0.9 18.6 15.2 0.3 2.2 1.6 9.2 5.8 SCAI "C9orf126, FLJ36664, NET40" ENSG00000173611 "Suppressor of cancer cell invasion" Q8N9R8 9 124942608-125143528 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 200.1;Excitatory neurons: 327.4;Inhibitory neurons: 171.6;Rod photoreceptor cells: 136.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020632 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nuclear membrane" "HPA020632: AB_1845804" "unprognostic (1.93e-1)" "unprognostic (1.88e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (6.90e-2)" "unprognostic (3.34e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-3)" "unprognostic (5.69e-2)" "unprognostic (2.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-2)" "unprognostic (3.57e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (1.26e-3)" 1.7 2.5 3.3 1.8 3.7 2.9 1.9 0.3 4.2 2.1 5.2 1.9 1.1 2.1 1.5 1.4 2.1 1.2 1.3 2.4 0.3 1.5 1.5 3.2 2.9 0.0 0.4 2.7 1.7 1.5 1.7 0.9 0.0 1.9 1.7 7.5 1.4 1.0 1.7 2.4 1.5 1.3 0.0 1.9 1.5 1.9 0.9 11.2 1.9 1.0 2.3 1.5 1.7 0.9 3.2 2.4 3.2 3.1 1.7 4.2 5.4 2.0 4.1 2.1 2.9 3.1 3.0 5.7 1.5 2.0 2.4 5.3 4.2 2.2 4.2 4.1 1.5 3.8 4.4 2.8 2.4 4.0 2.8 1.6 1.8 3.2 2.1 3.5 3.0 10.2 5.4 6.6 3.2 3.5 13.0 2.8 3.2 6.1 2.6 8.1 5.1 5.0 1.4 4.3 3.3 2.1 4.7 2.5 2.4 3.5 6.3 1.8 3.1 1.9 3.5 3.2 3.5 3.6 7.3 5.5 2.2 3.3 2.8 0.2 0.3 0.0 0.2 0.4 0.3 0.5 0.4 0.3 0.2 0.6 0.6 0.4 0.2 0.6 0.1 0.8 0.7 0.3 3.3 3.7 0.3 4.2 2.4 0.3 0.0 0.4 0.0 0.0 0.9 0.9 7.3 70.5 28.2 49.0 19.7 2.8 7.9 6.0 10.2 46.4 8.7 5.6 4.8 14.3 9.4 18.4 200.1 6.6 14.6 6.3 1.9 4.1 14.5 9.4 8.5 8.0 13.1 23.3 327.4 2.0 4.7 7.5 8.2 14.2 5.1 74.5 12.5 8.7 4.2 16.8 171.6 8.4 16.2 6.6 5.5 5.9 9.6 5.4 3.6 55.3 5.4 25.8 22.6 72.9 61.0 2.9 7.3 6.0 14.3 9.6 8.3 3.1 10.3 136.5 0.0 11.3 8.3 34.7 21.5 12.4 4.3 2.6 14.8 28.9 11.2 4.4 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 142.9 138.1 66.2 83.4 69.4 172.2 136.2 69.0 80.4 147.1 76.6 110.8 82.9 111.0 202.5 81.6 103.6 97.5 98.4 63.7 72.6 137.2 152.3 107.9 112.6 74.1 67.2 168.6 139.4 114.6 84.5 115.1 73.9 82.0 124.9 37.0 95.9 87.5 154.3 70.5 86.4 96.3 72.4 86.2 95.3 61.5 69.4 93.2 177.5 147.4 98.2 137.3 94.0 75.3 201.7 320.7 286.7 425.4 368.5 462.8 225.4 310.1 356.5 241.9 291.2 347.1 443.0 99.0 198.8 370.3 277.2 408.3 409.1 243.4 255.5 267.1 239.4 279.4 358.8 324.9 311.7 213.4 281.2 315.8 305.0 169.1 285.1 366.0 337.9 116.7 295.8 244.3 315.1 363.1 89.2 345.8 282.1 266.2 135.4 101.6 368.4 302.9 472.6 424.4 131.2 300.8 257.3 239.5 598.5 407.0 248.5 416.6 254.3 240.0 181.0 209.8 361.9 224.4 509.6 150.0 226.4 331.7 180.6 83.5 161.1 89.7 95.1 173.7 95.0 101.0 114.8 104.7 165.8 90.0 95.1 98.0 111.6 134.3 184.8 160.9 168.8 200.8 66.2 69.4 69.0 80.4 63.7 72.6 74.1 67.2 73.9 72.4 69.4 75.3 261.1 89.8 99.1 25.8 131.8 107.1 179.4 356.6 90.5 30.0 163.7 202.6 68.2 228.8 188.0 128.8 22.9 309.1 171.9 111.1 238.7 258.8 46.3 118.5 268.0 217.2 157.4 101.7 21.2 247.3 655.3 206.0 120.8 184.1 218.4 191.0 197.7 165.5 363.3 20.2 22.8 218.7 168.9 386.7 337.2 100.6 299.5 337.3 158.3 24.4 396.7 110.5 204.9 26.7 38.3 183.4 136.3 166.3 197.9 185.7 142.7 350.9 99.3 38.2 170.9 173.5 225.5 233.5 169.6 135.2 119.9 305.8 153.4 237.6 210.7 242.2 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139866-59158832 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: AB_2680078" "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 24.6 76.7 110.0 86.5 117.5 63.1 81.8 122.9 140.5 57.8 94.4 92.3 126.7 40.1 284.6 42.5 41.4 47.3 30.0 112.9 146.4 70.2 219.0 62.7 104.2 137.3 130.2 29.9 374.0 153.9 155.2 28.4 136.8 225.7 78.2 108.1 397.3 62.3 15.7 29.7 97.8 30.1 123.7 81.4 138.5 28.1 113.5 53.0 163.7 20.0 117.8 59.4 21.2 135.8 82.4 100.0 52.9 74.1 31.9 6.8 64.7 72.4 62.9 89.9 55.2 78.3 42.5 176.8 109.9 46.6 67.6 82.8 84.7 59.0 58.4 523.5 113.8 58.5 69.3 242.3 99.3 199.4 87.6 20.4 140.7 56.2 161.1 20.2 33.7 78.4 67.4 546.2 34.6 100.0 79.0 79.2 48.1 140.4 60.5 72.8 50.0 1150.0 67.5 76.1 223.2 90.5 43.1 162.5 252.8 29.9 76.0 148.5 24.7 98.5 45.4 36.5 86.9 587.3 434.4 176.0 99.4 131.8 124.5 76.4 70.7 57.9 146.1 97.6 187.6 197.8 150.4 142.5 78.8 127.9 77.7 105.4 12.2 108.3 108.8 299.6 223.7 222.1 110.0 117.5 122.9 140.5 112.9 146.4 137.3 130.2 136.8 123.7 113.5 135.8 64.8 28.9 120.7 19.2 295.9 32.6 49.3 92.4 12.5 63.6 120.0 128.3 59.3 144.4 102.5 60.7 50.1 70.8 148.7 76.3 88.0 164.4 45.4 58.7 34.2 60.3 339.3 43.8 12.2 263.1 109.1 29.2 60.6 147.1 47.5 21.5 56.4 224.7 112.9 50.5 13.3 223.1 685.6 37.1 56.9 18.8 12.5 63.9 256.1 10.3 46.4 544.7 96.8 17.1 31.2 148.9 78.4 23.0 1164.8 380.9 99.3 118.8 81.3 89.3 6.6 23.1 70.6 110.2 81.5 35.5 45.5 149.7 92.3 40.1 88.3 79.2 SIX2 ENSG00000170577 "SIX homeobox 2" Q9NPC8 2 45005182-45009452 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 21.1;skeletal muscle: 33.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 6.1;Cardiomyocytes: 3.3;Fibroblasts: 3.0;Ionocytes: 8.2;Skeletal myocytes: 8.5;Smooth muscle cells: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 48.8;LHCN-M2: 46.8;RH-30: 31.9;SCLC-21H: 54.3;U-2197: 35.3;U-698: 43.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA056958 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 59: Non-specific - Translation" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear membrane" "HPA056958: AB_2683287" "unprognostic (1.14e-3)" "unprognostic (2.73e-2)" "unprognostic (3.09e-6)" "unprognostic (1.28e-2)" "unprognostic (3.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.06e-3)" "unprognostic (9.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "unprognostic (1.07e-2)" "unprognostic (4.53e-9)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-5)" "unprognostic (1.05e-1)" 10.4 0.1 0.1 0.1 0.3 0.0 1.6 0.2 0.5 11.6 0.5 0.7 0.0 1.7 0.1 0.2 0.2 0.0 1.5 0.9 0.2 0.5 0.0 0.2 0.1 0.4 1.5 0.1 6.0 2.1 12.9 0.1 1.7 6.2 0.0 0.9 21.1 1.2 33.8 0.4 0.1 0.1 0.1 0.0 9.5 0.3 0.2 3.9 0.6 15.5 0.0 1.8 8.6 0.2 0.7 0.0 0.0 4.2 13.0 48.8 0.0 0.2 2.3 1.0 0.1 0.4 0.0 0.0 2.2 0.0 0.4 0.1 4.7 8.5 0.6 0.0 2.5 0.0 16.7 0.0 0.0 0.0 4.5 2.4 0.1 10.4 0.1 0.4 1.6 0.5 0.2 0.0 46.8 1.7 0.0 2.8 0.4 0.0 10.2 0.0 31.9 0.0 0.1 2.7 54.3 0.4 7.1 0.2 0.0 0.5 0.4 4.2 0.7 0.9 2.7 35.3 0.0 1.0 0.0 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.5 0.9 0.2 0.4 1.5 1.7 0.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.9 0.4 6.1 0.0 0.0 1.2 0.6 3.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.4 0.0 0.0 0.0 2.2 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 1.2 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.5 0.0 8.5 3.2 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.0 0.2 SLA "hSLAP, SLA1, SLAP, SLAP-1" ENSG00000155926 "Src like adaptor" Q13239 8 133036728-133102912 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 97.4;lymphoid tissue: 156.6" "Cell type enhanced" "Detected in many" "dendritic cells: 224.2;Hofbauer cells: 67.4;Kupffer cells: 199.4;Macrophages: 154.2;NK-cells: 109.2;Plasma cells: 83.0;T-cells: 160.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 47.9;JURKAT: 201.5;Karpas-707: 129.2;MOLT-4: 35.8;U-266/84: 76.1;U-937: 55.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012296, HPA074192" Enhanced Approved "Nuclear membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear membrane, Cytosol" "HPA012296: AB_1856946, HPA074192: AB_2686673" "unprognostic (1.19e-2)" "unprognostic (6.29e-3)" "unprognostic (2.73e-3)" "unprognostic (6.07e-3)" "unprognostic (1.66e-2)" "unprognostic (1.10e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (9.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.66e-1)" "unprognostic (3.05e-2)" "unprognostic (8.60e-2)" "unprognostic (1.65e-1)" 25.2 13.1 9.5 82.9 6.4 97.4 9.5 6.1 11.5 11.1 8.2 10.8 7.9 5.2 2.9 9.4 7.0 20.9 5.2 8.2 9.1 6.4 16.9 25.9 78.6 12.0 8.4 3.0 5.8 3.1 3.1 15.2 10.3 5.2 8.4 1.3 4.6 3.6 1.5 4.0 20.7 12.5 9.7 70.3 12.5 1.4 16.9 156.6 27.6 4.4 71.0 22.0 4.2 14.6 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.9 0.1 2.3 0.0 0.0 0.0 6.3 47.9 0.8 0.0 0.6 0.0 0.2 0.0 201.5 0.1 129.2 0.0 0.0 35.8 9.3 0.0 0.0 0.0 0.2 0.3 7.8 0.0 0.0 0.0 1.0 0.0 0.1 0.1 3.1 0.0 15.3 0.0 0.1 0.3 0.2 0.1 6.9 76.1 0.0 0.6 55.6 0.0 0.7 110.2 203.6 87.6 123.1 110.1 41.0 79.7 88.2 79.8 48.3 75.3 77.4 262.3 132.6 148.4 6.3 124.4 158.9 9.5 6.4 6.1 11.5 8.2 9.1 12.0 8.4 10.3 9.7 16.9 14.6 2.4 9.6 19.1 0.7 36.6 2.2 0.3 0.0 0.0 9.7 0.9 1.3 3.3 1.5 10.5 0.0 0.0 0.4 224.2 0.2 0.0 0.2 0.2 0.7 0.7 5.9 0.0 13.2 1.0 0.0 1.2 4.5 3.6 0.5 37.2 1.7 8.9 2.9 67.4 0.0 1.3 0.5 0.0 199.4 15.0 1.0 0.3 154.2 5.4 14.0 36.7 0.1 109.2 0.0 0.1 0.0 0.0 0.0 83.0 0.1 0.0 0.3 5.1 0.3 6.6 1.4 1.9 0.0 0.1 0.3 2.7 0.1 160.0 0.1 0.1 0.2 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82217934-82261129 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 198.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 1667.1;Syncytiotrophoblasts: 748.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 109.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" NA NA 260000 "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavorable (1.19e-7)" "prognostic unfavorable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 30.4 16.9 3.8 25.3 5.8 22.7 15.7 6.6 9.7 26.2 5.0 28.9 11.6 11.6 1.3 42.4 18.5 12.8 26.0 4.5 7.3 48.2 11.3 46.4 5.7 17.3 8.5 9.1 5.8 2.5 12.1 24.7 11.9 19.6 5.7 5.7 27.5 5.9 198.3 8.4 22.9 6.0 8.4 57.5 22.0 32.0 13.8 2.9 29.1 73.2 5.2 26.3 28.5 15.1 52.8 24.4 0.6 1.3 7.8 28.8 51.7 225.6 107.7 117.4 142.2 10.1 119.1 0.7 158.0 122.5 127.9 18.9 15.6 242.0 51.8 78.1 1.2 87.4 144.0 236.4 164.1 105.2 111.5 64.8 38.2 77.0 38.5 185.8 69.1 2.2 1.0 26.6 116.1 14.0 1.4 166.3 1.9 22.1 223.5 0.9 1.6 33.2 75.9 3.0 2.9 1.7 196.7 166.9 3.2 20.4 25.4 131.4 124.0 281.7 5.1 4.5 200.9 97.3 1.9 3.9 140.2 94.7 3.0 56.6 32.6 92.1 9.6 30.4 13.4 8.1 7.7 10.5 24.1 6.2 4.2 5.3 109.1 25.3 31.4 15.2 7.3 16.0 3.8 5.8 6.6 9.7 4.5 7.3 17.3 8.5 11.9 8.4 13.8 15.1 19.2 9.6 9.8 3.6 27.9 6.5 47.5 210.1 2.8 13.4 3.2 2.5 6.1 4.3 182.3 57.0 4.2 67.6 72.4 216.7 0.0 136.1 3.0 33.7 15.4 29.9 20.9 9.1 0.3 18.0 1667.1 17.2 45.3 65.1 75.0 15.9 16.8 1.1 271.0 127.9 0.3 28.3 148.5 99.9 84.6 3.8 3.1 168.6 14.2 9.4 184.9 20.3 40.2 0.0 1.0 305.5 190.2 3.8 35.7 16.5 62.4 5.6 91.1 11.6 0.0 1.6 50.5 1.9 9.5 1.6 6.7 748.8 38.5 0.8 33.4 119.6 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 39: CACO-2 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nuclear membrane" Cytosol "HPA046279: AB_2679611, HPA049426: AB_2680762" "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.73e-4)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 9.9 10.8 4.2 11.1 4.9 25.4 10.9 5.3 6.2 15.5 3.1 12.1 9.5 15.5 5.0 13.8 15.9 9.2 11.7 4.0 7.0 8.6 9.2 10.6 15.7 7.5 5.0 14.6 13.3 15.2 22.7 14.9 6.3 11.8 11.1 4.7 12.9 11.7 13.3 13.5 11.5 12.9 2.4 11.2 10.3 17.7 6.0 19.8 16.0 12.0 15.7 11.8 12.3 10.0 89.1 41.5 46.2 39.2 29.1 21.8 58.7 41.5 42.0 76.3 62.8 119.2 47.0 56.2 41.2 49.9 36.3 43.8 64.0 64.4 40.4 72.7 61.2 60.5 36.2 90.1 31.2 68.5 34.7 25.6 39.4 77.0 27.2 21.1 44.9 51.4 82.2 40.8 40.7 44.3 72.2 32.0 77.0 40.1 56.4 74.3 44.2 59.0 27.0 38.6 66.8 36.3 42.8 54.5 22.7 24.9 37.8 34.8 32.8 57.0 49.3 33.0 49.4 34.3 44.0 79.2 51.4 38.7 44.0 1.8 9.2 14.8 12.9 11.2 14.3 8.9 9.6 11.6 9.6 9.1 9.0 10.5 4.3 12.1 8.1 6.0 9.2 10.4 4.2 4.9 5.3 6.2 4.0 7.0 7.5 5.0 6.3 2.4 6.0 10.0 17.4 3.2 11.3 4.9 20.8 15.0 9.1 8.8 12.0 19.8 21.5 23.0 3.9 5.7 8.0 7.3 12.5 23.8 16.4 7.9 9.8 9.2 22.7 16.0 19.7 12.0 13.1 21.2 6.9 12.2 26.5 12.2 18.8 26.3 6.3 29.0 10.4 17.3 14.1 15.2 6.7 12.8 4.1 13.2 7.7 41.7 14.6 10.2 16.0 1.0 8.8 9.9 11.3 7.5 10.4 11.8 10.5 18.4 27.0 9.4 7.7 5.9 9.9 16.0 0.0 14.1 12.8 25.0 25.6 18.7 20.6 15.6 15.6 16.0 15.2 9.6 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 79.0" "Cell type enhanced" "Detected in many" "Fibroblasts: 140.8;Leydig cells: 185.8;Peritubular cells: 267.4;Skeletal myocytes: 139.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "memory B-cell: 57.4;naive B-cell: 16.9" "Lineage enriched" "Detected in many" 19 "B-cells: 57.4" "Group enriched" "Detected in many" 4 "ASC diff: 24.4;hTERT-RPE1: 91.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" No No "Cluster 19: B-cells - Humoral immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" "Nuclear membrane" Nucleoplasm "HPA066432: AB_2685669" "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 21.3 10.7 18.0 6.4 26.5 0.1 20.1 26.2 15.4 39.5 8.6 21.2 4.4 23.9 17.8 18.3 25.2 21.9 46.0 16.1 30.1 6.1 1.4 8.9 7.0 26.5 29.1 33.8 8.0 3.2 3.8 4.6 27.9 22.4 12.7 2.9 9.4 34.4 60.7 4.4 7.7 24.3 31.5 8.7 7.7 8.3 21.5 8.7 17.1 79.0 12.1 19.2 15.4 38.4 0.8 1.6 4.0 0.0 24.4 14.5 0.2 6.9 10.8 1.1 3.1 0.1 9.5 0.0 1.8 11.0 6.0 3.0 0.0 0.5 2.1 0.1 0.0 0.0 0.1 0.0 2.9 0.1 0.0 9.3 1.0 3.5 0.8 91.6 0.4 0.0 0.0 0.1 8.4 1.9 0.6 1.9 7.9 0.6 2.7 0.3 10.7 3.2 2.4 8.3 0.4 6.3 2.7 0.6 7.0 4.0 0.9 0.3 3.0 2.5 1.8 3.4 1.8 0.3 1.2 0.2 5.3 0.0 8.6 0.0 0.0 2.7 0.0 0.0 0.5 57.4 0.0 0.0 0.1 16.9 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.7 18.0 26.5 26.2 15.4 16.1 30.1 26.5 29.1 27.9 31.5 21.5 38.4 10.8 3.2 3.2 39.2 30.7 13.6 23.1 21.6 30.1 2.1 21.8 89.2 95.4 10.0 14.8 18.4 0.0 74.0 1.4 36.0 5.9 11.4 4.0 12.4 52.1 10.2 4.9 1.3 3.5 7.1 7.5 140.8 3.6 6.0 0.0 10.7 9.7 0.2 15.3 6.7 5.8 10.1 0.0 0.6 11.1 5.8 185.8 6.6 19.6 18.7 18.6 41.2 0.0 41.7 18.4 2.8 7.3 267.4 41.2 19.4 0.6 3.1 7.9 2.7 39.5 139.9 56.3 0.7 3.8 7.7 7.1 27.8 2.1 30.7 7.7 24.7 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 128.5;pituitary gland: 98.5" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 52.7;Excitatory neurons: 60.6;Pancreatic endocrine cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 139.9;U-87 MG: 92.2" "Group enriched" "Detected in all" 5 "amygdala: 246.2;basal ganglia: 93.9;cerebral cortex: 354.4;hippocampal formation: 229.1;white matter: 116.1" "Group enriched" "Detected in all" 8 "amygdala: 37.6;cerebral cortex: 103.4;hippocampal formation: 87.2" "CAB008372, HPA069176" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 10: Brain - Neuronal signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "Nuclear membrane" "CAB008372: AB_592786, HPA069176: AB_2686098" "unprognostic (5.12e-3)" "prognostic unfavorable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 2.5 6.8 55.0 2.5 70.6 11.9 2.4 28.8 128.5 5.3 13.3 10.8 4.4 3.9 1.5 1.8 3.8 6.8 1.7 76.1 24.5 3.4 2.3 3.4 1.0 16.8 20.1 3.1 10.8 0.9 98.5 2.3 17.8 4.6 2.0 2.5 3.0 1.4 2.1 1.8 4.3 2.7 15.8 2.5 7.8 4.6 23.3 1.2 2.7 0.7 0.6 4.1 4.1 55.3 4.6 21.9 3.4 10.1 4.4 11.7 2.3 14.3 9.5 5.9 3.9 7.4 12.2 5.8 2.1 10.3 32.2 3.7 5.0 9.2 4.4 10.2 3.9 1.8 8.7 4.4 4.9 2.7 5.2 6.8 3.8 41.4 14.4 26.7 10.4 0.9 4.9 6.5 11.4 10.8 1.7 21.1 2.7 8.1 47.8 0.0 2.4 5.7 4.9 3.9 139.9 22.5 4.3 12.1 3.0 4.0 3.9 1.8 39.7 28.9 9.6 22.4 39.0 3.7 2.5 2.7 92.2 2.2 34.5 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 55.0 70.6 28.8 128.5 76.1 24.5 16.8 20.1 17.8 15.8 23.3 55.3 0.9 0.0 2.8 8.1 0.4 4.2 10.7 6.2 0.6 6.2 4.6 3.4 3.2 4.3 5.9 1.8 4.2 0.4 5.0 1.3 0.0 4.0 0.1 4.5 2.9 1.6 52.7 0.4 60.6 3.6 1.9 2.2 3.1 11.1 15.2 2.2 1.8 0.2 0.7 8.4 16.6 2.8 8.2 1.2 2.1 0.2 1.8 6.1 3.6 5.6 0.1 1.0 6.2 8.5 4.8 29.8 1.2 1.5 1.0 10.5 3.4 0.5 7.4 1.9 0.0 1.9 2.8 1.6 3.8 0.6 2.7 0.7 5.3 1.7 1.5 18.9 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010638 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 137.2" "Cell type enhanced" "Detected in some" "Excitatory neurons: 36.8;Horizontal cells: 38.7;Inhibitory neurons: 31.1;Late spermatids: 13.8" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Region enhanced" "Detected in many" "cerebral cortex: 137.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 11.1;hTERT-RPE1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 62: Horizontal cells - Visual perception" Vesicles "Nuclear membrane" "CAB079008: , HPA069176: AB_2686098" "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.5 1.0 7.0 1.1 13.1 0.4 1.7 20.0 137.2 1.7 0.0 2.5 0.5 3.0 3.3 1.2 1.7 0.3 1.6 15.9 5.2 1.3 5.9 0.5 1.7 51.2 5.5 1.7 0.9 0.2 6.5 0.2 42.9 1.7 0.4 10.2 1.0 1.8 0.5 3.3 1.8 1.6 0.0 1.8 0.9 4.6 5.8 0.5 0.7 0.1 1.5 0.7 1.3 52.8 0.1 3.0 4.7 0.7 0.5 0.2 0.1 4.2 6.4 5.1 9.0 0.0 3.4 0.7 0.2 5.6 0.1 0.7 2.1 0.6 6.1 2.6 0.4 0.4 2.7 2.4 0.4 0.2 2.9 1.6 0.1 11.1 1.0 20.4 0.0 1.0 0.5 0.2 5.5 1.3 2.0 0.2 2.3 0.0 0.3 7.1 0.2 0.2 0.4 0.0 6.3 4.0 0.5 0.2 0.0 0.7 0.8 0.1 0.8 3.0 2.4 0.4 0.2 0.3 0.2 0.3 3.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 13.1 20.0 137.2 15.9 5.2 51.2 5.5 42.9 0.0 5.8 52.8 0.4 0.0 0.0 7.2 0.6 0.8 0.1 0.2 0.6 10.7 0.4 0.6 1.2 0.0 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.3 6.9 0.1 0.5 0.8 0.0 0.4 36.8 0.4 0.0 0.7 0.0 0.1 0.0 2.5 1.1 5.9 0.6 38.7 31.1 0.2 0.0 0.6 1.1 13.8 0.3 0.3 0.0 4.7 0.7 1.8 0.0 9.0 5.5 0.2 0.0 1.9 0.0 0.2 0.9 2.1 0.0 3.2 0.0 0.8 0.7 4.6 1.3 0.2 0.6 0.8 0.4 0.1 0.3 0.0 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 152.2;Endometrial ciliated cells: 86.4;Late spermatids: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079007" Uncertain Supported Approved "Nuclear membrane,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" Vesicles "Nuclear membrane" "CAB079007: , HPA069176: AB_2686098" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 17.7 11.0 11.2 9.1 11.7 6.4 12.0 12.3 13.4 15.1 24.7 21.2 4.2 14.3 9.8 6.0 16.3 9.9 17.0 12.2 12.1 14.4 13.3 17.8 8.6 15.5 12.3 15.3 10.9 5.9 14.6 13.2 14.5 8.4 6.8 16.7 5.0 10.6 6.7 5.1 11.4 17.2 13.0 12.4 11.4 17.0 11.8 6.9 12.4 7.9 6.2 14.5 10.7 16.3 9.6 18.3 26.8 22.4 27.8 63.2 2.8 44.2 35.8 50.8 35.7 5.5 6.6 11.7 6.6 50.5 16.4 2.8 24.4 6.6 54.9 18.7 9.2 6.4 15.9 15.7 30.6 9.2 15.5 23.4 8.3 24.9 20.1 48.2 27.6 12.7 25.7 11.2 46.2 5.6 13.3 10.6 17.9 2.9 28.2 13.7 18.9 7.0 28.7 2.1 24.3 25.4 20.4 1.8 18.1 23.4 6.1 6.4 36.5 30.1 20.3 33.1 19.6 8.1 6.7 7.9 35.0 10.8 24.4 1.0 0.4 0.6 0.5 0.5 0.5 0.5 0.6 0.5 0.3 0.3 0.6 0.6 0.4 0.2 0.2 0.3 0.4 0.2 11.2 11.7 12.3 13.4 12.2 12.1 15.5 12.3 14.5 13.0 11.8 16.3 35.3 22.4 14.8 20.5 6.2 3.4 1.2 2.1 3.4 5.6 2.1 3.0 17.2 11.5 6.9 29.5 0.0 1.8 12.3 0.4 9.8 19.1 152.2 86.4 40.0 22.4 6.7 32.4 33.6 7.4 7.1 26.5 2.6 7.6 1.3 10.9 17.9 19.0 11.5 0.0 17.6 0.7 2.0 11.5 12.3 114.4 28.0 15.1 14.2 23.4 10.3 12.3 6.2 15.1 24.3 14.5 0.1 24.5 10.2 2.0 0.1 17.6 33.9 31.4 13.1 26.1 29.6 42.0 34.2 1.7 1.4 0.8 14.2 11.7 0.6 0.5 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 313.2" "Cell type enhanced" "Detected in all" "Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 74.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 167.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 3: HMC-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Nuclear membrane" "HPA002191: AB_1080165, HPA069176: AB_2686098" "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 16.4 24.1 10.1 23.7 11.8 59.2 20.1 18.3 14.6 21.1 11.8 51.0 59.5 29.7 36.7 21.4 15.1 39.1 16.4 10.8 11.2 58.6 15.4 40.7 9.7 11.7 11.9 18.7 24.0 34.1 19.4 50.3 13.4 20.2 56.3 313.2 21.6 24.6 10.9 26.2 44.1 26.4 9.7 23.4 47.5 22.1 12.4 7.4 27.8 17.9 13.8 28.3 18.3 13.1 40.1 23.8 0.9 11.0 20.5 11.5 33.1 21.1 37.7 49.4 61.0 109.4 38.2 11.2 38.9 16.1 85.6 44.0 63.5 22.0 59.4 9.6 12.0 12.7 16.4 34.0 51.1 41.7 116.4 21.0 46.6 38.3 46.2 30.5 39.7 16.6 110.5 23.0 21.5 23.8 0.4 28.9 60.1 63.1 18.2 14.5 40.8 18.6 92.7 94.5 27.0 41.4 9.0 48.0 167.2 79.9 52.1 29.0 54.0 20.8 44.0 28.6 19.3 25.8 49.4 22.8 27.8 27.0 29.0 42.5 6.3 74.1 2.4 1.9 2.5 1.0 3.3 1.6 7.1 3.1 3.0 0.9 60.7 0.5 1.2 1.0 0.0 2.7 10.1 11.8 18.3 14.6 10.8 11.2 11.7 11.9 13.4 9.7 12.4 13.1 17.0 67.3 30.6 2.6 9.5 50.7 69.5 12.8 30.1 373.0 43.5 15.2 10.2 31.5 18.9 11.0 394.0 10.1 5.9 124.6 17.6 40.2 4.8 37.8 9.6 30.2 26.3 4.4 40.4 25.6 15.9 12.8 29.6 68.5 58.2 14.9 20.7 5.6 16.0 72.3 33.0 36.5 18.3 18.9 49.7 7.5 3.7 26.4 37.4 24.4 28.7 48.4 11.3 3.5 25.3 48.9 64.1 7.5 5.8 87.2 34.0 69.5 13.3 400.3 6.6 10.0 15.9 4.6 20.6 29.4 60.1 40.5 17.9 5.6 26.5 87.7 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860145 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.5;liver: 37.2;skin 1: 19.3;vagina: 30.4" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 65.8;Glandular and luminal cells: 35.1;Hepatocytes: 51.4;Paneth cells: 66.3;Proximal enterocytes: 21.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HHSteC: 71.1;HSkMC: 32.3;hTCEpi: 27.3;HUVEC TERT2: 20.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 7.8" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favorable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.1 14.5 0.1 0.0 0.1 0.1 0.1 0.1 0.2 13.5 4.1 0.2 27.5 0.3 1.0 0.8 0.2 0.2 0.0 0.1 0.0 0.3 37.2 2.3 0.0 0.1 0.1 0.0 0.2 0.0 0.6 0.1 0.1 0.7 0.1 0.0 6.6 0.4 0.0 19.3 27.3 0.1 0.0 0.0 2.1 0.1 0.1 0.5 0.0 0.0 1.5 0.7 30.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 71.1 0.0 0.0 32.3 27.3 0.0 0.9 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 11.9 1.0 8.7 0.0 0.0 0.1 0.0 0.1 1.5 2.8 1.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 65.8 1.3 0.3 0.0 0.0 0.1 1.3 0.1 0.2 0.0 35.1 0.0 0.0 2.5 51.4 0.3 0.0 0.0 4.7 0.0 0.8 0.7 0.0 0.3 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 66.3 0.0 0.0 0.0 21.5 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 3.4 1.5 0.1 0.0 13.8 0.2 SYNE1 "8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B" ENSG00000131018 "Spectrin repeat containing nuclear envelope protein 1" Q8NF91 6 152121684-152637801 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" Actin-binding "Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 152.5;choroid plexus: 182.9" "Cell type enhanced" "Detected in many" "Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "eosinophil: 56.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 56.8" "Cell line enhanced" "Detected in many" "U-2 OS: 29.8;U-266/70: 29.1" "Low region specificity" "Detected in all" HPA019113 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA 72000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nuclear membrane" "HPA019113: AB_1857707" "unprognostic (9.99e-2)" "unprognostic (1.91e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-1)" "unprognostic (2.28e-1)" "unprognostic (9.58e-3)" "unprognostic (1.11e-1)" "unprognostic (3.55e-3)" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (8.87e-3)" "unprognostic (2.70e-1)" "unprognostic (4.14e-3)" "unprognostic (5.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" 15.4 17.8 60.2 7.5 68.8 53.6 14.4 152.5 70.2 18.9 182.9 17.2 2.3 19.1 23.7 5.6 26.4 7.9 32.3 92.4 58.1 34.7 14.6 31.3 17.1 55.0 58.8 44.5 20.6 23.6 56.8 4.4 55.6 17.0 6.2 66.3 5.0 12.6 28.0 19.6 11.4 13.1 38.3 32.9 21.6 17.6 55.4 23.9 44.7 16.5 13.4 16.3 12.9 51.5 0.2 5.8 3.7 4.4 5.7 12.1 1.5 14.7 6.9 3.4 6.0 1.3 0.2 13.5 0.7 7.5 11.2 0.3 1.6 3.8 3.5 11.6 4.0 5.2 4.1 4.0 12.8 1.1 2.7 7.9 0.8 7.5 14.9 9.2 6.8 6.9 0.0 14.2 9.2 0.7 2.4 0.2 0.9 1.3 2.2 2.9 8.1 3.5 15.7 0.2 2.6 3.9 2.7 0.8 9.8 3.7 0.8 0.5 9.0 16.3 29.8 5.9 7.6 29.1 12.5 23.3 8.8 2.9 4.6 10.2 2.3 56.8 11.8 1.8 7.9 6.9 10.3 13.4 1.8 8.2 9.7 10.9 1.6 9.9 3.9 1.5 13.2 3.5 60.2 68.8 152.5 70.2 92.4 58.1 55.0 58.8 55.6 38.3 55.4 51.5 139.7 166.7 215.2 550.1 29.1 12.7 5.4 3.0 3.4 332.1 4.9 9.7 117.2 7.2 53.1 44.1 200.1 0.9 132.9 0.4 3.9 24.0 11.5 132.0 118.2 127.5 3.0 11.6 494.6 7.7 14.2 79.6 7.7 17.8 15.2 13.1 90.0 21.8 8.0 138.0 482.6 11.5 2.0 10.1 15.0 12.6 33.2 16.0 16.0 315.7 12.8 27.3 210.1 256.4 108.6 4.2 0.1 39.9 79.6 5.1 0.0 17.8 146.7 145.5 26.3 145.8 85.6 3.9 5.7 2.2 9.7 1.2 74.7 62.2 0.4 2.2 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63761899-64226433 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 198.5" "Cell type enhanced" "Detected in all" "Granulosa cells: 454.6;Rod photoreceptor cells: 568.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 73.8" "Group enriched" "Detected in many" 11 "granulocytes: 73.8;T-cells: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 48.8;SiHa: 29.8;U-698: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.1 6.0 8.8 3.4 9.2 7.9 28.0 21.1 8.7 15.4 89.5 13.3 4.5 18.1 9.9 24.3 14.3 5.5 58.3 9.6 7.6 29.0 19.5 18.4 8.5 7.7 9.6 35.9 37.7 66.6 16.7 9.9 7.5 11.5 4.4 24.8 16.1 3.7 198.5 39.7 11.4 4.6 7.0 10.0 12.4 13.1 11.4 5.5 24.4 96.7 6.1 13.6 19.0 6.9 23.2 8.7 11.0 3.5 11.3 3.2 12.3 1.3 1.6 2.7 4.2 2.8 3.3 48.8 2.3 1.7 2.6 11.0 6.2 3.5 3.2 8.9 3.5 0.4 7.9 0.7 3.0 1.0 0.3 4.4 15.1 3.4 2.2 2.6 7.0 7.5 0.4 4.8 1.8 11.2 6.2 0.3 3.4 5.4 3.3 6.9 14.5 1.8 20.0 13.6 9.9 8.2 29.8 3.8 7.0 5.5 5.0 0.3 7.3 4.2 7.5 1.5 4.5 4.9 3.5 27.5 1.8 0.0 5.7 0.5 0.1 73.8 38.5 0.3 27.6 5.2 24.3 28.0 0.0 5.3 11.8 18.5 30.1 3.9 0.3 1.2 30.1 3.4 8.8 9.2 21.1 8.7 9.6 7.6 7.7 9.6 7.5 7.0 11.4 6.9 414.4 307.7 140.1 8.5 44.9 111.3 138.9 46.4 174.2 27.4 70.3 59.1 261.4 105.8 184.5 202.3 183.5 168.8 226.8 51.0 19.6 108.2 9.4 249.9 71.2 238.8 46.2 10.5 9.5 55.4 65.7 59.6 126.9 365.2 25.9 454.6 73.5 33.3 17.7 6.7 13.9 60.9 59.0 5.7 13.2 14.3 100.9 12.8 48.0 128.4 8.9 107.2 300.7 33.2 6.6 71.7 27.9 53.4 180.3 65.0 35.9 72.2 196.1 568.7 111.7 73.5 167.0 13.0 17.0 104.6 87.5 224.0 222.1 69.5 80.6 80.6 TAF3 "TAF140, TAFII140" ENSG00000165632 "TATA-box binding protein associated factor 3" Q5VWG9 10 7818505-8016631 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066184 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nuclear membrane" "HPA066184: AB_2685631" "unprognostic (3.82e-2)" "unprognostic (2.87e-3)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (2.14e-7)" "unprognostic (2.97e-1)" "unprognostic (1.45e-1)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "unprognostic (6.30e-3)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.59e-2)" "unprognostic (3.44e-1)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" 5.4 4.9 7.1 4.8 7.9 6.9 4.5 9.9 9.0 4.7 4.8 5.1 2.8 5.2 2.2 3.0 4.3 3.3 5.9 6.1 7.6 4.0 3.7 3.9 6.1 7.9 9.0 7.0 4.3 5.2 3.1 4.5 7.9 3.5 3.5 5.3 3.6 4.4 10.7 5.2 3.8 4.2 7.2 5.5 3.7 7.5 8.2 7.0 4.3 7.6 4.6 5.0 4.2 7.2 7.9 7.2 8.0 4.3 9.0 6.2 11.1 9.2 3.5 6.8 7.7 15.6 5.8 13.4 6.9 5.4 2.8 8.4 8.9 7.9 8.5 10.9 9.8 11.5 5.0 10.0 7.7 7.8 10.1 4.2 7.8 9.5 4.6 4.3 6.5 14.5 13.0 13.5 7.8 14.9 17.7 5.5 6.1 11.5 4.2 14.2 7.6 9.0 3.9 4.9 4.3 6.1 10.0 7.2 9.4 7.8 13.1 8.1 8.1 6.1 10.7 16.3 9.1 8.0 10.3 14.4 5.9 8.8 5.6 5.8 3.9 5.7 6.0 3.4 7.1 5.2 5.4 5.9 3.2 5.6 6.7 5.8 1.5 6.2 6.6 3.1 4.9 3.9 7.1 7.9 9.9 9.0 6.1 7.6 7.9 9.0 7.9 7.2 8.2 7.2 26.2 28.9 29.5 41.1 45.2 32.0 20.7 13.3 23.3 28.6 15.3 16.5 40.1 14.3 10.5 27.6 35.5 26.6 32.0 18.0 0.0 17.0 39.6 16.7 22.9 29.9 18.7 25.2 45.1 14.7 36.8 23.2 19.9 16.7 22.1 18.0 19.6 14.5 19.8 26.9 54.4 14.6 8.2 21.3 24.2 22.0 27.4 25.3 24.9 71.2 25.7 27.0 53.5 43.2 63.9 15.0 5.9 28.6 37.7 14.1 20.5 4.5 16.3 47.8 26.3 39.3 31.0 58.9 46.2 16.4 43.0 20.0 48.6 16.4 16.5 17.6 TBC1D19 FLJ11082 ENSG00000109680 "TBC1 domain family member 19" Q8N5T2 4 26576437-26756223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 66.9;Excitatory neurons: 106.6;Inhibitory neurons: 95.3;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039592 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nuclear membrane" "HPA039592: AB_10671043" "unprognostic (2.64e-2)" "unprognostic (2.71e-2)" "unprognostic (2.94e-1)" "unprognostic (8.65e-2)" "unprognostic (1.03e-1)" "unprognostic (1.57e-1)" "unprognostic (2.86e-1)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.90e-1)" "unprognostic (3.29e-2)" "unprognostic (4.28e-2)" "prognostic favorable (1.21e-7)" "unprognostic (1.04e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.51e-1)" 3.4 5.8 5.2 2.5 4.5 1.6 4.3 5.3 5.1 7.4 10.7 4.4 1.8 7.6 7.0 2.9 7.7 7.5 5.7 4.2 6.2 17.3 2.9 4.3 2.2 7.1 6.2 8.8 3.0 14.6 5.0 3.8 7.0 5.2 3.0 9.2 3.2 6.3 3.1 2.2 1.7 8.7 4.8 2.8 3.1 4.9 5.7 17.4 7.8 5.0 2.6 4.8 3.0 6.0 2.4 1.9 8.5 5.3 11.5 18.5 2.4 11.1 8.2 4.9 4.8 4.1 5.8 5.6 9.5 15.0 15.2 1.0 4.8 5.6 4.7 1.7 2.2 1.4 6.6 1.2 6.3 3.2 1.4 9.3 4.5 9.4 5.7 19.7 6.7 7.2 5.3 0.0 77.1 0.1 6.3 3.5 3.9 3.2 9.2 4.7 8.4 0.6 18.9 2.5 8.4 3.2 5.3 1.2 5.5 6.9 2.1 1.2 6.5 6.2 1.7 4.7 2.8 1.2 3.1 2.6 22.1 1.7 6.4 1.1 0.5 1.8 4.2 0.6 5.1 1.6 3.2 4.7 0.9 2.0 2.4 2.9 0.0 4.5 0.6 1.7 1.7 1.3 5.2 4.5 5.3 5.1 4.2 6.2 7.1 6.2 7.0 4.8 5.7 6.0 6.0 3.2 4.1 66.9 8.2 3.6 5.3 7.6 7.4 7.4 5.7 5.3 6.4 1.5 2.5 20.2 14.6 4.0 18.1 1.0 5.9 4.8 11.1 15.7 18.9 6.8 9.5 2.1 106.6 3.1 2.2 9.3 6.1 9.0 8.9 9.3 7.1 1.9 1.6 5.0 95.3 2.1 10.2 2.4 2.7 3.1 9.0 2.4 10.6 42.2 0.8 7.4 13.4 102.5 72.4 2.6 0.4 9.1 5.5 1.9 0.6 19.2 17.4 19.3 0.0 9.5 11.1 25.6 8.9 3.1 4.5 1.9 14.4 13.1 1.6 2.3 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084141-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "SK-BR-3: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 8: SK-BR-3 - Unknown function" "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TET1 "bA119F7.1, CXXC6, KIAA1676, LCX" ENSG00000138336 "Tet methylcytosine dioxygenase 1" Q8NFU7 10 68560337-68694487 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9" "Cell type enhanced" "Detected in many" "Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7" "Cancer enriched" "Detected in some" 15 "testis cancer: 10.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019032, HPA057273" Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nuclear membrane" "HPA019032: AB_1847363, HPA057273: AB_2683391" "unprognostic (1.60e-1)" "unprognostic (8.30e-2)" "unprognostic (9.85e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (8.15e-2)" "unprognostic (3.60e-3)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (7.90e-3)" "unprognostic (1.83e-1)" "unprognostic (1.71e-1)" "unprognostic (1.18e-3)" "unprognostic (2.88e-4)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (9.52e-3)" 0.4 0.2 0.6 0.2 1.2 0.3 0.4 4.9 0.7 0.7 0.8 0.4 0.1 0.9 0.6 0.2 0.5 0.3 0.3 0.3 0.9 0.3 0.2 0.2 0.3 0.9 1.3 0.8 0.2 0.7 0.3 1.2 1.1 0.6 0.3 1.5 1.0 0.3 0.9 0.3 0.2 0.5 1.0 0.3 0.4 0.2 1.1 2.0 0.5 0.3 0.3 0.2 0.4 2.2 0.7 0.8 8.0 9.0 0.8 0.7 17.7 0.4 1.0 0.7 1.2 5.5 0.3 0.0 0.3 0.8 0.1 0.0 20.4 0.0 0.8 0.3 3.3 2.1 0.0 4.9 1.2 1.9 1.0 1.0 0.1 0.5 0.1 1.6 0.1 3.5 12.0 1.4 0.7 0.6 3.3 1.4 11.9 0.0 1.1 3.2 2.5 0.2 0.4 0.8 2.2 3.5 0.4 0.5 1.6 7.9 1.0 1.5 0.3 0.7 1.6 0.0 0.6 0.5 0.6 3.2 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.4 0.3 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.6 1.2 4.9 0.7 0.3 0.9 0.9 1.3 1.1 1.0 1.1 2.2 6.3 3.2 6.2 54.5 2.5 1.1 1.8 0.4 5.2 2.5 7.0 9.5 7.2 1.5 2.6 0.0 10.4 21.0 3.0 0.2 0.0 2.7 0.8 3.6 34.2 4.8 13.8 2.5 15.6 0.4 79.9 15.4 1.5 2.9 0.0 13.6 5.7 2.5 3.9 35.3 20.6 0.3 4.1 0.0 0.3 1.7 25.7 0.8 1.8 12.2 0.4 16.1 5.2 44.7 45.3 0.6 0.0 20.7 7.3 1.4 0.0 0.9 0.8 12.5 6.6 21.9 10.7 0.5 1.5 0.8 1.1 27.9 2.6 43.7 0.6 0.4 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354751-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;intestine: 2.5;testis: 5.0" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 9.6;Spermatocytes: 40.5;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 7.7;eosinophil: 10.9;neutrophil: 17.5" "Lineage enriched" "Detected in many" 11 "granulocytes: 17.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA040016 Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.2 1.2 0.2 1.7 0.5 0.1 2.5 2.1 0.1 0.5 0.2 0.8 0.1 0.2 0.2 0.1 0.1 0.4 1.2 1.0 0.3 0.2 0.2 0.4 1.1 1.2 0.3 0.5 0.4 1.2 0.1 1.0 0.2 0.1 0.9 0.3 0.1 0.2 0.1 2.5 0.0 1.1 1.0 0.3 5.0 1.1 1.3 0.1 0.3 0.2 0.1 0.1 1.2 0.8 1.6 1.3 3.5 0.0 0.0 0.5 0.0 0.1 0.3 0.4 1.2 0.2 0.6 0.5 0.1 0.6 0.8 1.3 0.0 0.1 1.1 1.4 0.2 0.9 2.8 0.0 0.5 2.6 0.0 0.1 0.1 0.0 0.0 0.2 1.3 0.9 1.8 0.0 2.1 1.7 1.1 0.7 0.7 0.6 2.5 0.6 2.4 0.0 0.8 3.9 2.4 1.0 1.5 0.6 0.1 2.5 0.8 0.0 0.1 0.6 0.9 0.6 3.7 2.5 0.8 0.0 1.1 0.4 7.7 0.6 10.9 0.0 0.3 0.0 0.4 0.0 0.0 1.0 0.2 0.2 0.0 17.5 0.1 1.5 1.5 0.0 0.2 1.2 1.7 2.5 2.1 1.2 1.0 1.1 1.2 1.0 1.1 1.1 1.2 1.0 0.0 1.1 0.7 4.5 1.5 0.4 0.5 5.7 4.0 1.7 0.9 2.6 0.0 0.3 0.0 0.0 0.4 4.0 0.4 0.0 1.1 4.3 1.0 0.3 0.6 0.0 2.7 0.7 0.6 0.3 0.4 1.1 1.1 0.0 2.9 0.0 0.4 0.3 0.0 1.0 0.6 0.0 0.6 5.7 2.2 0.0 1.3 1.8 1.0 1.9 1.1 0.0 1.0 0.4 0.4 0.1 0.4 3.0 0.8 9.6 0.9 0.6 3.4 0.0 1.2 0.8 40.5 13.5 3.5 1.6 0.8 1.0 0.7 1.1 0.1 TMEM109 MGC5508 ENSG00000110108 "Transmembrane protein 109" Q9BVC6 11 60914158-60923443 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011785 Approved Approved "Nuclear membrane,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 2: Karpas-707 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear membrane, Cytosol" "HPA011785: AB_1858075" "unprognostic (5.23e-2)" "unprognostic (9.02e-2)" "unprognostic (2.46e-2)" "unprognostic (2.69e-2)" "unprognostic (1.23e-1)" "unprognostic (2.40e-2)" "unprognostic (5.29e-3)" "unprognostic (2.95e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.52e-1)" "unprognostic (3.63e-2)" "unprognostic (1.83e-1)" "unprognostic (2.82e-1)" "unprognostic (1.51e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (2.68e-4)" 83.0 46.4 22.2 44.4 23.2 27.0 71.9 23.3 25.5 85.4 42.1 75.1 26.2 97.7 26.7 93.8 73.7 35.7 84.0 19.8 23.2 47.3 32.1 71.8 48.0 26.7 24.5 81.5 46.1 67.3 41.1 46.8 25.4 52.4 27.0 14.3 81.8 60.8 99.4 69.7 47.8 70.0 25.9 58.1 58.2 14.4 25.5 41.4 57.3 77.0 50.3 70.4 79.9 24.7 111.5 103.5 63.3 102.1 169.4 77.7 51.5 107.3 100.4 118.5 99.8 94.5 115.7 131.5 190.4 130.1 69.9 143.5 73.2 48.8 72.5 102.5 97.0 96.2 44.3 21.1 50.2 188.4 77.0 54.1 61.6 92.9 46.8 41.9 148.1 104.8 48.4 330.4 85.4 217.2 139.9 80.8 104.6 62.8 111.4 132.3 123.9 183.0 56.6 63.6 25.3 44.4 86.2 196.8 102.7 44.8 110.4 35.8 143.7 136.9 65.9 174.4 95.8 108.7 89.5 69.9 121.2 82.0 159.7 39.0 76.0 56.4 188.7 69.5 193.3 116.5 108.4 161.4 227.4 140.4 97.4 124.8 8.2 121.1 52.4 470.0 91.1 139.4 22.2 23.2 23.3 25.5 19.8 23.2 26.7 24.5 25.4 25.9 25.5 24.7 118.2 70.5 23.2 5.5 60.2 50.7 43.8 30.9 63.7 13.4 39.5 45.3 34.6 25.8 23.9 25.8 0.0 120.7 83.4 6.8 25.4 76.6 20.7 18.7 25.9 91.2 7.2 33.0 5.3 80.2 116.4 75.9 10.7 27.9 50.7 22.2 71.0 18.9 66.8 30.3 3.8 10.1 22.4 21.3 69.1 11.1 89.5 43.4 51.6 11.2 45.4 30.2 68.0 3.5 5.1 53.1 14.7 97.4 38.4 36.5 10.6 17.1 18.7 34.8 39.5 45.0 67.6 5.9 7.2 55.1 50.6 53.2 52.7 25.8 16.8 33.9 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618628-152680012 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 58.3;skin 1: 58.5" "Cell type enhanced" "Detected in many" "B-cells: 108.6;Basal keratinocytes: 74.2;Glandular and luminal cells: 75.0;granulocytes: 101.2;monocytes: 82.1;Squamous epithelial cells: 119.2;Suprabasal keratinocytes: 194.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 6.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "basophil: 403.7;eosinophil: 305.7;neutrophil: 477.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 477.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 63.0;HMC-1: 71.1;Karpas-707: 55.6;U-266/70: 69.7;U-937: 56.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Nuclear membrane" Nucleoplasm "HPA019184: AB_2670088, HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 3.1 0.5 0.3 17.2 0.7 18.6 4.3 0.6 1.7 5.7 0.5 3.1 2.6 1.6 0.7 58.3 1.4 5.1 0.8 0.4 0.7 0.6 5.9 5.1 14.3 0.8 0.6 0.2 1.0 0.3 0.8 3.8 1.1 2.0 2.6 0.2 6.9 2.3 0.4 58.5 3.6 1.8 0.7 12.4 5.9 0.2 1.0 6.2 3.6 1.9 26.4 11.6 7.9 1.0 32.1 0.1 0.3 0.1 0.5 8.7 14.1 8.0 29.1 8.5 16.2 0.4 4.2 32.5 3.3 7.6 9.3 22.8 0.0 63.0 15.5 0.1 0.1 1.8 0.5 0.0 8.9 25.7 71.1 8.3 29.7 27.1 23.4 0.0 21.4 19.7 0.1 55.6 0.7 2.3 10.1 8.0 1.6 0.1 7.8 1.2 0.1 0.2 47.5 19.4 0.1 1.2 2.2 6.2 1.0 8.4 1.0 17.8 8.6 1.2 5.1 0.7 11.1 69.7 26.0 18.1 11.7 56.6 6.6 403.7 37.8 305.7 4.9 38.2 9.2 51.6 10.9 7.9 19.6 45.1 10.7 7.4 477.5 0.8 43.7 2.5 22.5 17.2 0.3 0.7 0.6 1.7 0.4 0.7 0.8 0.6 1.1 0.7 1.0 1.0 6.5 12.8 19.3 0.0 108.6 74.2 9.0 23.6 20.5 0.1 8.8 4.8 1.7 0.0 20.9 22.0 2.1 25.0 9.8 0.9 0.0 6.4 0.1 31.9 13.4 6.7 1.2 6.6 0.5 3.7 14.5 5.2 8.2 75.0 101.2 0.1 0.7 4.6 4.5 3.3 0.3 0.7 14.2 9.8 15.7 0.2 0.6 28.2 5.4 15.9 82.1 0.1 5.2 3.5 0.1 21.5 7.1 0.0 45.7 5.4 0.0 0.3 60.5 0.7 0.0 3.0 3.6 0.1 0.5 119.2 194.4 25.9 28.6 0.5 2.6 27.2 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Nuclear membrane" "HPA057160: AB_2683356" "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.5 28.2 13.0 8.1 13.3 12.9 17.5 15.7 24.6 14.7 12.2 15.5 8.9 17.3 6.0 14.2 14.9 10.0 19.6 12.9 13.1 16.4 33.5 16.1 16.1 14.6 13.1 12.2 23.3 9.2 30.9 7.4 14.5 19.0 3.6 10.2 21.4 8.7 19.7 17.0 17.5 6.4 11.4 26.1 19.3 13.2 12.7 8.9 21.0 4.5 6.1 16.1 13.5 13.5 4.9 9.5 5.1 7.0 23.7 12.3 11.8 13.0 8.6 7.3 10.8 4.2 20.5 4.0 7.5 12.8 12.8 8.4 4.7 9.5 3.1 9.2 11.9 8.3 14.9 4.3 13.7 4.6 14.8 17.5 11.3 6.4 4.3 5.1 4.6 8.1 8.2 30.0 6.4 16.2 11.3 17.4 3.2 5.8 24.8 7.5 3.1 11.5 7.0 5.0 14.0 12.9 8.6 5.5 7.8 2.5 24.3 11.3 6.6 13.7 3.0 16.8 9.1 23.0 5.9 7.4 13.2 9.4 11.3 36.8 32.2 27.2 20.6 41.1 13.3 19.4 17.3 15.5 29.4 21.6 12.6 17.6 27.8 17.0 39.7 47.1 18.5 21.2 13.0 13.3 15.7 24.6 12.9 13.1 14.6 13.1 14.5 11.4 12.7 13.5 17.0 12.8 8.9 26.8 20.7 6.2 8.1 21.0 12.5 26.8 15.2 14.4 10.4 8.6 17.1 14.7 4.2 24.1 19.2 13.7 1.9 8.8 6.1 11.6 12.2 10.2 16.2 3.0 42.8 11.4 10.1 16.6 17.9 11.3 7.0 10.8 10.8 24.5 15.2 47.1 37.8 9.6 34.6 14.5 9.1 4.0 12.5 15.8 19.6 15.0 9.6 38.6 15.5 25.1 29.1 7.9 16.1 16.1 16.7 6.1 16.6 8.0 13.6 28.7 13.1 10.1 12.3 24.0 14.1 12.3 7.7 18.9 15.3 29.2 7.6 8.4 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588911-9614877 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favorable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 5.8 6.1 8.6 3.6 8.9 7.7 5.2 7.9 9.7 7.5 6.8 5.7 3.2 7.3 2.0 7.0 6.3 2.2 14.5 9.4 8.4 9.5 3.4 4.0 3.2 10.8 9.7 9.4 6.1 4.4 16.0 2.5 9.5 6.4 1.3 6.1 5.5 2.9 43.2 6.4 4.7 2.7 7.9 5.4 4.6 10.4 9.6 3.2 5.5 24.3 2.0 5.2 5.5 8.3 13.6 18.2 11.1 26.3 4.6 3.1 9.9 15.7 4.8 18.3 12.9 33.1 12.0 23.5 19.4 5.5 9.0 27.9 12.4 12.4 6.2 15.7 31.2 16.7 17.4 17.0 8.4 20.4 16.6 5.7 5.5 24.6 3.9 3.9 7.3 10.9 21.7 6.6 7.5 16.0 17.8 14.8 11.2 10.3 16.4 37.1 19.0 19.3 6.6 7.3 26.6 19.9 12.3 29.9 13.5 3.8 9.1 12.7 6.7 21.7 18.8 24.0 30.0 11.0 9.9 21.0 15.0 33.0 19.6 0.0 0.2 0.0 0.3 0.2 0.1 0.5 0.3 0.5 0.3 0.2 0.2 0.2 0.0 0.1 0.1 1.3 0.5 0.3 8.6 8.9 7.9 9.7 9.4 8.4 10.8 9.7 9.5 7.9 9.6 8.3 5.2 3.2 2.0 4.9 2.2 7.0 2.5 1.8 4.6 16.0 5.3 4.7 12.1 2.8 2.1 0.0 27.1 4.1 0.8 2.6 1.9 2.3 2.0 4.2 4.9 4.9 6.7 5.2 4.1 1.0 2.5 4.0 2.6 4.4 4.5 11.7 3.6 1.6 3.6 10.1 6.0 3.7 2.0 2.5 3.5 1.8 4.1 2.4 3.6 0.0 0.9 5.0 1.0 7.1 5.9 1.7 0.9 4.5 2.8 3.2 0.6 1.9 2.4 16.9 0.0 7.3 4.2 6.8 5.4 7.9 5.5 0.8 2.8 4.6 4.3 2.3 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812942-129824244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 20000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: AB_2681382" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 21.2 24.2 14.3 20.7 14.8 34.5 19.6 14.7 17.7 18.6 14.2 20.7 16.6 20.3 19.9 14.3 17.2 20.6 16.8 15.7 15.9 20.5 35.9 19.4 22.9 13.6 14.0 17.2 19.5 19.4 14.3 23.5 14.0 21.3 22.3 9.8 17.0 23.1 16.4 17.8 18.8 25.4 14.1 18.8 18.1 9.2 15.4 26.3 23.8 14.9 19.0 28.6 15.6 14.8 33.7 49.5 35.9 41.5 53.1 51.3 47.4 76.7 94.5 67.0 57.2 32.3 48.2 41.0 44.0 99.7 46.0 77.2 34.7 50.8 54.7 65.7 32.9 36.9 49.8 32.3 66.9 82.1 65.5 69.8 50.7 63.5 45.6 61.5 73.2 65.3 66.5 32.3 74.6 84.3 58.9 79.3 53.8 39.2 55.6 30.5 56.5 41.9 54.9 42.4 27.0 47.6 79.3 30.7 43.3 40.1 61.6 63.4 65.1 66.1 37.7 49.6 59.6 36.6 87.0 37.7 49.0 46.9 54.3 95.5 72.8 141.3 57.4 68.5 48.1 45.5 48.4 52.1 61.4 33.5 40.9 42.4 72.7 68.6 58.3 56.5 59.1 78.9 14.3 14.8 14.7 17.7 15.7 15.9 13.6 14.0 14.0 14.1 15.4 14.8 25.0 9.6 11.8 5.5 17.5 17.6 16.6 39.5 12.0 11.2 16.5 15.9 9.9 18.6 24.4 14.7 2.1 47.9 39.3 18.7 15.6 42.1 0.7 12.5 18.8 24.2 19.2 30.5 6.3 49.9 65.7 25.0 13.7 15.0 22.2 23.4 16.1 22.7 45.2 21.9 6.4 17.8 26.4 19.1 22.4 1.3 12.8 27.9 14.2 3.7 47.6 18.5 35.0 9.5 6.6 40.1 18.9 15.4 23.7 24.7 21.0 17.0 14.9 9.2 32.9 15.2 24.3 7.3 10.1 9.3 18.5 53.4 25.5 23.4 15.4 19.6 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325071-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.4" "Group enriched" "Detected in some" 184 "Early spermatids: 389.3;Late spermatids: 274.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.9" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 1.6 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 18.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 389.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 274.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284949-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "myeloid DC: 86.6" "Group enriched" "Detected in many" 16 "dendritic cells: 86.6;monocytes: 32.0" "Group enriched" "Detected in some" 5 "Hep G2: 29.9;RT4: 48.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.1 0.5 0.1 1.5 0.2 0.1 0.4 0.0 0.3 1.0 0.0 0.1 0.1 0.3 0.3 0.9 0.1 0.1 0.2 0.1 0.0 0.2 0.9 0.2 0.1 0.1 0.2 4.9 0.7 0.0 0.2 21.3 0.7 0.0 2.8 0.2 35.0 0.0 1.3 0.1 0.1 1.1 0.1 0.1 0.1 0.7 2.3 4.5 0.8 48.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 4.6 0.0 0.1 0.0 0.2 0.0 48.9 0.1 0.0 0.2 0.8 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 21.2 0.0 0.0 25.8 0.0 1.2 0.0 0.1 86.6 0.5 0.0 0.0 3.6 0.4 32.0 32.9 0.0 7.4 0.1 0.1 0.1 0.4 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.0 0.0 0.7 1.2 0.1 15.0 0.1 0.0 0.1 4.6 3.6 0.2 2.8 0.1 0.0 0.0 0.0 4.0 3.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.1 3.5 0.0 4.8 8.7 1.7 0.3 6.4 0.0 0.0 22.6 0.8 2.1 0.0 0.0 0.0 9.3 0.0 0.1 54.1 29.8 0.0 0.1 0.0 0.0 1.6 0.5 0.0 0.4 0.0 0.4 0.1 0.2 0.0 4.4 24.5 YEATS4 "GAS41, NuBI-1, YAF9" ENSG00000127337 "YEATS domain containing 4" O95619 12 69359710-69390870 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Spermatocytes: 364.9;Spermatogonia: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072532 Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Nuclear membrane" "HPA072532: AB_2686530" "unprognostic (7.23e-2)" "unprognostic (8.50e-3)" "unprognostic (2.05e-3)" "unprognostic (8.07e-3)" "unprognostic (1.64e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.77e-2)" "unprognostic (3.03e-3)" "unprognostic (1.80e-2)" "unprognostic (6.15e-2)" "unprognostic (2.13e-1)" "unprognostic (7.19e-2)" "unprognostic (8.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" 9.4 11.8 5.6 10.4 6.1 45.8 17.8 9.4 8.2 10.1 9.5 12.3 13.3 10.3 14.9 11.6 12.2 8.3 11.1 6.1 6.2 15.3 14.9 8.9 22.5 6.2 5.9 9.9 17.3 11.1 10.1 10.9 6.3 10.8 13.7 20.1 12.0 9.6 14.3 11.3 13.6 8.4 6.4 10.9 11.0 37.1 5.9 25.9 13.8 19.5 20.4 11.3 9.5 8.0 54.3 27.0 52.1 32.5 11.8 18.9 41.3 32.0 33.7 54.7 45.6 31.1 15.4 108.1 30.5 17.3 28.2 40.8 41.6 32.3 53.2 54.2 45.4 63.0 20.5 37.6 16.5 92.4 53.3 14.0 40.3 29.1 43.1 27.9 31.7 90.1 53.4 127.9 26.8 27.5 130.4 99.8 72.5 36.0 37.6 68.9 49.0 53.6 30.9 47.7 57.6 39.4 33.0 31.4 54.9 32.2 60.5 52.9 18.9 22.5 22.9 63.4 39.4 34.2 44.5 120.2 24.4 43.7 40.1 9.3 13.1 26.4 21.1 19.2 24.0 22.7 29.5 22.2 17.9 21.2 34.8 30.3 6.0 21.6 28.4 14.9 31.8 21.2 5.6 6.1 9.4 8.2 6.1 6.2 6.2 5.9 6.3 6.4 5.9 8.0 14.5 6.4 25.8 11.4 29.0 29.7 36.1 36.3 17.6 25.5 29.5 25.7 23.4 14.3 24.4 11.0 12.5 51.2 24.9 16.8 46.9 31.4 8.0 27.2 10.6 16.3 17.6 50.9 13.6 38.9 58.0 17.4 13.3 19.9 19.0 21.8 12.5 17.0 37.6 18.5 15.5 26.4 22.4 15.1 24.3 14.6 18.6 19.8 12.4 6.5 44.1 26.5 20.6 10.1 18.4 33.2 17.3 24.0 18.3 37.0 23.7 35.2 26.1 28.2 19.7 26.4 18.6 364.9 109.1 26.5 32.0 23.5 33.0 30.7 34.3 34.9 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150322639-150332721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 72.3;parathyroid gland: 25.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4;Exocrine glandular cells: 13.3;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 85.2;K-562: 34.5" "Low region specificity" "Detected in all" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 1: Pancreatic cells - Digestion" "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: AB_2682929" "prognostic favorable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favorable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 1.3 72.3 1.0 5.2 0.8 3.8 2.1 0.6 0.8 3.0 3.1 4.0 3.3 4.3 1.2 3.0 4.1 1.6 1.2 1.1 1.1 5.3 12.1 3.1 6.9 1.1 1.0 6.0 7.2 25.6 5.4 0.8 0.8 3.5 3.1 1.7 2.7 2.1 0.5 3.6 5.0 1.8 0.6 4.9 4.2 1.1 1.2 5.6 4.0 0.2 6.7 2.7 2.1 0.6 8.1 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.3 0.9 10.9 8.4 4.8 4.0 0.1 0.0 3.5 0.0 0.0 0.7 85.2 5.4 6.3 13.3 17.6 2.1 0.0 8.4 1.4 3.9 0.0 0.0 0.3 0.4 16.2 34.5 11.8 0.0 3.3 14.5 2.8 5.3 3.4 0.0 0.0 0.5 10.2 3.2 16.4 15.1 8.4 14.9 3.2 0.5 2.4 1.0 3.6 0.2 0.0 0.0 0.0 0.1 10.0 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.2 0.8 0.5 0.6 0.9 0.2 0.8 0.8 0.8 0.8 0.7 0.0 0.2 0.6 0.7 1.0 0.8 0.6 0.8 1.1 1.1 1.1 1.0 0.8 0.6 1.2 0.6 0.0 0.0 1.5 0.0 0.6 0.3 0.5 1.0 0.0 1.0 1.2 0.9 0.9 2.8 1.6 1.8 8.4 1.5 2.2 2.2 5.9 2.8 0.0 3.1 0.4 0.9 4.8 0.8 0.0 13.3 0.8 0.6 1.5 3.3 1.3 1.3 0.4 3.7 0.6 0.0 0.0 2.4 4.1 1.2 0.0 0.4 2.8 0.7 0.0 0.0 3.4 1.2 3.1 0.0 0.0 13.4 1.2 1.2 0.2 0.4 1.3 0.9 0.6 0.6 0.0 0.9 0.2 0.4 0.9 0.9 0.1 1.9 1.4 1.1 2.3 0.4 ZC3H12C "KIAA1726, MCPIP3" ENSG00000149289 "Zinc finger CCCH-type containing 12C" Q9C0D7 11 110093392-110171841 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 36 "basophil: 5.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 5.9" "Cell line enhanced" "Detected in many" "HSkMC: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038836, HPA038837" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nuclear membrane, Golgi apparatus" "HPA038836: AB_2676229, HPA038837: AB_10675953" "unprognostic (1.22e-1)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (6.96e-3)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "unprognostic (8.91e-3)" "unprognostic (1.30e-2)" "unprognostic (3.20e-1)" "unprognostic (2.34e-2)" "unprognostic (8.90e-2)" "prognostic favorable (9.90e-6)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (8.03e-2)" "unprognostic (1.11e-1)" 4.6 4.2 4.0 2.4 6.7 3.2 2.5 6.5 3.9 4.0 2.7 4.6 1.7 3.7 1.7 3.2 3.2 4.7 4.4 4.2 4.9 3.4 4.0 4.0 1.5 6.8 5.6 6.7 3.5 4.7 3.2 2.6 5.5 3.5 3.7 4.1 2.3 3.3 10.5 5.9 2.6 4.4 4.1 1.8 2.4 3.4 5.4 1.5 8.1 13.2 1.4 5.4 2.1 6.5 6.1 3.6 14.0 0.0 6.4 14.8 2.7 2.3 15.7 4.1 6.8 4.6 5.6 0.1 8.7 7.1 10.3 5.8 2.8 8.5 8.1 23.2 2.0 9.7 4.5 1.7 7.2 0.0 4.4 23.8 8.0 7.2 11.7 8.1 5.8 0.0 0.9 1.3 8.6 0.9 0.0 0.0 2.2 0.1 12.7 0.0 4.9 0.6 4.6 12.4 6.4 11.5 5.6 0.4 10.5 2.7 3.5 3.6 9.8 9.1 4.4 4.8 5.2 0.5 0.0 0.0 5.5 1.7 10.8 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 6.7 6.5 3.9 4.2 4.9 6.8 5.6 5.5 4.1 5.4 6.5 21.1 35.3 8.6 102.2 1.1 47.4 4.8 19.1 7.4 8.8 3.5 5.0 15.5 2.8 9.1 5.5 4.2 1.5 0.2 17.0 0.0 6.1 10.6 8.6 6.7 14.9 8.9 2.1 23.8 3.5 0.5 8.9 5.6 14.1 0.0 5.2 13.6 6.4 10.9 15.2 50.0 8.1 0.0 5.7 39.3 11.8 9.6 9.9 23.2 26.2 3.9 5.6 0.0 52.3 56.1 3.4 15.2 8.2 0.6 21.0 5.7 6.6 8.9 2.7 0.0 9.1 5.7 4.6 0.8 3.2 66.5 0.8 1.1 5.6 8.0 7.8 ZC3H13 "DKFZp434D1812, KIAA0853, Xio" ENSG00000123200 "Zinc finger CCCH-type containing 13" Q5T200 13 45954465-46052759 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 166.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039340, HPA040140, HPA047806" Uncertain Approved "Nuclear membrane,Actin filaments" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear membrane, Actin filaments" "HPA039340: AB_2676454, HPA040140: AB_2676858, HPA047806: AB_2680161" "unprognostic (1.50e-1)" "unprognostic (6.28e-3)" "unprognostic (1.25e-1)" "unprognostic (2.22e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.77e-1)" "unprognostic (1.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.69e-4)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.45e-1)" "unprognostic (9.21e-3)" 15.4 10.1 21.9 13.4 26.9 15.0 15.9 16.9 22.0 14.8 6.7 15.0 9.3 18.5 15.3 10.7 12.0 11.4 11.7 17.4 24.9 12.7 58.6 12.6 15.9 18.4 24.2 17.7 9.4 17.7 9.1 15.5 20.4 15.6 12.3 15.7 12.5 14.3 16.0 13.8 11.7 14.6 17.9 16.4 12.0 11.4 25.2 22.5 17.5 15.8 13.1 12.9 11.0 27.3 16.6 20.9 51.1 19.9 36.0 36.6 21.4 29.9 24.5 24.1 15.9 32.3 28.9 46.4 18.8 31.9 16.6 29.0 32.1 25.0 38.4 41.4 32.5 53.3 21.0 28.2 21.2 68.5 28.3 28.2 20.4 25.5 30.0 22.9 26.6 26.5 29.1 13.8 25.6 21.6 34.8 34.7 46.2 31.7 13.4 34.9 33.1 14.2 19.9 25.4 13.4 30.4 29.6 19.0 166.2 33.6 14.7 32.0 44.7 21.5 19.3 19.6 26.3 13.8 17.2 45.5 24.5 35.9 27.8 15.3 4.6 10.5 7.4 5.7 7.4 5.4 5.2 5.8 4.6 5.1 5.1 4.6 7.7 8.8 6.9 7.9 6.3 3.9 21.9 26.9 16.9 22.0 17.4 24.9 18.4 24.2 20.4 17.9 25.2 27.3 79.1 214.7 186.1 37.5 70.9 40.7 65.6 44.2 34.7 84.6 47.3 63.5 164.0 90.1 89.0 55.2 43.8 88.3 75.8 43.6 27.4 64.5 4.2 67.0 114.7 82.7 55.6 117.6 69.4 48.6 78.6 76.2 29.6 79.8 129.3 64.1 75.7 269.2 63.5 85.8 71.2 42.4 40.7 82.5 31.4 11.8 76.7 66.0 28.4 48.7 90.2 87.1 112.3 55.3 149.5 54.7 38.7 81.6 44.0 60.9 34.4 19.5 83.9 69.2 52.6 120.2 99.4 183.6 106.0 37.7 50.6 80.3 80.8 66.9 49.7 54.5 ZC3HC1 NIPA ENSG00000091732 "Zinc finger C3HC-type containing 1" Q86WB0 7 130018287-130051451 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019089, HPA024023" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA019089: AB_1858976, HPA024023: AB_1858977" "unprognostic (7.14e-3)" "unprognostic (4.07e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.89e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (1.02e-6)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (5.11e-2)" "unprognostic (2.60e-2)" "unprognostic (1.53e-1)" 8.4 12.4 11.2 7.3 11.3 4.7 8.4 10.9 11.4 9.1 11.9 9.5 5.4 9.3 8.6 7.4 8.3 5.7 16.5 11.1 12.1 11.8 14.1 6.3 10.6 11.4 11.5 9.3 7.5 11.6 7.5 8.4 11.4 8.3 7.2 5.8 7.1 7.0 32.7 6.3 7.6 11.5 11.4 12.5 8.7 15.6 12.1 10.4 7.4 29.1 10.6 9.1 7.6 11.8 15.2 24.8 30.3 35.1 17.2 15.5 20.6 19.5 23.5 36.5 36.3 29.7 25.5 34.2 13.7 24.4 48.5 13.4 40.1 29.2 35.0 22.7 34.2 24.1 21.4 29.1 27.7 27.4 22.9 18.4 21.2 38.1 24.2 20.1 39.5 28.9 73.7 11.7 35.5 26.5 33.2 51.9 62.5 26.0 28.0 31.0 23.6 29.5 37.0 10.7 19.3 34.3 27.5 39.4 30.7 42.9 17.3 28.6 17.6 24.2 11.5 20.5 32.8 22.9 36.8 44.7 37.8 34.9 41.2 34.5 24.6 23.8 26.0 29.4 29.5 39.3 26.6 27.5 31.2 37.1 35.2 27.7 2.0 29.5 28.3 18.6 30.8 24.6 11.2 11.3 10.9 11.4 11.1 12.1 11.4 11.5 11.4 11.4 12.1 11.8 5.2 6.4 2.3 12.4 8.8 1.5 5.4 16.0 11.4 6.1 4.3 5.8 13.5 4.3 7.5 7.3 0.0 19.2 4.8 2.3 17.6 12.8 3.3 3.1 5.5 8.6 3.6 5.2 13.8 9.7 16.9 8.1 4.1 2.6 4.5 12.4 11.4 9.1 9.0 6.7 15.7 4.2 16.2 5.0 3.0 5.2 8.7 4.3 1.8 9.4 11.6 6.9 9.2 11.6 12.4 8.9 7.7 6.4 9.1 2.3 2.6 22.1 8.9 5.9 0.0 7.4 8.3 42.0 22.9 5.0 1.7 7.4 7.0 9.4 4.9 2.2 ZNF124 "HZF-16, HZF16" ENSG00000196418 "Zinc finger protein 124" Q15973 1 247121975-247172016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.3;salivary gland: 42.6" "Group enriched" "Detected in many" 16 "Early spermatids: 343.2;Late spermatids: 1250.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031127 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 4: Stomach - Digestion" "Cluster 5: NTERA-2 - Transcription" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA031127: AB_10602685" "unprognostic (3.97e-1)" "unprognostic (3.50e-1)" "unprognostic (2.14e-1)" "unprognostic (2.43e-1)" "unprognostic (2.01e-2)" "unprognostic (2.23e-2)" "unprognostic (4.54e-3)" "unprognostic (1.42e-3)" "unprognostic (1.66e-3)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (3.35e-2)" "unprognostic (5.40e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (2.41e-1)" "prognostic favorable (1.03e-4)" 2.4 2.3 0.9 4.1 2.8 6.0 3.5 14.3 5.2 2.6 0.4 7.0 6.3 4.3 3.9 2.0 2.2 3.5 2.0 2.5 4.4 4.6 3.2 4.0 6.1 2.5 2.9 3.2 3.4 1.5 1.0 4.3 1.9 2.9 6.9 4.8 42.6 2.4 1.8 4.3 5.9 3.5 0.5 5.5 4.4 3.9 3.3 6.7 3.7 1.4 6.3 3.3 1.9 6.6 5.8 4.3 12.0 15.8 4.4 2.5 29.9 5.8 3.5 6.0 6.0 6.5 5.1 11.6 6.8 4.7 4.0 6.2 14.4 4.6 8.6 0.7 3.8 10.0 5.6 14.0 4.3 18.5 11.3 3.5 3.7 5.9 5.7 2.9 8.8 13.4 14.6 8.0 7.5 5.1 18.9 11.8 31.1 11.1 9.9 19.9 9.7 8.2 5.7 17.0 18.5 18.9 8.7 6.7 6.0 14.0 4.8 28.8 10.0 4.5 6.8 5.0 10.7 6.8 9.0 16.8 1.9 18.6 9.6 8.1 7.9 9.2 5.8 9.1 8.2 9.3 7.4 7.1 11.2 5.1 9.9 9.8 1.8 9.5 14.5 8.7 6.2 5.5 0.9 2.8 14.3 5.2 2.5 4.4 2.5 2.9 1.9 0.5 3.3 6.6 8.2 16.0 8.9 5.5 14.9 3.6 5.8 10.2 6.2 3.7 4.1 6.5 4.6 7.2 11.2 3.7 4.2 3.6 13.8 8.6 1.9 5.3 343.2 7.2 6.8 8.9 7.8 5.5 13.5 5.0 6.6 4.5 13.3 7.9 11.4 10.7 3.3 0.7 7.9 0.0 47.8 5.1 12.2 26.8 5.3 1250.3 12.2 16.7 7.2 18.7 10.5 2.3 5.2 25.6 12.7 5.0 10.6 12.0 9.3 6.8 7.7 6.2 4.5 5.6 6.6 9.3 5.1 8.8 12.3 3.7 1.6 1.4 10.6 4.7 9.0 5.5 ZNF224 "BMZF-2, KOX22, ZNF255, ZNF27" ENSG00000267680 "Zinc finger protein 224" Q9NZL3 19 44094339-44109886 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054045 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear membrane" Nucleoplasm "HPA054045: AB_2682354" "unprognostic (1.01e-3)" "unprognostic (4.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.40e-3)" "unprognostic (8.47e-2)" "unprognostic (4.25e-4)" "unprognostic (9.61e-2)" "unprognostic (6.35e-3)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.81e-3)" "unprognostic (2.64e-2)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.68e-1)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.53e-7)" 15.5 15.4 12.5 17.6 14.2 9.6 17.0 15.9 13.9 16.2 16.0 15.0 18.1 17.8 23.1 9.4 16.1 13.8 12.5 12.3 13.3 14.3 15.8 16.3 22.4 13.1 13.2 20.6 14.7 14.1 19.5 14.8 13.7 17.1 21.2 17.8 15.6 15.7 7.5 24.6 22.2 13.3 12.6 27.2 16.0 6.4 13.4 18.3 19.8 5.9 22.6 12.7 13.0 16.7 8.5 13.9 14.7 12.1 14.4 15.0 12.0 10.5 15.6 7.1 16.2 7.0 6.6 10.2 11.3 13.9 5.4 9.5 8.1 9.0 9.4 10.5 16.4 19.7 26.5 7.3 7.6 14.3 22.0 18.6 16.0 8.8 13.1 22.6 13.1 10.1 6.1 12.0 12.0 2.2 12.6 17.2 6.4 4.7 9.5 7.4 15.9 6.3 10.8 26.9 7.5 17.1 14.4 6.2 5.0 14.4 6.1 18.5 13.8 15.7 10.1 7.1 7.4 16.2 16.3 5.8 8.4 11.0 7.4 49.6 9.1 22.0 18.4 6.3 20.3 16.9 15.5 18.7 9.7 17.8 19.5 15.1 6.9 16.7 13.7 8.7 19.5 10.4 12.5 14.2 15.9 13.9 12.3 13.3 13.1 13.2 13.7 12.6 13.4 16.7 16.0 22.4 14.6 16.3 26.2 5.6 7.3 14.7 10.8 26.8 9.1 5.7 4.7 18.6 11.3 25.8 18.8 13.1 30.4 14.5 1.9 8.1 14.5 7.9 9.9 12.2 9.6 12.0 26.2 5.3 8.1 12.4 8.6 8.2 21.0 20.5 16.1 7.6 7.3 26.9 23.4 11.2 20.3 13.9 8.9 4.4 16.1 10.4 5.4 14.0 19.8 11.8 47.4 14.1 29.0 8.6 13.3 13.9 12.1 10.4 29.8 3.3 7.4 22.1 13.1 10.9 9.3 5.4 4.1 6.8 6.8 8.2 27.3 19.9 11.0 9.3 ZNF292 "bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16" ENSG00000188994 "Zinc finger protein 292" O60281 6 87152833-87265943 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032154, HPA050618" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear membrane" "HPA032154: AB_10601930, HPA050618: AB_2681190" "unprognostic (6.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (2.08e-3)" "unprognostic (2.28e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" "unprognostic (8.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.06e-2)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.02e-1)" "unprognostic (7.36e-2)" 6.8 6.3 4.4 7.8 4.6 25.4 9.6 17.8 8.7 8.7 1.8 7.3 7.9 10.3 9.5 6.6 6.2 6.7 6.2 3.9 3.1 6.3 6.4 5.7 10.9 3.2 2.5 13.7 6.9 13.8 8.5 8.8 3.8 8.2 6.8 26.4 8.3 7.2 5.5 8.6 8.8 6.4 2.2 8.0 8.1 6.2 3.7 14.3 9.6 5.6 9.1 7.1 7.3 10.3 8.3 4.7 16.1 14.2 9.0 8.1 16.8 6.4 8.1 7.4 10.1 8.2 5.7 12.8 9.0 8.4 10.4 8.4 10.1 9.6 15.9 29.3 7.6 17.3 6.4 6.8 6.7 14.0 7.6 8.1 9.2 7.3 9.4 11.8 6.9 13.6 12.8 19.1 8.1 4.6 8.1 12.0 8.1 2.9 4.4 16.9 15.9 4.9 6.2 17.8 11.9 16.8 8.0 5.3 6.1 9.2 5.4 16.0 7.8 9.8 6.8 7.2 10.1 17.5 12.3 8.6 10.8 11.8 7.2 60.3 16.9 20.0 15.7 5.4 14.8 46.6 16.8 17.3 8.0 42.8 18.7 16.1 83.6 11.2 5.7 25.0 18.3 8.3 4.4 4.6 17.8 8.7 3.9 3.1 3.2 2.5 3.8 2.2 3.7 10.3 64.2 60.9 72.4 147.2 99.0 66.2 31.2 46.1 70.0 167.7 48.0 47.9 76.8 48.6 51.8 25.8 123.0 27.0 89.9 64.9 9.8 122.3 44.4 119.3 89.6 55.6 47.3 43.5 176.6 38.5 36.6 52.3 66.3 203.1 29.1 135.6 40.0 19.0 26.8 186.7 225.7 52.7 40.7 29.2 53.1 12.4 60.0 46.3 32.0 124.6 53.0 62.5 65.9 210.6 209.8 52.2 49.5 66.2 90.8 49.4 72.5 14.5 50.1 99.4 32.9 84.6 59.5 56.3 34.1 36.7 51.4 211.8 90.8 66.8 44.5 58.5 ZNF383 "FLJ35863, Zfp383" ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" No No "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "HPA063945: AB_2685158" "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favorable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favorable (3.71e-4)" 3.6 3.2 2.5 3.4 4.4 3.5 5.1 8.5 3.4 4.1 1.5 3.3 3.5 3.8 3.6 3.6 3.7 2.9 4.9 2.7 3.5 4.4 3.2 3.5 6.1 3.7 3.1 5.8 2.9 4.4 2.8 3.2 3.8 4.1 3.5 5.4 4.0 3.9 7.4 5.4 3.4 3.8 2.0 5.1 3.9 3.9 3.7 5.7 5.3 9.0 6.0 3.4 3.4 7.1 2.9 6.8 4.6 7.1 5.7 5.8 3.1 4.1 5.6 4.0 5.9 3.1 3.6 4.0 5.9 3.9 3.8 3.0 3.6 5.5 5.9 5.4 4.2 5.7 5.2 2.6 6.1 6.9 6.2 7.1 4.6 3.9 7.6 5.1 3.7 5.5 3.2 2.1 5.0 1.4 6.3 3.2 4.2 5.8 1.9 4.4 8.4 3.7 3.6 8.2 5.2 4.1 6.6 3.8 5.7 5.8 4.6 4.1 2.3 5.0 3.5 3.7 4.0 6.5 6.4 7.9 0.7 3.2 4.7 3.7 3.2 5.3 5.8 3.9 8.2 8.0 5.4 7.1 3.3 10.7 8.6 6.9 3.5 4.8 4.9 3.1 6.0 3.9 2.5 4.4 8.5 3.4 2.7 3.5 3.7 3.1 3.8 2.0 3.7 7.1 7.2 3.2 4.4 7.5 10.2 2.7 4.0 3.4 5.7 9.8 3.7 5.2 12.8 7.2 2.5 1.8 14.6 3.8 7.5 3.8 1.9 3.5 8.9 3.6 5.4 5.1 2.4 11.0 7.4 3.6 4.8 5.8 4.6 3.7 5.7 7.8 6.4 2.2 3.8 15.2 8.7 3.8 2.0 6.3 3.5 3.0 6.5 4.5 8.8 4.7 5.5 6.2 10.3 9.5 10.4 2.7 3.6 7.5 3.8 5.1 5.8 3.9 2.5 9.9 13.1 9.9 6.1 5.8 5.2 3.9 3.3 4.9 8.5 6.6 4.8 4.1 ZNF398 "KIAA1339, P51, P71, ZER6" ENSG00000197024 "Zinc finger protein 398" Q8TD17 7 149126416-149183042 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 32.3;Inhibitory neurons: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NTERA-2: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073151 Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear membrane" "HPA073151: " "unprognostic (4.11e-1)" "unprognostic (8.56e-2)" "unprognostic (3.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (6.65e-3)" "unprognostic (2.94e-3)" "unprognostic (2.27e-2)" "unprognostic (3.64e-3)" "unprognostic (1.43e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (1.45e-1)" "unprognostic (3.97e-2)" "unprognostic (9.27e-2)" "unprognostic (9.17e-2)" "unprognostic (1.89e-1)" 3.9 3.3 1.6 3.6 1.8 7.6 4.4 6.3 3.7 4.9 0.6 4.4 3.7 4.1 4.3 6.4 4.3 3.0 3.3 1.6 2.2 3.5 3.6 3.8 4.7 0.1 0.4 4.4 4.5 5.0 4.9 3.8 0.2 4.8 3.6 7.6 4.8 5.1 4.4 6.8 3.7 4.0 0.0 4.5 4.5 8.5 1.8 5.3 3.6 4.5 5.6 4.8 5.0 2.5 9.8 9.5 7.1 13.8 10.4 7.4 8.4 5.8 8.6 7.3 8.2 7.9 5.0 12.5 6.8 10.6 6.5 8.0 12.0 8.2 5.3 7.3 14.4 8.3 7.2 5.3 7.3 9.8 8.1 8.3 12.1 8.2 8.4 5.4 5.2 4.9 11.9 4.7 8.3 13.9 13.6 10.3 47.1 9.4 8.9 10.3 7.9 9.1 5.7 19.0 9.8 10.9 9.2 11.2 5.7 7.7 6.8 10.6 6.2 7.4 1.9 13.3 7.6 12.7 6.6 9.6 9.6 8.0 7.4 2.4 0.6 2.3 1.1 0.7 1.4 1.0 0.8 1.2 0.5 0.8 1.2 1.3 1.2 0.7 0.6 0.7 1.1 0.4 1.6 1.8 6.3 3.7 1.6 2.2 0.1 0.4 0.2 0.0 1.8 2.5 3.9 6.4 4.6 19.2 6.6 7.8 4.5 4.0 5.7 8.8 5.6 3.7 5.9 0.0 5.5 5.5 6.2 4.2 7.7 4.4 0.0 3.9 23.5 7.0 8.6 5.9 1.8 8.6 32.3 2.8 4.9 5.1 12.2 7.5 4.5 7.1 3.9 2.8 3.7 3.3 31.3 3.7 2.0 5.0 3.3 25.2 7.2 3.9 8.8 21.5 4.8 4.5 3.1 20.6 28.6 4.6 2.1 9.1 10.9 6.6 3.8 3.1 6.9 11.6 0.0 6.4 4.5 21.4 13.5 10.1 8.5 3.1 5.2 4.7 3.8 9.9 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345944-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell type enhanced" "Detected in many" "Adipocytes: 7.7;Granulosa cells: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 5.5" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: AB_2682138" "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 1.6 1.0 2.5 1.0 4.3 0.5 1.7 3.4 2.3 1.8 5.7 1.1 0.6 1.9 1.1 0.9 2.1 0.6 1.2 2.0 4.5 2.1 2.0 1.2 1.3 10.0 6.0 4.9 1.7 1.3 0.9 1.0 7.7 1.7 1.3 1.2 0.9 2.1 0.8 1.3 0.8 1.6 3.9 1.7 0.9 1.3 6.1 1.2 2.0 1.5 1.0 1.8 1.5 5.3 0.2 0.0 1.7 2.2 1.0 0.5 0.1 2.3 0.6 2.0 1.6 1.6 0.5 2.0 0.7 1.2 0.8 0.4 1.4 1.1 1.9 0.0 0.2 0.1 3.2 1.5 0.8 0.0 1.9 0.9 1.2 0.8 0.3 0.1 0.2 1.4 2.9 0.2 1.8 1.5 2.4 0.3 1.4 0.3 1.0 0.1 2.5 0.1 0.8 1.3 0.1 0.4 0.0 0.0 0.0 1.9 2.2 1.5 0.0 2.6 1.3 3.3 1.4 2.0 5.5 0.0 0.1 0.0 1.0 0.5 0.3 2.2 0.8 0.5 0.5 2.5 0.5 0.5 0.5 0.4 1.3 0.8 0.6 0.4 0.4 0.5 0.0 0.3 2.5 4.3 3.4 2.3 2.0 4.5 10.0 6.0 7.7 3.9 6.1 5.3 7.7 0.0 2.6 1.0 2.4 0.4 1.1 2.2 1.8 1.6 1.9 1.9 2.8 1.5 0.6 1.8 6.2 0.4 1.6 0.7 1.9 0.9 1.0 0.9 1.6 3.2 1.2 0.4 0.9 0.9 0.4 2.5 0.0 1.2 2.5 7.0 3.6 1.6 1.5 0.0 1.5 0.7 2.0 2.4 0.6 0.5 0.6 1.5 3.6 1.9 1.6 2.2 3.1 0.5 1.3 0.2 0.1 0.4 2.7 0.8 0.3 3.7 1.8 1.7 0.0 4.8 3.9 2.4 2.5 1.2 0.6 0.4 1.3 0.6 0.5 0.6 ZNF474 "4933409D10Rik, FLJ32921" ENSG00000164185 "Zinc finger protein 474" Q6S9Z5 5 122129546-122153569 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.2;choroid plexus: 7.1;fallopian tube: 17.1;testis: 7.6" "Group enriched" "Detected in some" 5 "Early spermatids: 23.0;Endometrial ciliated cells: 23.2;Late spermatids: 12.4;Respiratory ciliated cells: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.0;CAPAN-2: 1.1;GAMG: 1.3;TIME: 1.2" "Low region specificity" "Detected in many" HPA036594 Approved "Nuclear membrane,Plasma membrane" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane" "Plasma membrane" "HPA036594: " "unprognostic (9.98e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (5.90e-3)" "unprognostic (7.82e-2)" "unprognostic (2.49e-2)" "unprognostic (3.94e-2)" "unprognostic (7.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (1.51e-3)" "unprognostic (1.12e-3)" "unprognostic (9.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.09e-4)" 0.2 0.1 0.6 0.1 0.7 0.0 0.2 0.5 0.3 0.6 7.1 0.3 0.1 0.7 0.0 0.4 17.1 0.5 0.1 0.6 1.2 0.3 0.1 1.7 0.0 2.2 4.2 0.2 0.1 0.0 0.2 0.0 2.0 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 1.7 0.1 0.1 7.6 1.2 0.3 0.9 0.1 0.1 0.1 0.1 1.9 0.0 0.4 0.1 0.0 0.2 0.1 0.0 1.0 0.2 0.1 0.0 0.0 1.1 0.0 0.0 0.7 1.3 0.2 0.0 0.0 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.3 0.0 0.1 0.5 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.1 0.1 1.2 0.3 0.2 0.7 0.2 0.1 0.2 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.5 0.3 0.6 1.2 2.2 4.2 2.0 1.7 1.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.0 23.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.0 0.0 0.0 0.1 0.6 2.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ZNF749 FLJ16360 ENSG00000186230 "Zinc finger protein 749" O43361 19 57435325-57447101 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 27.9;Excitatory neurons: 24.2;Inhibitory neurons: 21.1;Melanocytes: 23.2;Oligodendrocyte precursor cells: 18.1;Squamous epithelial cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 24.0" "HPA042082, HPA042091, HPA056001" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear membrane" "HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005" "unprognostic (2.54e-1)" "unprognostic (1.55e-1)" "unprognostic (6.67e-2)" "unprognostic (9.92e-2)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.87e-1)" "unprognostic (8.23e-2)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (9.27e-3)" "unprognostic (2.76e-2)" "unprognostic (3.05e-5)" "unprognostic (1.35e-1)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-1)" 1.3 1.2 1.6 1.8 1.4 1.4 1.7 3.6 1.5 1.1 1.0 1.0 1.5 1.3 0.9 1.4 1.6 0.9 1.0 1.6 1.2 1.1 1.6 1.0 1.8 0.8 1.1 1.7 1.1 1.5 1.1 1.3 1.1 1.2 0.9 4.0 1.5 0.9 1.3 2.2 1.2 1.1 0.3 1.6 1.2 1.3 1.2 1.9 1.3 0.4 1.6 1.3 1.3 1.7 2.8 6.2 5.5 5.9 1.3 1.3 2.3 1.6 1.1 2.6 4.6 2.5 2.0 5.4 1.5 1.6 1.9 2.1 4.9 4.2 3.8 2.3 24.0 4.6 6.5 3.0 1.9 5.6 3.0 1.9 4.6 3.1 7.7 2.5 1.3 5.6 4.7 6.4 2.0 1.3 6.6 2.4 5.6 1.8 8.8 6.9 7.8 4.2 1.4 6.5 5.7 4.7 3.2 2.0 1.5 4.2 2.9 1.8 1.5 5.0 3.7 1.7 4.8 5.0 6.8 5.8 2.8 2.4 3.2 0.2 0.4 0.1 0.6 0.9 0.9 0.9 1.1 0.8 1.1 0.8 1.2 0.8 0.2 0.6 0.4 0.5 0.8 0.8 1.6 1.4 3.6 1.5 1.6 1.2 0.8 1.1 1.1 0.3 1.2 1.7 1.1 3.2 1.1 7.2 6.7 2.4 1.3 2.9 27.9 1.2 4.0 2.9 0.5 7.2 3.2 0.0 0.0 0.9 2.3 0.4 3.9 1.1 1.0 7.1 1.4 2.3 3.0 8.8 24.2 0.4 0.6 2.5 10.7 3.5 0.0 1.2 1.1 4.0 0.8 3.3 21.1 1.7 2.0 0.8 1.6 0.1 0.6 1.9 23.2 5.6 0.7 0.2 0.0 18.1 10.6 0.8 0.3 0.0 11.6 0.9 3.8 8.1 3.4 0.8 6.6 1.8 2.0 1.2 1.8 35.9 3.1 0.8 4.3 0.3 1.1 1.1